Reaxys
PubChem
eMolecules
Reactions (1179)
Substances (24)
Citations (747)
Structure
Structure/Compound Data Chemical Name: 5-methoxytryptamine Reaxys Registry Number: 145587
CAS Registry Number: 608-07-1 Type of Substance: heterocyclic Molecular Formula: C11H14N2O Linear Structure Formula: NH2CH2CH2(NC8H5)OCH3
Molecular Weight: 190.245
InChI Key: JTEJPPKMYBDEMY-UHFFFAOYSA-N
1
N° of preparations All Preps | All Reactions 45 prep out of 1031 reactions.
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine, 2-(5-methoxyindol-3-yl)ethylamine Identification Substance Label (61) Label
Reference
5
Haefelinger, Guenter; Nimtz, Manfred; Horstmann, Volker; Benz, Thomas
Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1999 , vol. 54, # 3 p. 397 - 414 Title/Abstract Full Text View citing articles Show Details
Aubriot, Silvere; Nicolle, Edwige; Lattier, Mireille; Morel, Cecile; Cao, Wenhong; Daniel, Kiefer W.; Collins, Sheila; Leclerc, Gerard; Faure, Patrice
Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 2 p. 209 - 212 Title/Abstract Full Text View citing articles Show Details
Sun Yat-Sen University; Pi, Rongbiao; Yang, Xiaohong; Liu, Xingguo; Chen, Ziwei; Wang, Shengnan
Patent: CN105906608 A, 2016 ; Title/Abstract Full Text Show Details
Available Data
N° of ref.
Identification Physical Data (52) Spectra (91) Bioactivity (241) Other Data (6)
639
4
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
Faulkner, Katherine C.; Hurley, Katherine A.; Weibel, Douglas B.
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 22 p. 5539 - 5544 Title/Abstract Full Text Show Details
3b
Klochkov; Afanas'Eva; Bulychev, Yu. N.; Neganova; Shevtsova
Russian Chemical Bulletin, 2012 , vol. 61, # 2 p. 409 - 415 Title/Abstract Full Text View citing articles Show Details
Ionescu, Alexandra; Cornut, Damien; Soriano, Sebastien; Guissart, Celine; Van Antwerpen, Pierre; Jabin, Ivan
Tetrahedron Letters, 2013 , vol. 54, # 45 p. 6087 - 6089 Title/Abstract Full Text View citing articles Show Details
Sawant, Rajiv T.; Stevens, Marc Y.; Sköld, Christian; Odell, Luke R.
Organic Letters, 2016 , vol. 18, # 20 p. 5392 - 5395 Title/Abstract Full Text Show Details
2e
Zhu, Yan-Ping; Liu, Mei-Cai; Cai, Qun; Jia, Feng-Cheng; Wu, An-Xin
Chemistry - A European Journal, 2013 , vol. 19, # 31 p. 10132 - 10137 Title/Abstract Full Text View citing articles Show Details
Shmatova, Olga I.; Khrustalev, Victor N.; Nenajdenko, Valentine G.
Organic Letters, 2016 , vol. 18, # 18 p. 4494 - 4497 Title/Abstract Full Text Show Details
1
Zhao, Fei; Dai, Jiang-Kun; Liu, Dan; Wang, Shi-Jun; Wang, Jun-Ru
Molecules, 2016 , vol. 21, # 3 art. no. 390 Title/Abstract Full Text View citing articles Show Details
Benchekroun, Mohamed; Romero, Alejandro; Egea, Javier; León, Rafael; Michalska, Patrycja; Buendía, Izaskun; Jimeno, María Luisa; Jun, Daniel; Janockova, Jana; Sepsova, Vendula; Soukup, Ondrej; Bautista-Aguilera, Oscar M.; Refouvelet, Bernard; Ouari, Olivier; Marco-Contelles, José; Ismaili, Lhassane
Journal of Medicinal Chemistry, 2016 , vol. 59, # 21 p. 9967 - 9973 Title/Abstract Full Text Show Details
1l
Wang, Jin; Wang, Zhi-Min; Li, Xue-Mei; Li, Fan; Wu, Jia-Jia; Kong, Ling-Yi; Wang, Xiao-Bing
Bioorganic and Medicinal Chemistry, 2016 , vol. 24, # 18 p. 4324 - 4338 Title/Abstract Full Text View citing articles Show Details
11b
Yokoo, Hidetomo; Ohsaki, Ayumi; Kagechika, Hiroyuki; Hirano, Tomoya
Tetrahedron, 2016 , vol. 72, # 39 p. 5872 - 5879 Title/Abstract Full Text Show Details
14b
Zhao, Gaoyuan; Xie, Xingang; Sun, Haiyu; Yuan, Ziyun; Zhong, Zhuliang; Tang, Shouchu; She, Xuegong
Organic Letters, 2016 , vol. 18, # 10 p. 2447 - 2450 Title/Abstract Full Text View citing articles Show Details
5methoxytryptamine
NATIONAL HEALTH RESEARCH INSTITUTES; KUO, Cheng-Chin; WU, Kenneth Kun-Yu
Patent: WO2016/115188 A1, 2016 ; Title/Abstract Full Text Show Details
2
Chu, Lin; Lo, Jane-Ling; Yang, Yi-Tien; Cheng, Kang; Smith, Roy G.; Fisher, Michael H.; Wyvratt, Matthew J.; Goulet, Mark T.
Bioorganic and Medicinal Chemistry Letters, 2001 , vol. 11, # 4 p. 515 - 517 Title/Abstract Full Text View citing articles Show Details
Wu, Tom Y. H.; Schulte, Peter G.
Organic Letters, 2002 , vol. 4, # 23 p. 4033 - 4035 Title/Abstract Full Text View citing articles Show Details
Aziz, Jessy; Brion, Jean-Daniel; Hamze, Abdallah; Alami, Mouad
Advanced Synthesis and Catalysis, 2013 , vol. 355, # 11-12 p. 2417 - 2429 Title/Abstract Full Text View citing articles Show Details
Luo, Xiao-Ting; Wang, Chun-Ming; Liu, Yun; Huang, Zhen-Guang
European Journal of Medicinal Chemistry, 2015 , vol. 103, p. 302 - 311 Title/Abstract Full Text View citing articles Show Details
Sosi, Izidor; Anderluh, Marko; Sova, Matej; Gobec, Martina; Mlinari Raan, Irena; Derouaux, Adeline; Amoroso, Ana; Terrak, Mohammed; Breukink, Eefjan; Gobec, Stanislav
Journal of Medicinal Chemistry, 2015 , vol. 58, # 24 p. 9712 - 9721 Title/Abstract Full Text View citing articles Show Details
1b
Mumford, Peter M.; Shiers, Jason J.; Tarver, Gary J.; Hayes, Jerome F.; Shipman, Michael
Tetrahedron Letters, 2008 , vol. 49, # 21 p. 3489 - 3491 Title/Abstract Full Text View citing articles Show Details
Li, Zeng; Li, Jing; Yang, Nan; Chen, Ying; Zhou, Yu; Ji, Xun; Zhang, Lei; Wang, Jinfang; Xie, Xin; Liu, Hong
Journal of Organic Chemistry, 2013 , vol. 78, # 21 p. 10802 - 10811 Title/Abstract Full Text View citing articles Show Details
Danda, Adithi; Kumar, Kamal; Waldmann, Herbert
Chemical Communications, 2015 , vol. 51, # 35 p. 7536 - 7539 Title/Abstract Full Text View citing articles Show Details
7b
Bartolucci, Silvia; Mari, Michele; Bedini, Annalida; Piersanti, Giovanni; Spadoni, Gilberto
Journal of Organic Chemistry, 2015 , vol. 80, # 6 p. 3217 - 3222
Title/Abstract Full Text View citing articles Show Details
6a;33
Wang, Shengzheng; Fang, Kun; Dong, Guoqiang; Chen, Shuqiang; Liu, Na; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan
Journal of Medicinal Chemistry, 2015 , vol. 58, # 16 p. 6678 - 6696 Title/Abstract Full Text View citing articles Show Details
351
Oda, Shingo; Fujiwara, Ryoichi; Kutsuno, Yuki; Fukami, Tatsuki; Itoh, Tomoo; Yokoi, Tsuyoshi; Nakajima, Miki
Drug Metabolism and Disposition, 2015 , vol. 43, # 6 p. 812 - 818 Title/Abstract Full Text View citing articles Show Details
6
Prabhakar; Kumar, N. Vasanth; Reddy, M. Ravikanth; Sarma; Reddy, G. Om
Organic Process Research and Development, 1999 , vol. 3, # 3 p. 155 - 160 Title/Abstract Full Text View citing articles Show Details
Abd Razik, Basma M.; Osman, Hasnah; Basiri, Alireza; Salhin, Abdussalam; Kia, Yalda; Ezzat, Mohammed Oday; Murugaiyah, Vikneswaran
Bioorganic Chemistry, 2014 , vol. 57, p. 162 - 168 Title/Abstract Full Text View citing articles Show Details
2b
Beasley, Benjamin O.; Alli-Balogun, Abimbola; Clarkson, Guy J.; Shipman, Michael
Tetrahedron Letters, 2014 , vol. 55, # 2 p. 541 - 543 Title/Abstract Full Text View citing articles Show Details
SI12
Nelson, Hosea M.; Reisberg, Solomon H.; Shunatona, Hunter P.; Patel, Jigar S.; Toste, F. Dean
Angewandte Chemie - International Edition, 2014 , vol. 53, # 22 p. 5600 - 5603 Angew. Chem., 2014 , vol. 126, # 22 p. 5706 - 5709,4 Title/Abstract Full Text View citing articles Show Details
4k
Blough, Bruce E.; Landavazo, Antonio; Partilla, John S.; Decker, Ann M.; Page, Kevin M.; Baumann, Michael H.; Rothman, Richard B.
Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 19 p. 4754 - 4758 Title/Abstract Full Text View citing articles Show Details
1d
Desroses, Matthieu; Koolmeister, Tobias; Jacques, Sylvain; Llona-Minguez, Sabin; Jacques-Cordonnier, Marie-Caroline; Cazares-Koerner, Armando; Helleday, Thomas; Scobie, Martin
Tetrahedron Letters, 2013 , vol. 54, # 27 p. 3554 - 3557 Title/Abstract Full Text View citing articles Show Details
21b
Mori, Mattia; Tintori, Cristina; Christopher, Robert Selwyne Arul; Radi, Marco; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, Patrizia; DelleMonache, Simona; Angelucci, Adriano; Kissova, Miroslava; Crespan, Emmanuele; Maga, Giovanni; Botta, Maurizio
ChemMedChem, 2013 , vol. 8, # 3 p. 484 - 496 Title/Abstract Full Text View citing articles Show Details
Show next 20
Hide facts
Label
Reference
1e
Liu, Song; Scotti, John S.; Kozmin, Sergey A.
Journal of Organic Chemistry, 2013 , vol. 78, # 17 p. 8645 - 8654 Title/Abstract Full Text View citing articles Show Details
11
Adams, David; Benardeau, Agnes; Bickerdike, Mike J.; Bentley, Jon M.; Bissantz, Caterina; Bourson, Anne; Cliffe, Ian A.; Hebeisen, Paul; Kennett, Guy A.; Knight, Antony R.; Malcolm, Craig S.; Mizrahi, Jacques; Plancher, Jean-Marc; Richter, Hans; Roever, Stephan; Taylor, Sven; Vickers, Steven P.
Chimia, 2004 , vol. 58, # 9 p. 613 - 620 Title/Abstract Full Text View citing articles Show Details
Iskander, Magdy N.; Leung, Lok M.; Buley, Trevor; Ayad, Fadi; Di Iulio, Juliana; Tan, Yean Y.; Coupar, Ian M.
European Journal of Medicinal Chemistry, 2006 , vol. 41, # 1 p. 16 - 26 Title/Abstract Full Text View citing articles Show Details
Peshkov, Vsevolod A.; Pereshivko, Olga P.; Der Eycken, Erik V. Van
Advanced Synthesis and Catalysis, 2012 , vol. 354, # 14-15 p. 2841 - 2848 Title/Abstract Full Text View citing articles Show Details
4g
Dong, Guoqiang; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Yongqiang; Guo, Zizhao; Zhang, Wannian; Sheng, Chunquan
Journal of Medicinal Chemistry, 2012 , vol. 55, # 17 p. 7593 - 7613 Title/Abstract Full Text View citing articles Show Details
4b
Sanaboina, Chakrapani; Jana, Samaresh; Chidara, Sridhar; Patro, Balaram; Raolji, Gajendrasinh Balvantsinh; Eppakayala, Laxminarayana
Tetrahedron Letters, 2012 , vol. 53, # 37 p. 5027 - 5029,3 Title/Abstract Full Text Show Details
G
HERCULES TECHNOLOGY MANAGEMENT CO V, INC.; BLAGG, Julian
Patent: WO2011/47156 A1, 2011 ; Title/Abstract Full Text Show Details
5-MT
Bayari; Ide
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2003 , vol. 59, # 6 p. 1255 - 1263 Title/Abstract Full Text View citing articles Show Details
Ostrom, Rennolds S.; Ehlert, Frederick J.
Journal of Pharmacology and Experimental Therapeutics, 1997 , vol. 280, # 1 p. 189 - 199 Title/Abstract Full Text View citing articles Show Details
Sogawa; Tagawa; Fujino; Ohyama; Asanuma; Funada; Kitayama
Toxicology Letters, 2007 , vol. 170, # 1 p. 75 - 82 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
5-MeOT
Pan, Hui; Galligan, James J.
European Journal of Pharmacology, 1995 , vol. 278, # 1 p. 67 - 74 Title/Abstract Full Text View citing articles Show Details
Ramirez; Garcia-Garayoa; Romero; Monge; Roca; Del Rio; Lasheras
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 1 p. 58 - 65 Title/Abstract Full Text View citing articles Show Details
Adham, Nika; Zgombick, John M.; Bard, Jonathan
Journal of Pharmacology and Experimental Therapeutics, 1998 , vol. 287, # 2 p. 508 - 514 Title/Abstract Full Text View citing articles Show Details
Leung; Walsh; Pulido-Rios; Eglen
British Journal of Pharmacology, 1996 , vol. 117, # 5 p. 926 - 930 Title/Abstract Full Text View citing articles Show Details
Leung; Blissard; Jett; Eglen
Naunyn-Schmiedeberg's Archives of Pharmacology, 1995 , vol. 351, # 6 p. 596 - 602 Title/Abstract Full Text View citing articles Show Details
Ge, Jian; Barnes, Nicholas M.
British Journal of Pharmacology, 1996 , vol. 117, # 7 p. 1475 - 1480 Title/Abstract Full Text View citing articles Show Details
El Mansari; Blier
British Journal of Pharmacology, 1996 , vol. 118, # 3 p. 681 - 689 Title/Abstract Full Text View citing articles Show Details
Ansanay; Sebben; Bockaert; Dumuis
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 165 - 174 Title/Abstract Full Text View citing articles Show Details
McLean, Peter G.; Coupar, Ian M.
European Journal of Pharmacology, 1996 , vol. 312, # 2 p. 215 - 225 Title/Abstract Full Text View citing articles Show Details
Hemedah; Coupar; Mitchelson
British journal of pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text View citing articles Show Details
Prins, Nicolaas H.; Briejer, Michel R.; Schuurkes, Jan A.J.
British Journal of Pharmacology, 1997 , vol. 120, # 4 p. 714 - 720 Title/Abstract Full Text View citing articles Show Details
Suzuki; Ohuchi; Asanuma; Kaneko; Yokomori; Ito; Isobe; Muramatsu
Chemical and Pharmaceutical Bulletin, 2001 , vol. 49, # 1 p. 29 - 39 Title/Abstract Full Text View citing articles Show Details
Pauwels, Petrus J.; Colpaert, Francis C.
Biochemical Pharmacology, 1995 , vol. 50, # 10 p. 1651 - 1658 Title/Abstract Full Text View citing articles Show Details
Kloda, Anna; Adams, David J.
British Journal of Pharmacology, 2005 , vol. 144, # 3 p. 323 - 330 Title/Abstract Full Text View citing articles Show Details
Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.
Molecular Pharmacology, 1998 , vol. 54, # 1 p. 94 - 104 Title/Abstract Full Text View citing articles Show Details
Bower, Kiowa S.; Price, Kerry L.; Sturdee, Laura E.C.; Dayrell, Mariza; Dougherty, Dennis A.; Lummis, Sarah C.R.
European Journal of Pharmacology, 2008 , vol. 580, # 3 p. 291 - 297 Title/Abstract Full Text View citing articles Show Details
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
8
Choo, Yeun-Mun; Hamann, Mark T.
Heterocycles, 2007 , vol. 71, # 2 p. 245 - 252 Title/Abstract Full Text View citing articles Show Details
5MT
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
45
Trujillo, John I.; Meyers, Marvin J.; Anderson, David R.; Hegde, Shridhar; Mahoney, Matthew W.; Vernier, William F.; Buchler, Ingrid P.; Wu, Kun K.; Yang, Syaluan; Hartmann, Susan J.; Reitz, David B.
Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 16 p. 4657 - 4663 Title/Abstract Full Text View citing articles Show Details
IIb
Shestakov; Sidorenko; Shikhaliev; Pavlenko
Russian Journal of General Chemistry, 2007 , vol. 77, # 10 p. 1749 - 1760 Title/Abstract Full Text View citing articles Show Details
7
Somei, Masanori; Fukui, Yoshikazu; Hasegawa, Masakazu; Oshikiri, Naoki; Hayashi, Toshikatsu
Heterocycles, 2000 , vol. 53, # 8 p. 1725 - 1736 Title/Abstract Full Text View citing articles Show Details
Somei, Masanori; Iwaki, Takako; Yamada, Fumio; Tanaka, Yoshio; Shigenobu, Koki; Koike, Katsuo; Suzuki, Nobuo; Hattori, Atsuhiko
Heterocycles, 2006 , vol. 68, # 8 p. 1565 - 1569 Title/Abstract Full Text View citing articles Show Details
I-4b
Ates-Alagoz, Zeynep; Coban, Tulay; Buyukbingol, Erdem
Archiv der Pharmazie, 2006 , vol. 339, # 4 p. 193 - 200 Title/Abstract Full Text View citing articles Show Details
3d
Van Tilburg, Erica W.; Windhorst, Albert D.; Van Der Mey, Margreet; Herscheid, Jacobus D. M.
Journal of Labelled Compounds and Radiopharmaceuticals, 2006 , vol. 49, # 4 p. 321 - 330 Title/Abstract Full Text View citing articles Show Details
III-4b
Gurkan, A. Selen; Karabay, Arzu; Buyukbingol, Zeliha; Adejare, Adeboye; Buyukbingol, Erdem
Archiv der Pharmazie, 2005 , vol. 338, # 2-3 p. 67 - 73 Title/Abstract Full Text View citing articles Show Details
12b
Soriano-Agaton, Flor; Lagoutte, Delphine; Poupon, Erwan; Roblot, Francois; Fournet, Alain; Gantier, Jean-Charles; Hocquemiller, Reynald
Journal of Natural Products, 2005 , vol. 68, # 11 p. 1581 - 1587 Title/Abstract Full Text View citing articles Show Details
275
SEQUELLA, INC.
Patent: WO2005/34857 A2, 2005 ; Title/Abstract Full Text Show Details
15
Jayaprakasam, Bolleddula; Strasburg, Gale A.; Nair, Muraleedharan G.
Tetrahedron, 2004 , vol. 60, # 13 p. 3109 - 3121 Title/Abstract Full Text View citing articles Show Details
BB3-F
Schreiber, Stuart L.; Stavenger, Robert A.; Mitchison, Timothy J.; Maliga, Zoltan
Patent: US2004/59138 A1, 2004 ; Title/Abstract Full Text Show Details
13
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
5, R = 5OCH3
Jiang, Weiqin; Zhang, Xuqing; Sui, Zhihua
Organic letters, 2003 , vol. 5, # 1 p. 43 - 46 Title/Abstract Full Text View citing articles Show Details
36
Karimi, Farhad; Langstroem, Bengt
European Journal of Organic Chemistry, 2003 , # 11 p. 2132 - 2137 Title/Abstract Full Text View citing articles Show Details
5b
Mohanta, Pramod K.; Kim, Kyongtae
Tetrahedron Letters, 2002 , vol. 43, # 22 p. 3993 - 3996 Title/Abstract Full Text View citing articles Show Details
Substr., Tab.1, run 8
Connors, Richard V.; Zhang, Alex J.; Shuttleworth, Stephen J.
Tetrahedron Letters, 2002 , vol. 43, # 37 p. 6661 - 6663 Title/Abstract Full Text View citing articles Show Details
5-Me-OT
Zhang, Zhang-Jin; Trivedi, Bakula L.; De Paulis, Tomas; Schmidt, Dennis E.; Hewlett, William A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 2002 , vol. 365, # 2 p. 123 - 132 Title/Abstract Full Text View citing articles Show Details
14
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
8h
Amat; Seffar; Llor; Bosch
Synthesis, 2001 , # 2 p. 267 - 275 Title/Abstract Full Text View citing articles Show Details
6d
Pouilhes, Annie; Duval-Lungulescu, Monica; Lambel, Stephanie; Leonce, Stephane; Langlois, Yves
Tetrahedron Letters, 2001 , vol. 42, # 47 p. 8297 - 8299 Title/Abstract Full Text View citing articles Show Details
5-MT, 1
Nakagawa, Hidehiko; Sumiki, Erika; Takusagawa, Mitsuko; Ikota, Nobuo; Matsushima, Yoshikazu; Ozawa, Toshihiko
Chemical and Pharmaceutical Bulletin, 2000 , vol. 48, # 2 p. 261 - 265 Title/Abstract Full Text View citing articles Show Details
Tab.4., run 9, amine
Chung, In Hwa; Cha, Ki Suk; Seo, Jae Hong; Kim, Joong Hyup; Chung, Bong Young; Kim, Choong Sup
Heterocycles, 2000 , vol. 53, # 3 p. 529 - 533 Title/Abstract Full Text View citing articles Show Details
MTA
Wang, Hexiang; Ng, Tzi Bun
Pharmacology and Toxicology, 2000 , vol. 86, # 3 p. 125 - 128 Title/Abstract Full Text View citing articles Show Details
9
Lee; Rangisetty; Dukat; Slassi; Maclean; Glennon
Medicinal Chemistry Research, 2000 , vol. 10, # 4 p. 230 - 242 Title/Abstract Full Text View citing articles Show Details
9 (note 1)
Somei, Masanori; Oshikiri, Naoki; Hasegawa, Masakazu; Yamada, Fumio
Heterocycles, 1999 , vol. 51, # 6 p. 1237 - 1242 Title/Abstract Full Text View citing articles Show Details
1f
Koike, Takeshi; Takeuchi, Naoki; Tobinaga, Seisho
Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 1 p. 128 - 130 Title/Abstract Full Text View citing articles Show Details
Merck 8607: 5HT
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
5-MeO-T
De Vries; Villalon; Heiligers; Saxena
Naunyn-Schmiedeberg's archives of pharmacology, 1997 , vol. 356, # 1 p. 90 - 99 Title/Abstract Full Text View citing articles Show Details
Merck 6083
Molinari; North; Dubocovich
European Journal of Pharmacology, 1996 , vol. 301, # 1-3 p. 159 - 168 Title/Abstract Full Text View citing articles Show Details
Merck: 9927
Pang; Tang; Song; Brown
Life Sciences, 1996 , vol. 58, # 13 p. 1047 - 1057 Title/Abstract Full Text View citing articles Show Details
mexamine
Dalpiaz, Alessandro; Borea, Pier Andrea; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 312, # 1 p. 107 - 114 Title/Abstract Full Text View citing articles Show Details
Merck 6983
Carter; Champney; Hwang; Eglen
European Journal of Pharmacology, 1995 , vol. 280, # 3 p. 243 - 250 Title/Abstract Full Text View citing articles Show Details
5, 5-OMeT
Hong, Seoung-Soo; Dukat, Malgorzata; Teitler, Milt; Herrick-Davis, Kathy; McCallum, Kirk; et al.
Medicinal Chemistry Research, 1995 , vol. 5, # 9 p. 690 - 699 Title/Abstract Full Text Show Details
Patent-Specific Data (6) Prophetic Compound
Related Markush Structure (RN)
Location in Patent
Page/Page column
Bedos, Philippe; Baltas, Michel
Patent: US2015/31740 A1, 2015 ;
ELI LILLY AND COMPANY; Chen, Zhaogen; Cohen, Michael Philip; Fisher, Matthew Joseph; Gillig, James Ronald; McCowan, Jefferson Ray; Miller, Shawn Christopher; Schaus, John Mehnert; Giethlen, Bruno
Patent: EP1859798 B1, 2015 ;
29089273
Reference
Title/Abstract Full Text Show Details
Title/Abstract Full Text Show Details
23734867
NATREON, INC.; Ghosal, Shibnath; Veeraragavan, Muruganandam; Kalidindi, Sanyasi R.
Patent: US2013/115316 A1, 2013 ; Title/Abstract Full Text Show Details
22948333
CHEMILIA AB; HOeGBERG, Marita; DAHLSTEDT, Emma; SMITT, Olof; JOHANSSON, Tommy
Patent: WO2012/127032 A1, 2012 ; Title/Abstract Full Text Show Details
19816369
Aventis Pharma Limited
Patent: US6352977 B1, 2002 ; Title/Abstract Full Text Show Details
prophetic product
Eli Lilly and Company
Patent: US5096908 A1, 1992 ; Title/Abstract Full Text Show Details
Eli Lilly and Company
Patent: US5158956 A1, 1992 ; Title/Abstract Full Text Show Details
Derivative (27) Comment (Derivative)
Reference
Hydrochlorid: F:241-242grad
Suvorov et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1974 , vol. 10, p. 1316,1320 Khimiya Geterotsiklicheskikh Soedinenii, 1974 , vol. 10, p. 1496 Full Text Show Details
Picrat: F:216-217grad
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Tartrat: F:166-167grad
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Pikrat: F:212-213grad
Grandberg et al.
Doklady Chemistry, 1967 , vol. 176, p. 828 Doklady Akademii Nauk SSSR, 1967 , vol. 176, p. 583 Full Text Show Details
Salz m. 6-Hydroxy-5-methoxyindol-3-acetic acid C11H11NO4*C11H14N2O: B; P
Taborsky; Delvigs
Journal of Medicinal Chemistry, 1966 , vol. 9, p. 251,253 Full Text Show Details
Salz m. 6-Benzyloxy-5-methoxyindole-3-acetic Acid C18H17NO4*C11H14N2O: B; P
Taborsky; Delvigs
Journal of Medicinal Chemistry, 1966 , vol. 9, p. 251,253 Full Text Show Details
Pikrat: F:220grad (A., Zers.), braun
Tacconi
Farmaco, Edizione Scientifica, 1965 , vol. 20, p. 891,895,899 Full Text View citing articles Show Details
Hydrochlorid: C11H14N2O*HCl; IR-Sp. (KBr) von 2-16 μ
Taborski et al.
Journal of Medicinal Chemistry, 1965 , vol. 8, p. 460,465 Full Text Show Details
Acetat C11H14N2O*C2H4O2; F:141-143grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
O...t C11H14N2O*C8H16O2; F:114-115grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Benzoat C11H14N2O*C7H6O2; F:160-161grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Mandelat C11H14N2O*C8H8O3; F:156-159grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Stearat C11H14N2O*C18H36O2; F:94-97grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Cyanacetat C11H14N2O*C3H3NO2; F:166.5-168grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Phenoxyacetat C11H14N2O*C8H9O3; F:173-176grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
trans-Cinnamat C11H14N2O*C9H8O2; F:178-180grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Indol-3-ylacetat C11H14N2O*C10H9NO2; F:192-193grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Toluol-4-sulfonat C11H14N2O*C7H9O3S; F:183-187grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Salz m. Oxalsaeure: C11H14N2O*C2H2O4; F:170-171grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
3-Nitro-salicylat C11H14N2O*C7H5NO5; F:202-203grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Hide facts Comment (Derivative)
Reference
4-Methoxy-phenylacetat C11H14N2O*C9H10O3; F:169-170grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
5-Methoxy-indol-3-ylacetat C11H14N2O*C11H11NO3; F:181.5-183grad
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Pikrat: C11H14N2O*C6H3N3O7: F: 202-203grad; in A. ll., in W. wl.
Petrowa; Kawerina
J. Gen. Chem. USSR (Engl. Transl.), 1963 , vol. 33, p. 1333,1303 Full Text Show Details
Hydrochlorid C11H14N2O*HCl: Prep.: 1. 5-Hydroxy-tryptamin-hydrochlorid, A., Diazomethan, Ae. 2. HCl, A.; F: 239-240grad
Petrowa; Kawerina
J. Gen. Chem. USSR (Engl. Transl.), 1963 , vol. 33, p. 1333,1303 Full Text Show Details
Pikrat: C11H14N2O*C6H3N3O7: Prep.: 4-Methoxy-phenylhydrazin-hydrochlorid, 4-Amino-1,1-diethoxy-butan, wss. Essigsaeure (80grad, 2h); F: 219grad,aus A., Zers.
Keglevic et al.
Croatica Chemica Acta, 1961 , vol. 33, p. 83,86 Full Text Show Details
Hydrochlorid: C11H14N2O*HCl: F.: 249-250grad (Kofler), aus A.
Adlerova,E. et al.
Collection of Czechoslovak Chemical Communications, 1960 , vol. 25, p. 784 - 796 Full Text View citing articles Show Details
Sulfat: F.: 230-232grad (geschl. evac. Kapillare), aus aq. A.
May and Baker Ltd.
Patent: GB841524 , 1956 ; Chem.Abstr., 1962 , vol. 56, # 1431 Full Text Show Details
Physical Data Melting Point (21) Melting Point
Solvent (Melting Point)
Location
Reference
101 - 102 °C
Page/Page column 3
LES LABORATOIRES SERVIER
Patent: US2010/204276 A1, 2010 ; Title/Abstract Full Text Show Details
119 - 121 °C
benzene
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
124 - 126 °C
Somei, Masanori; Oshikiri, Naoki; Hasegawa, Masakazu; Yamada, Fumio
Heterocycles, 1999 , vol. 51, # 6 p. 1237 - 1242 Title/Abstract Full Text View citing articles Show Details
121 - 123 °C
Wang, Alan P. L.; Li, Liang
Analytical Chemistry, 1992 , vol. 64, # 7 p. 769 - 775
Title/Abstract Full Text View citing articles Show Details
118 - 120 °C
Suvorov et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1974 , vol. 10, p. 1316,1320 Khimiya Geterotsiklicheskikh Soedinenii, 1974 , vol. 10, p. 1496 Full Text Show Details
Saito; Kikugawa
Journal of Heterocyclic Chemistry, 1979 , vol. 16, p. 1325,1327,1328 Full Text View citing articles Show Details
119 - 122 °C
Flaugh; Crowell; Clemens; Sawyer
Journal of Medicinal Chemistry, 1979 , vol. 22, # 1 p. 63 - 69 Title/Abstract Full Text View citing articles Show Details
122 °C
Buzas et al.
Synthesis, 1977 , p. 129 Full Text Show Details
120 - 121 °C
Richter Gedeon Vegyeszeti Gyar R.T.
Patent: FR2261271DE2344919 , 1973 ; Chem.Abstr., vol. 80, # 146016 Full Text Show Details
Szantay et al.
Synthesis, 1974 , p. 354 Full Text Show Details
118 - 119 °C
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
120 - 125.5 °C
Suvorov,N.N. et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 1361 - 1366 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 1505 - 1511 Full Text View citing articles Show Details
115 - 116 °C
Grandberg et al.
Doklady Chemistry, 1967 , vol. 176, p. 828 Doklady Akademii Nauk SSSR, 1967 , vol. 176, p. 583 Full Text Show Details
119.5 - 120.5 °C
Bertaccini; Vitali
Farmaco, Edizione Scientifica, 1967 , vol. 22, p. 229,231 Full Text Show Details
121.5 - 122.5 °C
Yajima et al.
Chemical and Pharmaceutical Bulletin, 1966 , vol. 14, p. 884,887 Full Text Show Details
119 °C
Julia; Manoury
Bulletin de la Societe Chimique de France, 1965 , p. 1411,1413 Full Text Show Details
Julia et al.
Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1960 , vol. 251, p. 394 Full Text Show Details
124 - 125 °C
petroleum ether
Takatori; Takashima
Yakugaku Zasshi, 1963 , vol. 83, p. 795,798 Full Text Show Details
119 - 120 °C
Adlerova,E. et al.
Collection of Czechoslovak Chemical Communications, 1960 , vol. 25, p. 784 - 796 Full Text View citing articles Show Details
Petrowa; Kawerina
J. Gen. Chem. USSR (Engl. Transl.), 1963 , vol. 33, p. 1333,1303 Full Text Show Details
215 - 217 °C
Mndzhoyan; Papayan
Izvestiya Akademii Nauk Armyanskoi SSR, Khimicheskie Nauki, 1961 , vol. 14, p. 603 Chem.Abstr., 1963 , vol. 58, # 4497c Full Text Show Details
117 - 119 °C
benzene
Kralt,T. et al.
Recueil des Travaux Chimiques des Pays-Bas, 1961 , vol. 80, p. 313 - 324 Full Text View citing articles Show Details
121.5 - 122.5 °C
benzene
Szmuszkovicz et al.
Journal of Organic Chemistry, 1960 , vol. 25, p. 857,858 Full Text Show Details
122 - 123 °C
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Hide facts Melting Point
Solvent (Melting Point)
Reference
121 - 122 °C
diethyl ether
Wieland et al.
Justus Liebigs Annalen der Chemie, 1934 , vol. 513, p. 1,18 Full Text Show Details
Boiling Point (2) Boiling Point
Pressure (Boiling Point)
Reference
165 - 170 °C
0.08 Torr
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
165 - 170 °C
0.1 Torr
Grandberg et al.
Doklady Chemistry, 1967 , vol. 176, p. 828 Doklady Akademii Nauk SSSR, 1967 , vol. 176, p. 583 Full Text Show Details
Density (1) Density
Type (Density)
Reference
1.242 g·cm-3
crystallographic
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Association (MCS) (3) Description (Association (MCS))
Partner (Association (MCS))
Solvent (Association (MCS))
Comment (Association (MCS))
Formation constant of a complex
cetyltrimethylammonim bromide
H2O methanol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Formation constant of a complex
sodium dodecyl-sulfate
H2O methanol
pH dependence
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Dipole moment of the complex
I2
1,2-dichloro-ethane
Abu-Eittah; Abdou
Journal de Chimie Physique et de Physico-Chimie Biologique, 1996 , vol. 93, # 11-12 p. 1958 - 1973 Title/Abstract Full Text View citing articles Show Details
Reference
Chromatographic Data (1) Chromatographic data
Reference
HPLC (High performance liquid chromatography)
Prabhakar; Kumar, N. Vasanth; Reddy, M. Ravikanth; Sarma; Reddy, G. Om
Organic Process Research and Development, 1999 , vol. 3, # 3 p. 155 - 160 Title/Abstract Full Text View citing articles Show Details
Crystal Phase (3) Description (Crystal Phase)
Comment (Crystal Phase)
Reference
Crystal structure determination
β=98.7 grad, a=6.11 Angstroem, b=9.53 Angstroem, c=8.83 Angstroem, n=2.
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Crystal structure determination
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Solid state structure properties
Quarles et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1974 , vol. 30, p. 99,100, 101 Full Text Show Details
Crystal Property Description (2) Colour & Other Properties
Reference
colourless
Bartolucci, Silvia; Mari, Michele; Bedini, Annalida; Piersanti, Giovanni; Spadoni, Gilberto
Journal of Organic Chemistry, 2015 , vol. 80, # 6 p. 3217 - 3222 Title/Abstract Full Text View citing articles Show Details
light-yellow
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
Crystal System (1) Crystal System
Reference
monoclinic
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Dissociation Exponent (3) Dissociation Exponent (pK)
Dissociation Group
Method (Dissociation Exponent)
Type (Dissociation Exponent)
Comment (Dissociation Exponent)
4.8
H
spectrophotometric
a1/apparent
Hela; Anipindi; Priyadarsini; O'Neill
Journal of Physical Chemistry B, 1999 , vol. 103, # 40 p. 8606 - 8611 Title/Abstract Full Text View citing articles Show Details
(pk')pK(b)
Julia; Lallemand
Bulletin de la Societe Chimique de France, 1973 , p. 2058,2059, 2061 Full Text Show Details
(pk')pK(a) (50percentig. wss. A.): 8.81
Grandberg et al.
Doklady Chemistry, 1967 , vol. 176, p. 828 Doklady Akademii Nauk SSSR, 1967 , vol. 176, p. 583 Full Text Show Details
Further Information (9) Description (Further Information)
Reference
Further information
Dimicoli; Helene
Biochemistry, 1974 , vol. 13, # 4 p. 714 - 723 Title/Abstract Full Text View citing articles Show Details
Further information
Agurell; Holmstedt; Lindgren; Schultes
Acta chemica Scandinavica, 1969 , vol. 23, # 3 p. 903 - 916 Title/Abstract Full Text View citing articles Show Details
Further information
Smaller et al.
Journal of Chemical Physics, 1967 , vol. 46, p. 3976,3979 Full Text Show Details
Further information
Taborsky; Delvigs
Journal of Medicinal Chemistry, 1966 , vol. 9, p. 251,253 Full Text Show Details
Further information
Taborski et al.
Journal of Medicinal Chemistry, 1965 , vol. 8, p. 460,465 Full Text Show Details
Reference
Further information
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Further information
Heinzelman; Szmuszkovicz
Progress in Drug Research, 1963 , vol. 6, p. 75,76-150 Chem.Abstr., 1964 , vol. 60, # 13215b Full Text Show Details
Further information
Petrowa; Kawerina
J. Gen. Chem. USSR (Engl. Transl.), 1963 , vol. 33, p. 1333,1303 Full Text Show Details
Further information
May and Baker Ltd.
Patent: GB841524 , 1956 ; Chem.Abstr., 1962 , vol. 56, # 1431 Full Text Show Details
Interatomic Distances and Angles (2) Description
Comment (Interatomic Distances and Angles)
Reference
Interatomic distances and angles
Roentgen-Diagramm.
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Interatomic distances and angles
Quarles et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1974 , vol. 30, p. 99,100, 101 Full Text Show Details
Liquid/Liquid Systems (MCS) (1) Description (Liquid/Liquid Systems (MCS))
Reference
Distribution between solvent 1 + 2
Kang; Green
Nature (London, United Kingdom), 1969 , vol. 222, p. 794 Full Text View citing articles Show Details
Partition octan-1-ol/water (MCS) (1) log POW
Reference
1.06
Faulkner, Katherine C.; Hurley, Katherine A.; Weibel, Douglas B.
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 22 p. 5539 - 5544 Title/Abstract Full Text Show Details
Space Group (1) Space Group
Reference
7 0
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Transport Phenomena (MCS) (1)
Description (Transport Phenomena (MCS))
Partner (Transport Phenomena (MCS))
Temperature (Transport Phenomena (MCS))
Diffusion
aq. sodium phosphate buffer
25 °C
Reference Robinson, David; Anderson, James E.; Lin, Jeong-long
Journal of Physical Chemistry, 1990 , vol. 94, # 2 p. 1003 1005 Title/Abstract Full Text View citing articles Show Details
Spectra NMR Spectroscopy (18) Description (NMR Spectroscopy)
Nucleus (NMR Spectroscopy)
Coupling Nuclei
Chemical shifts Spectrum
1H
Solvents (NMR Spectroscopy)
Temperature (NMR Spectroscopy)
Frequency (NMR Spectroscopy)
Original Text (NMR Spectroscopy)
chloroform-d1
200 MHz
Location supporting information
Comment (NMR Spectroscopy)
Reference Bartolucci, Silvia; Mari, Michele; Bedini, Annalida; Piersanti, Giovanni; Spadoni,
Gilberto
Journal of Organic Chemistry, 2015 , vol. 80, # 6 p. 3217 - 3222 Title/Abstract Full Text View citing articles Show Details
1H
chloroform-d1
NMR (CDC13): δ 10.58 (bs, 1H), 7.20 (t, J= 8.78 Hz; 1H), 7.07 (s, 1H), 6.98 (s, 1H), 6.71-6.68 (m, III), 3.75 (s, 3U), 2.81-2.69 (m, 4H), 1.39 (bs, 2H).
Page/Page column 40
Signals given
HERCULES TECHNOLOGY MANAGEMENT CO V, INC.; BLAGG, Julian
Patent: WO2011/47156 A1, 2011 ; Title/Abstract Full Text Show Details
Chemical shifts
1H
CDCl3
200 MHz
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
1H
1H
CDCl3
200 MHz
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
13C
CDCl3
100.61 MHz
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
1H
CDCl3
400 MHz
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
1H
1H
CDCl3
400 MHz
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
Spectrum
1H
23.84 °C
300.133 MHz
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
Spectrum
13C
23.84 °C
75 MHz
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
13C
CDCl3
75 MHz
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
1H
CDCl3
300 MHz
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, #
7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
1H
1H
CDCl3
300 MHz
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
1H
1H
CDCl3
Somei, Masanori; Fukui, Yoshikazu; Hasegawa, Masakazu; Oshikiri, Naoki; Hayashi, Toshikatsu
Heterocycles, 2000 , vol. 53, # 8 p. 1725 - 1736 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
1H
CDCl3
Somei, Masanori; Fukui, Yoshikazu; Hasegawa, Masakazu; Oshikiri, Naoki; Hayashi, Toshikatsu
Heterocycles, 2000 , vol. 53, # 8 p. 1725 - 1736 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
1H
chloroform-d1
200 MHz
Prabhakar; Kumar, N. Vasanth; Reddy, M. Ravikanth; Sarma; Reddy, G. Om
Organic Process Research and Development, 1999 , vol. 3, # 3 p. 155 - 160 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
1H
Grin, L. M.; Khlaponina, L. N.; Pivnenko, N. S.; Selichenko, A. G.; Brutov, V. D.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 7 p. 476 - 479 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 7 p. 819 - 822 Title/Abstract Full Text View citing articles Show Details
Chemical shifts
13C
CDCl3
40 °C
Alapishvili, M. G.; Popova, G. V.; Vorontsov, E. D.; Kireev, V. V.; Suvorov, N. N.
J. Gen. Chem. USSR (Engl. Transl.), 1983 , vol. 53, # 5 p. 1040 - 1044,919 - 923 Title/Abstract Full Text Show Details
NMR
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Saito; Kikugawa
Journal of Heterocyclic Chemistry, 1979 , vol. 16, p. 1325,1327,1328 Full Text View citing articles Show Details
IR Spectroscopy (5) Description (IR Spectroscopy)
Solvent (IR Spectroscopy)
Reference
Bands
KBr
Somei, Masanori; Fukui, Yoshikazu; Hasegawa, Masakazu; Oshikiri, Naoki; Hayashi, Toshikatsu
Heterocycles, 2000 , vol. 53, # 8 p. 1725 - 1736 Title/Abstract Full Text View citing articles Show Details
Bayari; Ide
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2003 , vol. 59, # 6 p. 1255 - 1263 Title/Abstract Full Text View citing articles Show Details
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
Spectrum
KBr
Bayari; Ide
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2003 , vol. 59, # 6 p. 1255 - 1263 Title/Abstract Full Text View citing articles Show Details
Bands
CDCl3
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
Bands
Szmuszkovicz et al.
Journal of Organic Chemistry, 1960 , vol. 25, p. 857,858 Full Text Show Details
Prabhakar; Kumar, N. Vasanth; Reddy, M. Ravikanth; Sarma; Reddy, G. Om
Organic Process Research and Development, 1999 , vol. 3, # 3 p. 155 - 160 Title/Abstract Full Text View citing articles Show Details
IR
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Mass Spectrometry (6) Description (Mass Spectrometry)
Reference
electrospray ionisation (ESI) spectrum
Bartolucci, Silvia; Mari, Michele; Bedini, Annalida; Piersanti, Giovanni; Spadoni, Gilberto
Journal of Organic Chemistry, 2015 , vol. 80, # 6 p. 3217 - 3222 Title/Abstract Full Text View citing articles Show Details
spectrum electron impact (EI)
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
spectrum
Wang, Alan P. L.; Li, Liang
Analytical Chemistry, 1992 , vol. 64, # 7 p. 769 - 775 Title/Abstract Full Text View citing articles Show Details
spectrum chemical ionization (CI)
Duarte, M. F. N.; Hutchinson, D. W.; Jennings, K. R.
Organic Mass Spectrometry, 1985 , vol. 20, # 7 p. 476 - 478 Title/Abstract Full Text Show Details
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
negative ion spectroscopy
Duarte, M. F. N.; Hutchinson, D. W.; Jennings, K. R.
Organic Mass Spectrometry, 1985 , vol. 20, # 7 p. 476 - 478 Title/Abstract Full Text Show Details
Sergeev; Manusadzhyan
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 1228 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 1357 Full Text Show Details
Wood et al.
Analytical Chemistry, 1976 , vol. 48, p. 981 Full Text View citing articles Show Details
Shaw; Wright; Milne
Biomedical mass spectrometry, 1977 , vol. 4, # 6 p. 348 - 353 Title/Abstract Full Text View citing articles Show Details
Agurell; Holmstedt; Lindgren; Schultes
Acta chemica Scandinavica, 1969 , vol. 23, # 3 p. 903 - 916 Title/Abstract Full Text View citing articles Show Details
UV/VIS Spectroscopy (41)
Solvent (UV/VIS Spectroscopy)
Absorption Maxima (UV/VIS)
Comment (UV/VIS Spectroscopy)
H2O
276.007 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
ethane-1,2-diol
275.005 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
methanol
275.005 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
Reference
butan-1-ol
277.001 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
propan-2-ol
277.001 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
acetonitrile
276.007 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
2-methyl-propan-2-ol
277.001 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
dimethylformamide
279.002 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
CH2Cl2
277.001 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
ethyl acetate
277.001 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
dioxane
272.005 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
cyclohexane
276.007 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
hexane
276.007 nm
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 176 Title/Abstract Full Text View citing articles Show Details
aq. H2SO4
271 nm
Remark: Ho -3.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
aq. H2SO4
274 nm 310 nm
Remark: Ho -2.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
aq. H2SO4
274 nm 309 nm
Remark: Ho -1.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
aq. H2SO4
273 nm 309 nm
Remark: pH 1.0 - 2.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
aq. H2SO4
275 nm 309 nm
Remark: pH 4.0 - 5.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
275 nm 309 nm
Remark: pH 8.0 - 9.5
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 -
aq. NaOH
Show next 20
276 nm 309 nm
941 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 941 Title/Abstract Full Text View citing articles Show Details
Remark: pH 10.4
Hide facts
Description (UV/VIS Spectroscopy)
Solvent (UV/VIS Spectroscopy)
Absorption Maxima (UV/VIS)
Comment (UV/VIS Spectroscopy)
aq. NaOH
277 nm 309 nm
Remark: pH 11.3 - 12.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
276 nm 327 nm
Remark: pH 13.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
275 nm 327 nm
Remark: H- 14.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
274 nm 326 nm
Remark: H- 14.7
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
278 nm
Remark: H- 16.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
280 nm
Remark: H- 17.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
aq. NaOH
297 nm
Remark: H- 18.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
273 nm 275 nm 310 nm
Remark: Ho 0.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
272 nm 274 nm 310 nm
Remark: pH 1.1
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
273 nm 310 nm
Remark: pH 2.1
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
274 nm 310 nm
Remark: pH 3.3 - 4.2
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
272 nm 310 nm
Remark: pH 4.9
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
273 nm 310 nm
Remark: pH 7.0 - 9.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Reference
various solvent(s)
275 nm 310 nm
Remark: pH 10.0 -11.1
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
274 nm
Remark: pH 2.2 - 11.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
275 nm
Remark: pH 12.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
275 nm 277 nm
Remark: pH 13.0
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
various solvent(s)
278 nm
Remark: H- 13.9
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Spectrum
gaseous matrix
302.5 - 306.8 nm
Li, Liang; Lubman, David M.
Analytical Chemistry, 1988 , vol. 60, # 23 p. 2591 - 2598 Title/Abstract Full Text View citing articles Show Details
UV/VIS
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Millie et al.
Journal of Medicinal Chemistry, 1968 , vol. 11, # 2 p. 207,209,210 Full Text View citing articles Show Details
Absorption maxima
Szmuszkovicz et al.
Journal of Organic Chemistry, 1960 , vol. 25, p. 857,858 Full Text Show Details
Taborsky; McIsaac
Journal of Medicinal Chemistry, 1964 , vol. 7, p. 135,140 Full Text Show Details
Fluorescence Spectroscopy (20) Description (Fluorescence Spectroscopy)
Solvent (Fluorescence Spectroscopy)
Fluorescence quenching
Comment (Fluorescence Spectroscopy)
Reference
Quenching with Br(1-)
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Maxima
micellar solution
concentration dependence. Object(s) of Study: pH dependence
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Spectrum
micellar solution
concentration dependence
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Maxima
H2O
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
ethane-1,2-diol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
methanol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176
Title/Abstract Full Text View citing articles Show Details
Maxima
butan-1-ol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
propan-2-ol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
acetonitrile
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
2-methyl-propan-2-ol
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
dimethylformamide
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
CH2Cl2
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
ethyl acetate
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
dioxane
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
cyclohexane
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
hexane
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Maxima
H2O
pH dependence
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Maxima
various solvent(s)
pH dependence
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Fluorescence intensity
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Fluorescence
Taborsky; McIsaac
Journal of Medicinal Chemistry, 1964 , vol. 7, p. 135,140 Full Text Show Details
Other Spectroscopic Methods (1) Description (Other Spectroscopic Methods)
Reference
Photoelectron spectrum
Domelsmith et al.
Journal of the American Chemical Society, 1977 , vol. 99, p. 4311,4315 Full Text Show Details
Bioactivity Pharmacological Data (239)
1 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Adlerova,E. et al.
Collection of Czechoslovak Chemical Communications, 1960 , vol. 25, p. 784 - 796 Full Text View citing articles Show Details
Sandoz Ltd.
Patent: US4146643 A1, 1979 ; Title/Abstract Full Text Show Details
Suvorov,N.N. et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 1361 - 1366 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 1505 - 1511 Full Text View citing articles Show Details
Nestec S. A.
Patent: US4506080 A1, 1985 ; Title/Abstract Full Text Show Details
Adir et Compagnie
Patent: US5276051 A1, 1994 ; Title/Abstract Full Text Show Details
Richter Gedeon Vegyeszeti Gyar Rt.
Patent: US4843080 A1, 1989 ; Title/Abstract Full Text Show Details
Flaugh; Crowell; Clemens; Sawyer
Journal of Medicinal Chemistry, 1979 , vol. 22, # 1 p. 63 - 69 Title/Abstract Full Text View citing articles Show Details
Lectec Corporation
Patent: US5776956 A1, 1998 ; Title/Abstract Full Text Show Details
Merck Sharp and Dohme Ltd.
Patent: US6187805 B1, 2001 ; Title/Abstract Full Text Show Details
Synaptic Pharmaceutical Corporation
Patent: US5476782 A1, 1995 ; Title/Abstract Full Text Show Details
Merck Patent Gesellschaft mit beschrankter Haftung
Patent: US5532241 A1, 1996 ; Title/Abstract Full Text Show Details
Cemaf; Laboratories Besins Iscovesco
Patent: US6048868 A1, 2000 ; Title/Abstract Full Text Show Details
CEMAF and Laboratoires Besins Iscovesco S.A.
Patent: US6004991 A1, 1999 ; Title/Abstract Full Text Show Details
Eli Lilly and Company
Patent: US5096908 A1, 1992 ; Title/Abstract Full Text Show Details
Fraschini; Franco; Di Bella; Luigi; Duranti; Ermanno
Patent: US5122535 A1, 1992 ; Title/Abstract Full Text Show Details
Eli Lilly and Company
Patent: US5158956 A1, 1992 ; Title/Abstract Full Text Show Details
Sibley, David R.; Monsma JR., Frederick J.; Hamblin, Mark
Patent: US2002/91235 A1, 2002 ; Title/Abstract Full Text Show Details
Kralt,T. et al.
Recueil des Travaux Chimiques des Pays-Bas, 1961 , vol. 80, p. 313 - 324 Full Text View citing articles Show Details
Synpatic Pharmaceutical Corporation
Patent: US2003/105318 A1, 2003 ; Title/Abstract Full Text Show Details
Synaptic Pharmaceutical Corporation
Patent: US2003/166066 A1, 2003 ; Title/Abstract Full Text Show Details
2 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
RICHTER GEDEON VEGYESZETI GYAR R.T.
Patent: EP202774 A3, 1989 ; Title/Abstract Full Text Show Details
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Patent: WO1999/28456 A1, 1999 ; Title/Abstract Full Text Show Details
JANSSEN PHARMACEUTICA N.V.
Patent: WO2000/77199 A1, 2000 ; Title/Abstract Full Text Show Details
ASTRAZENECA AB
Patent: WO2001/85146 A1, 2001 ; Title/Abstract Full Text Show Details
FAUST PHARMACEUTICALS
Patent: WO2004/85392 A1, 2004 ; Title/Abstract Full Text Show Details
Board of Trustees of Michigan State University
Patent: US2005/59727 A1, 2005 ; Title/Abstract Full Text Show Details
The Board of Governors for Higher Education the State of Rhode Island and Providence Plantation.
Patent: US5863928 A1, 1999 ; Title/Abstract Full Text Show Details
BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
Patent: WO2006/113557 A3, 2006 ; Title/Abstract Full Text Show Details
THE UNIVERSITY OF MONTANA
Patent: WO2008/24660 A2, 2008 ; Title/Abstract Full Text Show Details
GUILFORD, F., Timothy
Patent: WO2008/36979 A2, 2008 ; Title/Abstract Full Text Show Details
Velluz et al.
Bulletin de la Societe Chimique de France, 1958 , p. 673,676 Full Text View citing articles Show Details
Spaeth; Lederer
Chemische Berichte, 1930 , vol. 63, p. 2102,2106 Full Text View citing articles Show Details
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Wieland et al.
Justus Liebigs Annalen der Chemie, 1934 , vol. 513, p. 1,18 Full Text Show Details
Velluz
Annales Pharmaceutiques Francaises, 1959 , vol. 17, p. 15,21 Full Text Show Details
Quadbeck; Roehm
Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1954 , vol. 297, p. 229,233 Full Text Show Details
Hoshino; Shimodaira
Bulletin of the Chemical Society of Japan, 1936 , vol. 11, p. 221,222 Full Text Show Details
Pietra
Farmaco, Edizione Scientifica, 1958 , vol. 13, p. 75,78 Full Text Show Details
Quarles et al.
Acta Crystallographica, 1974 , vol. <B> 30, p. 95 Full Text Show Details
Wilkinson
Journal of the Chemical Society, 1958 , p. 2079 Full Text Show Details
3 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Abramovitch; Shapiro
Journal of the Chemical Society, 1956 , p. 4589,4591 Full Text Show Details
Asero et al.
Justus Liebigs Annalen der Chemie, 1952 , vol. 576, p. 69,72, 73 Full Text Show Details
Matsushima
Chemical and pharmaceutical bulletin, 1968 , vol. 16, # 10 p. 2046 - 2055 Title/Abstract Full Text View citing articles Show Details
Muraseva et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1968 , vol. 4, p. 211 Khimiya Geterotsiklicheskikh Soedinenii, 1968 , vol. 4, p. 284 Full Text Show Details
Iskric; Kveder
Croatica Chemica Acta, 1965 , vol. 37, p. 233 Full Text Show Details
Julia; Manoury
Bulletin de la Societe Chimique de France, 1965 , p. 1411,1413 Full Text Show Details
Smaller et al.
Journal of Chemical Physics, 1967 , vol. 46, p. 3976,3979 Full Text Show Details
Julia et al.
Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1960 , vol. 251, p. 394 Full Text Show Details
Bowd et al.
Photochemistry and Photobiology, 1970 , vol. 11, p. 445,447 Full Text Show Details
Taborsky
Analytical Chemistry, 1964 , vol. 36, p. 1663 Full Text View citing articles Show Details
Heinzelman; Szmuszkovicz
Progress in Drug Research, 1963 , vol. 6, p. 75,76-150 Chem.Abstr., 1964 , vol. 60, # 13215b Full Text Show Details
Buzas et al.
Synthesis, 1977 , p. 129 Full Text Show Details
Sergeev; Manusadzhyan
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 1228 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 1357 Full Text Show Details
Szmuszkovicz et al.
Journal of Organic Chemistry, 1960 , vol. 25, p. 857,858 Full Text Show Details
Taborski et al.
Journal of Medicinal Chemistry, 1965 , vol. 8, p. 460,465 Full Text Show Details
Wood et al.
Analytical Chemistry, 1976 , vol. 48, p. 981 Full Text View citing articles Show Details
Taborsky; Delvigs
Journal of Medicinal Chemistry, 1966 , vol. 9, p. 251,253 Full Text Show Details
Shaw; Wright; Milne
Biomedical mass spectrometry, 1977 , vol. 4, # 6 p. 348 - 353 Title/Abstract Full Text View citing articles Show Details
Bertaccini; Vitali
Farmaco, Edizione Scientifica, 1967 , vol. 22, p. 229,231 Full Text Show Details
Takatori; Takashima
Yakugaku Zasshi, 1963 , vol. 83, p. 795,798 Full Text Show Details
4 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Ernest; Protiva
Collection of Czechoslovak Chemical Communications, 1961 , vol. 26, p. 1137,1140 Full Text Show Details
Sokolova; Magidson
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1968 , vol. 4, p. 254 Khimiya Geterotsiklicheskikh Soedinenii, 1968 , vol. 4, p. 343 Full Text Show Details
Agurell; Holmstedt; Lindgren; Schultes
Acta chemica Scandinavica, 1969 , vol. 23, # 3 p. 903 - 916 Title/Abstract Full Text View citing articles Show Details
Taborsky; McIsaac
Journal of Medicinal Chemistry, 1964 , vol. 7, p. 135,140 Full Text Show Details
Grandberg et al.
Doklady Chemistry, 1967 , vol. 176, p. 828 Doklady Akademii Nauk SSSR, 1967 , vol. 176, p. 583 Full Text Show Details
Richter Gedeon Vegyeszeti Gyar R.T.
Patent: FR2261271DE2344919 , 1973 ; Chem.Abstr., vol. 80, # 146016 Full Text Show Details
Kang; Green
Nature (London, United Kingdom), 1969 , vol. 222, p. 794 Full Text View citing articles Show Details
Suvorov et al.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1974 , vol. 10, p. 1316,1320 Khimiya Geterotsiklicheskikh Soedinenii, 1974 , vol. 10, p. 1496 Full Text Show Details
Szantay et al.
Synthesis, 1974 , p. 354 Full Text Show Details
Macek; Vanecek
Collection of Czechoslovak Chemical Communications, 1961 , vol. 26, p. 2705,2718 Full Text Show Details
Domelsmith et al.
Journal of the American Chemical Society, 1977 , vol. 99, p. 4311,4315 Full Text Show Details
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Mndzhoyan; Papayan
Izvestiya Akademii Nauk Armyanskoi SSR, Khimicheskie Nauki, 1961 , vol. 14, p. 603 Chem.Abstr., 1963 , vol. 58, # 4497c Full Text Show Details
Supniewski et al.
Dissertationes Pharmaceuticae, 1961 , vol. 13, p. 205,206-217 Chem.Abstr., 1962 , # 692 Full Text Show Details
Erspamer et al.
Journal of Pharmacy and Pharmacology, 1960 , vol. 12, p. 761,762 Full Text Show Details
Julia; Lallemand
Bulletin de la Societe Chimique de France, 1973 , p. 2058,2059, 2061 Full Text Show Details
Lab.francais de chimiotherapie
Patent: US2920080 , 1960 ; Chem.Abstr., 1960 , vol. 54, # 13019a Full Text Show Details
Quarles et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1974 , vol. 30, p. 99,100, 101 Full Text Show Details
Kametani et al.
Chemical and Pharmaceutical Bulletin, 1972 , vol. 20, p. 2057 Full Text Show Details
Dimicoli; Helene
Biochemistry, 1974 , vol. 13, # 4 p. 714 - 723 Title/Abstract Full Text View citing articles Show Details
5 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Kobayashi et al.
Journal of Medicinal Chemistry, 1969 , vol. 12, # 4 p. 636 Full Text View citing articles Show Details
Keglevic et al.
Croatica Chemica Acta, 1961 , vol. 33, p. 83,86 Full Text Show Details
May and Baker Ltd.
Patent: GB841524 , 1956 ; Chem.Abstr., 1962 , vol. 56, # 1431 Full Text Show Details
Yajima et al.
Chemical and Pharmaceutical Bulletin, 1966 , vol. 14, p. 884,887 Full Text Show Details
Petrowa; Kawerina
J. Gen. Chem. USSR (Engl. Transl.), 1963 , vol. 33, p. 1333,1303 Full Text Show Details
Tacconi
Farmaco, Edizione Scientifica, 1965 , vol. 20, p. 891,895,899 Full Text View citing articles Show Details
Millie et al.
Journal of Medicinal Chemistry, 1968 , vol. 11, # 2 p. 207,209,210 Full Text View citing articles Show Details
Saito; Kikugawa
Journal of Heterocyclic Chemistry, 1979 , vol. 16, p. 1325,1327,1328 Full Text View citing articles Show Details
Robinson, David; Anderson, James E.; Lin, Jeong-long
Journal of Physical Chemistry, 1990 , vol. 94, # 2 p. 1003 - 1005 Title/Abstract Full Text View citing articles Show Details
Hoelscher, Peter; Knoelker, Hans-Joachim; Winterfeldt, Ekkehard
Tetrahedron Letters, 1990 , vol. 31, # 19 p. 2705 - 2706 Title/Abstract Full Text View citing articles Show Details
Kobayashi; Cheng; Ohta; Nozoe; Ohizumi; Sasaki
Journal of Organic Chemistry, 1990 , vol. 55, # 11 p. 3666 - 3670 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.; Chaurasia, Chandra; Titeler, Milt
Journal of Medicinal Chemistry, 1990 , vol. 33, # 10 p. 2777 - 2784
Title/Abstract Full Text View citing articles Show Details
Laronze, Jean-Yves; Gauvin-Hussenet, Christine; Levy, Jean
Tetrahedron Letters, 1991 , vol. 32, # 5 p. 619 - 622 Title/Abstract Full Text View citing articles Show Details
Wasserman, Harry H.; Kelly, Terence A.
Tetrahedron Letters, 1989 , vol. 30, # 50 p. 7117 - 7120 Title/Abstract Full Text View citing articles Show Details
Bobowski; Shavel Jr.
Journal of Heterocyclic Chemistry, 1985 , vol. 22, # 6 p. 1679 - 1688 Title/Abstract Full Text View citing articles Show Details
Bobowski, George
Journal of Heterocyclic Chemistry, 1981 , vol. 18, p. 1179 - 1187 Title/Abstract Full Text Show Details
Bobowski, George
Journal of Heterocyclic Chemistry, 1983 , vol. 20, p. 267 - 272 Title/Abstract Full Text Show Details
Hudlicky, Tomas; Kutchan, Toni M.; Shen, Grace; Sutliff, Vincent E.; Coscia, Carmine J.
Journal of Organic Chemistry, 1981 , vol. 46, # 8 p. 1738 - 1741 Title/Abstract Full Text View citing articles Show Details
Vercauteren, Joseph; Lavaud, Catherine; Levy, Jean; Massiot, Georges
Journal of Organic Chemistry, 1984 , vol. 49, # 12 p. 2278 - 2279 Title/Abstract Full Text View citing articles Show Details
Wang, Alan P. L.; Li, Liang
Analytical Chemistry, 1992 , vol. 64, # 7 p. 769 - 775 Title/Abstract Full Text View citing articles Show Details
6 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Massiot, Georges; Levy, Jean
Bulletin de la Societe Chimique de France, 1981 , vol. 2, # 11-12 p. 463 - 467 Title/Abstract Full Text Show Details
Krause; Halls; Karavolas
Steroids, 1980 , vol. 36, # 3 p. 305 - 320 Title/Abstract Full Text View citing articles Show Details
Elliott, Arthur J.; Gold, Elijah H.; Guzik, Henry
Journal of Medicinal Chemistry, 1980 , vol. 23, # 11 p. 1268 - 1269 Title/Abstract Full Text View citing articles Show Details
Bergman, Jan; Bergman, Solveig
Journal of Organic Chemistry, 1985 , vol. 50, # 8 p. 1246 - 1255 Title/Abstract Full Text View citing articles Show Details
Burov, Yu. V.; Zagorevskii, V. A.; Zhukov, V. N.; Novikova, N. N.; Silenko, I. D.
Pharmaceutical Chemistry Journal, 1983 , vol. 17, # 8 p. 559 - 563 Khimiko-Farmatsevticheskii Zhurnal, 1983 , vol. 17, # 8 p. 936 - 940 Title/Abstract Full Text View citing articles Show Details
Partsvaniya, D. A.; Akhvlediani, R. N.; Gordeev, E. N.; Vigdorchik, M. M.; Kuleshova, L. N.; et al.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 12 p. 833 - 838 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 12 p. 1454 - 1459 Title/Abstract Full Text View citing articles Show Details
Mizrakh, L. I.; Polonskaya, L. Yu.; Gvozdetskii, A. N.; Vasil'ev, A. M.; Ivanova, T. M.; Lisina, N. I.
Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 3 p. 210 - 217 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 3 p. 322 - 328 Title/Abstract Full Text View citing articles Show Details
Grin, L. M.; Khlaponina, L. N.; Pivnenko, N. S.; Selichenko, A. G.; Brutov, V. D.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 7 p. 476 - 479 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 7 p. 819 - 822 Title/Abstract Full Text View citing articles Show Details
Yous; Andrieux; Howell; Morgan; Renard; Pfeiffer; Lesieur; Guardiola-Lemaitre
Journal of Medicinal Chemistry, 1992 , vol. 35, # 8 p. 1484 - 1486 Title/Abstract Full Text View citing articles Show Details
Macor; Fox; Johnson; Koe; Lebel; Zorn
Journal of Medicinal Chemistry, 1992 , vol. 35, # 20 p. 3625 - 3632 Title/Abstract Full Text View citing articles Show Details
Hibert; McDermott; Middlemiss; Mir; Fozard
European Journal of Medicinal Chemistry, 1989 , vol. 24, # 1 p. 31 - 37 Title/Abstract Full Text View citing articles Show Details
Li, Liang; Lubman, David M.
Analytical Chemistry, 1988 , vol. 60, # 23 p. 2591 - 2598 Title/Abstract Full Text View citing articles Show Details
Repke, David B.; Grotjahn, Douglas B.; Shulgin, Alexander T.
Journal of Medicinal Chemistry, 1985 , vol. 28, # 7 p. 892 - 896 Title/Abstract Full Text View citing articles Show Details
Ivanova, E. V.; Popova, G. V.; Suvorov, N. N.
Journal of Organic Chemistry USSR (English Translation), 1992 , vol. 28, # 3.1 p. 385 - 390 Zhurnal Organicheskoi Khimii, 1992 , vol. 28, # 3 p. 474 - 481 Title/Abstract Full Text Show Details
Strobl; Von Kruedener; Stockigt; Guengerich; Wolff
Journal of Medicinal Chemistry, 1993 , vol. 36, # 9 p. 1136 - 1145 Title/Abstract Full Text View citing articles Show Details
Dijkstra, Gerard D. H.; Tulp, Martin Th. M.; Hermkens, Pedro H. H.; Maarseveen, Jan H. van; Scheeren, Hans W.; Kruse, Chris G.
Recueil des Travaux Chimiques des Pays-Bas, 1993 , vol. 112, # 2 p. 131 - 136 Title/Abstract Full Text View citing articles Show Details
Duarte, M. F. N.; Hutchinson, D. W.; Jennings, K. R.
Organic Mass Spectrometry, 1985 , vol. 20, # 7 p. 476 - 478 Title/Abstract Full Text Show Details
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Suvorov, N. N.; Popova, G. V.; Neklyudov, A. D.; Tsvetkov, E. V.; Turchin, K. F.; et al.
J. Gen. Chem. USSR (Engl. Transl.), 1982 , vol. 52, # 10 p. 2337 - 2342,2079 - 2083 Title/Abstract Full Text Show Details
Hoelscher, Peter; Knoelker, Hans-Joachim; Winterfeldt, Ekkehard
Israel Journal of Chemistry, 1991 , vol. 31, # 3 p. 187 - 194 Title/Abstract Full Text Show Details
7 of 239
8 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Maki, Yasuo; Kimoto, Hiroshi; Fujii, Shozo; Nishida, Masakazu; Cohen, Louis A.
Journal of Fluorine Chemistry, 1989 , vol. 43, p. 189 - 206 Title/Abstract Full Text View citing articles Show Details
Nichols; Lloyd; Johnson; Hoffman
Journal of Medicinal Chemistry, 1988 , vol. 31, # 7 p. 1406 - 1412 Title/Abstract Full Text View citing articles Show Details
Glennon; Titeler; Lyon; Slusher
Journal of Medicinal Chemistry, 1988 , vol. 31, # 4 p. 867 - 870 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.; Naiman, Noreen A.; Pierson, M. Edward; Smith, J. Doyle; Ismaiel, Abd M.; et al.
Journal of Medicinal Chemistry, 1989 , vol. 32, # 8 p. 1921 - 1926 Title/Abstract Full Text View citing articles Show Details
Blickenstaff; Brandstadter; Reddy; Witt
Journal of Pharmaceutical Sciences, 1994 , vol. 83, # 2 p. 216 - 218 Title/Abstract Full Text View citing articles Show Details
Wilkins, David J.; Jackson, Anthony H.; Shannon, Patrick V. R.
Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994 , # 3 p. 299 - 308 Title/Abstract Full Text View citing articles Show Details
Spadoni; Stankov; Duranti; Biella; Lucini; Salvatori; Fraschini
Journal of Medicinal Chemistry, 1993 , vol. 36, # 25 p. 4069 - 4074 Title/Abstract Full Text View citing articles Show Details
Balsamini; Spadoni; Duranti; Cerrini; Lamba; Fedeli
Farmaco, 1989 , vol. 44, # 4 p. 399 - 413 Title/Abstract Full Text View citing articles Show Details
Alapishvili, M. G.; Popova, G. V.; Vorontsov, E. D.; Kireev, V. V.; Suvorov, N. N.
J. Gen. Chem. USSR (Engl. Transl.), 1983 , vol. 53, # 5 p. 1040 - 1044,919 - 923 Title/Abstract Full Text Show Details
Guengoer, Timur; Malabre, Patrice; Teulon, J.M.
Synthetic Communications, 1994 , vol. 24, # 16 p. 2247 - 2256 Title/Abstract Full Text Show Details
Corcuera, Luis J.
Phytochemistry (Elsevier), 1984 , vol. 23, # 3 p. 539 - 542 Title/Abstract Full Text View citing articles Show Details
Petrunin, I. A.; Vinograd, L. Kh.; Przhiyalgovskaya, N. M.; Suvorov, N. N.
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1987 , vol. 23, # 8 p. 839 - 842 Khimiya Geterotsiklicheskikh Soedinenii, 1987 , # 8 p. 1050 - 1053 Title/Abstract Full Text View citing articles Show Details
Glennon; Dukat; El-Bermawy; Law; De los Angeles; Teitler; King; Herrick-Davis
Journal of Medicinal Chemistry, 1994 , vol. 37, # 13 p. 1929 - 1935 Title/Abstract Full Text View citing articles Show Details
Jackson, Anthony; Shannon, Patrick V. R.; Wilkins, David J.
Journal of the Chemical Society, Chemical Communications, 1987 , # 9 p. 653 - 654 Title/Abstract Full Text View citing articles Show Details
Kon-Ya, Kazumi; Shimidzu, Nobuyoshi; Miki, Wataru; Endo, Mamoru
Bioscience, Biotechnology, and Biochemistry, 1994 , vol. 58, # 12 p. 2178 - 2181 Title/Abstract Full Text Show Details
Pellegrini; Strassler; Weber; Borschberg
Tetrahedron Asymmetry, 1994 , vol. 5, # 10 p. 1979 - 1992 Title/Abstract Full Text View citing articles Show Details
Suvorova, E. V.; Popova, G. V.; Suvorov, N. N.
Russian Journal of General Chemistry, 1993 , vol. 63, # 9.2 p. 1480 - 1483 Zhurnal Obshchei Khimii, 1993 , vol. 63, # 9 p. 2126 - 2130 Title/Abstract Full Text Show Details
Mokrosz, M.J.; Paluchowska, M.H.; Misztal, S.
Polish Journal of Chemistry, 1995 , vol. 69, # 2 p. 264 - 268 Title/Abstract Full Text Show Details
Bascop, Sophie-Isabelle; Sapi, Janos; Laronze, Jean-Yves; Levy, Jean
Heterocycles, 1994 , vol. 38, # 4 p. 725 - 732 Title/Abstract Full Text View citing articles Show Details
Hardcastle
Journal of Pharmacy and Pharmacology, 1995 , vol. 47, # 9 p. 744 - 749 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Bioactivities present
Reference
Garaeva, L. D.; Goryunova, O. V.; Yartseva, I. V.; Mashalova, N. A.; Melnik, S. Ya.
Russian Journal of Bioorganic Chemistry, 1995 , vol. 21, # 9 p. 619 - 625 Bioorganicheskaya Khimiya, 1995 , vol. 21, # 9 p. 717 - 723 Title/Abstract Full Text Show Details
Gaillard, Patrick; Carrupt, Pierre-Alain; Testa, Bernard; Schambel, Philippe
Journal of Medicinal Chemistry, 1996 , vol. 39, # 1 p. 126 - 134 Title/Abstract Full Text View citing articles Show Details
Lasheras, Berta; Berjon, Angel; Montanes, Rafael; Roca, Joan; Romero, Gonzalo; Ramirez, Maria J.; Del Rio, Joaquin
Arzneimittel-Forschung/Drug Research, 1996 , vol. 46, # 4 p. 401 - 406 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.; Hong, Seoung-Soo; Bondarev, Mikhail; Law, Ho; Dukat, Malgorzata; Rakhit, Suman; Power, Patricia; Fan, Ermei; Kinneau, Diana; Kamboj, Rajender; Teitler, Milt; Herrick-Davis, Katharine; Smith, Carol
Journal of Medicinal Chemistry, 1996 , vol. 39, # 1 p. 314 - 322 Title/Abstract Full Text View citing articles Show Details
Kurihara, Takushi; Sakamoto, Yasuhiko; Kimura, Tetsuya; Ohishi, Hirofumi; Harusawa, Shinya; Yoneda, Ryuji; Suzutani, Tatsuo; Azuma, Masanobu
Chemical and Pharmaceutical Bulletin, 1996 , vol. 44, # 5 p. 900 - 908 Title/Abstract Full Text View citing articles Show Details
Chu, Lin; Fisher, Michael H.; Goulet, Mark T.; Wyvratt, Matthew J.
Tetrahedron Letters, 1997 , vol. 38, # 22 p. 3871 - 3874 Title/Abstract Full Text View citing articles Show Details
Abu-Eittah; Abdou
Journal de Chimie Physique et de Physico-Chimie Biologique, 1996 , vol. 93, # 11-12 p. 1958 - 1973 Title/Abstract Full Text View citing articles Show Details
Vera; Tijmes; Valladares
Steroids, 1997 , vol. 62, # 2 p. 226 - 229 Title/Abstract Full Text View citing articles Show Details
Yu, Qian-Sheng; Pei, Xue-Feng; Holloway, Harold W.; Greig, Nigel H.; Brossi, Arnold
Journal of Medicinal Chemistry, 1997 , vol. 40, # 18 p. 2895 - 2901 Title/Abstract Full Text View citing articles Show Details
Pacofsky, Gregory J.; Lackey, Karen; Alligood, Krystal J.; Berman, Judd; Charifson, Paul S.; Crosby, Renae M.; Dorsey Jr., George F.; Feldman, Paul L.; Gilmer, Tona M.; Hummel, Conrad W.; Jordan, Steven R.; Mohr, Christopher; Shewchuk, Lisa M.; Sternbach, Daniel D.; Rodriguez, Marc
Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1894 - 1908 Title/Abstract Full Text View citing articles Show Details
Lin, Pen-Yuan; Shi, Sheng-Jie; Hsu, Feng-Lin; Chen, Chieh-Fu
Journal of the Chinese Chemical Society, 1998 , vol. 45, # 2 p. 323 - 326 Title/Abstract Full Text View citing articles Show Details
Barf, Tjeerd; Wikstroem, Hakan; Pauwels, Petrus J.; Palmier, Christiane; Tardif, Stephanie; Lundmark, Max; Sundell, Staffan
Bioorganic and Medicinal Chemistry, 1998 , vol. 6, # 9 p. 1469 - 1479 Title/Abstract Full Text View citing articles Show Details
Suzuki, Takeshi; Imanishi, Naoki; Itahana, Hirotsune; Watanuki, Susumu; Miyata, Keiji; Ohta, Mitsuaki; Nakahara, Hideaki; Yamagiwa, Yoko; Mase, Toshiyasu
Chemical and Pharmaceutical Bulletin, 1998 , vol. 46, # 7 p. 1116 - 1124 Title/Abstract Full Text View citing articles Show Details
Carter; Champney; Hwang; Eglen
European Journal of Pharmacology, 1995 , vol. 280, # 3 p. 243 - 250 Title/Abstract Full Text View citing articles Show Details
Henin; Noe; Laronze; Pfeiffer; Renard; Guardiola-Lemaitre; Delagrange
Pharmaceutical Sciences, 1997 , vol. 3, # 5-6 p. 289 - 290 Title/Abstract Full Text View citing articles Show Details
Pan, Hui; Galligan, James J.
European Journal of Pharmacology, 1995 , vol. 278, # 1 p. 67 - 74 Title/Abstract Full Text View citing articles Show Details
Hong, Seoung-Soo; Dukat, Malgorzata; Teitler, Milt; Herrick-Davis, Kathy; McCallum, Kirk; et al.
Medicinal Chemistry Research, 1995 , vol. 5, # 9 p. 690 - 699 Title/Abstract Full Text Show Details
Ramirez; Garcia-Garayoa; Romero; Monge; Roca; Del Rio; Lasheras
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 1 p. 58 - 65 Title/Abstract Full Text View citing articles Show Details
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Hardcastle
Journal of Pharmacy and Pharmacology, 1998 , vol. 50, # 5 p. 539 - 547 Title/Abstract Full Text View citing articles Show Details
9 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Vacher, Bernard; Bonnaud, Bernard; Funes, Philippe; Jubault, Nathalie; Koek, Wouter; Assie, Marie-Bernadette; Cosi, Cristina
Journal of Medicinal Chemistry, 1998 , vol. 41, # 25 p. 5070 - 5083 Title/Abstract Full Text View citing articles Show Details
Charlet-Fagnere, Catherine; Jiang, Wei-Qun; Laronze, Jean-Yves
Tetrahedron Letters, 1999 , vol. 40, # 9 p. 1685 - 1688 Title/Abstract Full Text View citing articles Show Details
Somei, Masanori; Oshikiri, Naoki; Hasegawa, Masakazu; Yamada, Fumio
Heterocycles, 1999 , vol. 51, # 6 p. 1237 - 1242 Title/Abstract Full Text View citing articles Show Details
Adham, Nika; Zgombick, John M.; Bard, Jonathan
Journal of Pharmacology and Experimental Therapeutics, 1998 , vol. 287, # 2 p. 508 - 514 Title/Abstract Full Text View citing articles Show Details
Hewlett, William A.; Trivedi, Bakula L.; Zhang, Zhang-Jin; De Paulis, Tomas; Schmidt, Dennis E.; Lovinger, David M.; Ansari, M. Sib; Ebert, Michael H.
Journal of Pharmacology and Experimental Therapeutics, 1999 , vol. 288, # 1 p. 221 - 231 Title/Abstract Full Text View citing articles Show Details
Koike, Takeshi; Takeuchi, Naoki; Tobinaga, Seisho
Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 1 p. 128 - 130 Title/Abstract Full Text View citing articles Show Details
Leung; Walsh; Pulido-Rios; Eglen
British Journal of Pharmacology, 1996 , vol. 117, # 5 p. 926 - 930 Title/Abstract Full Text View citing articles Show Details
Leung; Blissard; Jett; Eglen
Naunyn-Schmiedeberg's Archives of Pharmacology, 1995 , vol. 351, # 6 p. 596 - 602 Title/Abstract Full Text View citing articles Show Details
Ge, Jian; Barnes, Nicholas M.
British Journal of Pharmacology, 1996 , vol. 117, # 7 p. 1475 - 1480 Title/Abstract Full Text View citing articles Show Details
El Mansari; Blier
British Journal of Pharmacology, 1996 , vol. 118, # 3 p. 681 - 689 Title/Abstract Full Text View citing articles Show Details
Haefelinger, Guenter; Nimtz, Manfred; Horstmann, Volker; Benz, Thomas
Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 1999 , vol. 54, # 3 p. 397 - 414 Title/Abstract Full Text View citing articles Show Details
Hela; Anipindi; Priyadarsini; O'Neill
Journal of Physical Chemistry B, 1999 , vol. 103, # 40 p. 8606 - 8611 Title/Abstract Full Text View citing articles Show Details
Wu, Shengde; Janusz, John M.
Tetrahedron Letters, 2000 , vol. 41, # 8 p. 1165 - 1169 Title/Abstract Full Text View citing articles Show Details
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Hope, Anthony G.; Peters, John A.; Brown, Angus M.; Lambert, Jeremy J.; Blackburn, Thomas P.
British Journal of Pharmacology, 1996 , vol. 118, # 5 p. 1237 - 1245 Title/Abstract Full Text View citing articles Show Details
Candura; Messori, Eliana; Franceschetti; D'Agostino; Vicini; Tagliani, Monica; Tonini
British Journal of Pharmacology, 1996 , vol. 118, # 8 p. 1965 - 1970 Title/Abstract Full Text View citing articles Show Details
Borea, Pier Andrea; Dalpiaz, Alessandro; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 298, # 3 p. 329 - 334 Title/Abstract Full Text View citing articles Show Details
Budhoo, Misra R.; Harris, R. Paul; Kellum, John M.
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 137 - 140 Title/Abstract Full Text View citing articles Show Details
Ansanay; Sebben; Bockaert; Dumuis
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 165 - 174 Title/Abstract Full Text View citing articles Show Details
Terron, Jose A.
British Journal of Pharmacology, 1996 , vol. 118, # 6 p. 1421 - 1428 Title/Abstract Full Text View citing articles Show Details
10 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Somei, Masanori; Fukui, Yoshikazu; Hasegawa, Masakazu; Oshikiri, Naoki; Hayashi, Toshikatsu
Heterocycles, 2000 , vol. 53, # 8 p. 1725 - 1736 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.; Lee, Mase; Rangisetty, Jagadeesh B.; Dukat, Malgorzata; Roth, Bryan L.; Savage, Jason E.; McBride, Ace; Rauser, Laura; Hufeisen, Sandy; Lee, David K. H.
Journal of Medicinal Chemistry, 2000 , vol. 43, # 5 p. 1011 - 1018 Title/Abstract Full Text View citing articles Show Details
Nakagawa, Hidehiko; Sumiki, Erika; Takusagawa, Mitsuko; Ikota, Nobuo; Matsushima, Yoshikazu; Ozawa, Toshihiko
Chemical and Pharmaceutical Bulletin, 2000 , vol. 48, # 2 p. 261 - 265 Title/Abstract Full Text View citing articles Show Details
Molinari; North; Dubocovich
European Journal of Pharmacology, 1996 , vol. 301, # 1-3 p. 159 - 168 Title/Abstract Full Text View citing articles Show Details
Pang; Tang; Song; Brown
Life Sciences, 1996 , vol. 58, # 13 p. 1047 - 1057 Title/Abstract Full Text View citing articles Show Details
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Amat; Seffar; Llor; Bosch
Synthesis, 2001 , # 2 p. 267 - 275 Title/Abstract Full Text View citing articles Show Details
Chung, In Hwa; Cha, Ki Suk; Seo, Jae Hong; Kim, Joong Hyup; Chung, Bong Young; Kim, Choong Sup
Heterocycles, 2000 , vol. 53, # 3 p. 529 - 533 Title/Abstract Full Text View citing articles Show Details
Zgombick, John M.; Schechter, Lee E.; Adham, Nika; Kucharewicz, Stefan A.; Weinshank, Richard L.; Branchek, Theresa A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 354, # 3 p. 226 - 236 Title/Abstract Full Text View citing articles Show Details
Bard, Jonathan A.; Kucharewicz, Stefan A.; Zgombick, John M.; Weinshank, Richard L.; Branchek, Theresa A.; Cohen, Marlene L.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 354, # 3 p. 237 - 244 Title/Abstract Full Text View citing articles Show Details
Dalpiaz, Alessandro; Borea, Pier Andrea; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 312, # 1 p. 107 - 114 Title/Abstract Full Text View citing articles Show Details
McLean, Peter G.; Coupar, Ian M.
European Journal of Pharmacology, 1996 , vol. 312, # 2 p. 215 - 225 Title/Abstract Full Text View citing articles Show Details
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Adham, Nika; Gerald, Christophe; Schechter, Lee; Vaysse, Pierre; Weinshank, Richard; Branchek, Theresa
European Journal of Pharmacology, 1996 , vol. 304, # 1-3 p. 231 - 235 Title/Abstract Full Text View citing articles Show Details
Hemedah; Coupar; Mitchelson
British journal of pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text View citing articles Show Details
Chu, Lin; Lo, Jane-Ling; Yang, Yi-Tien; Cheng, Kang; Smith, Roy G.; Fisher, Michael H.; Wyvratt, Matthew J.; Goulet, Mark T.
Bioorganic and Medicinal Chemistry Letters, 2001 , vol. 11, # 4 p. 515 - 517 Title/Abstract Full Text View citing articles Show Details
Meadows; De Wall; Barbour; Gokel
Journal of the American Chemical Society, 2001 , vol. 123, # 13 p. 3092 - 3107 Title/Abstract Full Text View citing articles Show Details
Wang, Hexiang; Ng, Tzi Bun
Pharmacology and Toxicology, 2000 , vol. 86, # 3 p. 125 - 128 Title/Abstract Full Text View citing articles Show Details
Pouilhes, Annie; Duval-Lungulescu, Monica; Lambel, Stephanie; Leonce, Stephane; Langlois, Yves
Tetrahedron Letters, 2001 , vol. 42, # 47 p. 8297 - 8299 Title/Abstract Full Text View citing articles Show Details
Prins, Nicolaas H.; Briejer, Michel R.; Schuurkes, Jan A.J.
British Journal of Pharmacology, 1997 , vol. 120, # 4 p. 714 - 720 Title/Abstract Full Text View citing articles Show Details
11 of 239
12 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Bi, Lanrong; Zhao, Ming; Wang, Chao; Peng, Shiqi; Winterfeldt, Ekkehard
Journal of Organic Chemistry, 2002 , vol. 67, # 1 p. 22 - 26 Title/Abstract Full Text View citing articles Show Details
Centurion, David; Ortiz, Mario I; Sanchez-Lopez, Araceli; De Vries, Peter; Saxena, Pramod R; Villalon, Carlos M
British Journal of Pharmacology, 2001 , vol. 132, # 5 p. 983 - 990 Title/Abstract Full Text View citing articles Show Details
Xue; Voss; Nelson; Duan; Cherney; Jacobson; He; Roderick; Chen; Corbett; Wang; Meyer; Kennedy; Degrado; Hardman; Teleha; Jaffee; Liu; Copeland; Covington; Christ; Trzaskos; Newton; Magolda; Wexler; Decicco
Journal of Medicinal Chemistry, 2001 , vol. 44, # 16 p. 2636 - 2660 Title/Abstract Full Text View citing articles Show Details
Padmanabhan, Seetharamaiyer; Lavin, Ruth C; Thakker, Paresh M; Guo, Jinqing; Zhang, Lu; Moore, Deke; Perlman, Michael E; Kirk, Cassandra; Daly, Deborah; Burke-Howie, Kathy J; Wolcott, Teresa; Chari, Suchitra; Berlove, David; Fischer, James B; Holt, William F; Durant, Graham J; McBurney, Robert N
Bioorganic and Medicinal Chemistry Letters, 2001 , vol. 11, # 24 p. 3151 - 3155 Title/Abstract Full Text View citing articles Show Details
Suzuki; Ohuchi; Asanuma; Kaneko; Yokomori; Ito; Isobe; Muramatsu
Chemical and Pharmaceutical Bulletin, 2001 , vol. 49, # 1 p. 29 - 39 Title/Abstract Full Text View citing articles Show Details
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
Revial, Gilbert; Jabin, Ivan; Lim, Sethy; Pfau, Michel
Journal of Organic Chemistry, 2002 , vol. 67, # 7 p. 2252 - 2256 Title/Abstract Full Text View citing articles Show Details
Russell; Baker; Barden; Beer; Bristow; Broughton; Knowles; McAllister; Patel; Castro
Journal of Medicinal Chemistry, 2001 , vol. 44, # 23 p. 3881 - 3895 Title/Abstract Full Text View citing articles Show Details
Aubriot, Silvere; Nicolle, Edwige; Lattier, Mireille; Morel, Cecile; Cao, Wenhong; Daniel, Kiefer W.; Collins, Sheila; Leclerc, Gerard; Faure, Patrice
Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 2 p. 209 - 212 Title/Abstract Full Text View citing articles Show Details
Pauwels, Petrus J.; Colpaert, Francis C.
Biochemical Pharmacology, 1995 , vol. 50, # 10 p. 1651 - 1658 Title/Abstract Full Text View citing articles Show Details
Mohanta, Pramod K.; Kim, Kyongtae
Tetrahedron Letters, 2002 , vol. 43, # 22 p. 3993 - 3996 Title/Abstract Full Text View citing articles Show Details
Dubocovich, Margarita L.; Masana, Monica I.; Iacob, Stanca; Sauri, Daniel M.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 355, # 3 p. 365 - 375 Title/Abstract Full Text View citing articles Show Details
Connors, Richard V.; Zhang, Alex J.; Shuttleworth, Stephen J.
Tetrahedron Letters, 2002 , vol. 43, # 37 p. 6661 - 6663 Title/Abstract Full Text View citing articles Show Details
Lee; Rangisetty; Dukat; Slassi; Maclean; Glennon
Medicinal Chemistry Research, 2000 , vol. 10, # 4 p. 230 - 242 Title/Abstract Full Text View citing articles Show Details
Antilla, Jon C.; Klapars, Artis; Buchwald, Stephen L.
Journal of the American Chemical Society, 2002 , vol. 124, # 39 p. 11684 - 11688 Title/Abstract Full Text View citing articles Show Details
Wu, Tom Y. H.; Schulte, Peter G.
Organic Letters, 2002 , vol. 4, # 23 p. 4033 - 4035 Title/Abstract Full Text View citing articles Show Details
Jiang, Weiqin; Zhang, Xuqing; Sui, Zhihua
Organic letters, 2003 , vol. 5, # 1 p. 43 - 46 Title/Abstract Full Text View citing articles Show Details
Terron
British journal of pharmacology, 1997 , vol. 121, # 3 p. 563 - 571 Title/Abstract Full Text View citing articles Show Details
Bayari; Ide
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2003 , vol. 59, # 6 p. 1255 - 1263 Title/Abstract Full Text View citing articles Show Details
Popova, Galina; Kireev, Vjacheslav; Spitsyn, Alexander; Ihara, Hirotaka; Scherbina, Maxim; Chvalun, Sergei
Molecular Crystals and Liquid Crystals Science and Technology Section A: Molecular Crystals and Liquid Crystals, 2002 , vol. 390, p. 91 - 96 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Bioactivities present
13 of 239
Reference
Ostrom, Rennolds S.; Ehlert, Frederick J.
Journal of Pharmacology and Experimental Therapeutics, 1997 , vol. 280, # 1 p. 189 - 199 Title/Abstract Full Text View citing articles Show Details
Ebersole, Barbara J.; Visiers, Irache; Weinstein, Harel; Sealfon, Stuart C.
Molecular Pharmacology, 2003 , vol. 63, # 1 p. 36 - 43 Title/Abstract Full Text View citing articles Show Details
He, Ling; Li, Ju-Lian; Zhang, Jian-Jun; Su, Pu; Zheng, Shi-Long
Synthetic Communications, 2003 , vol. 33, # 5 p. 741 - 747 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.
Journal of Medicinal Chemistry, 2003 , vol. 46, # 14 p. 2795 - 2812 Title/Abstract Full Text View citing articles Show Details
Castro, Alfredo C.; Dang, Luan C.; Soucy, Francois; Grenier, Louis; Mazdiyasni, Hormoz; Hottelet, Maria; Parent, Lana; Pien, Christine; Palombella, Vito; Adams, Julian
Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 14 p. 2419 - 2422 Title/Abstract Full Text View citing articles Show Details
Kiso, Tetsuo; Ito, Hiroyuki; Miyata, Keiji
European Journal of Pharmacology, 1997 , vol. 320, # 2-3 p. 187 - 192 Title/Abstract Full Text View citing articles Show Details
Karimi, Farhad; Langstroem, Bengt
European Journal of Organic Chemistry, 2003 , # 11 p. 2132 - 2137 Title/Abstract Full Text View citing articles Show Details
Thomson, Douglas W.; Commeureuc, Aurelien G. J.; Berlin, Stefan; Murphy, John A.
Synthetic Communications, 2003 , vol. 33, # 20 p. 3631 - 3641 Title/Abstract Full Text View citing articles Show Details
Remiszewski, Stacy W.; Sambucetti, Lidia C.; Bair, Kenneth W.; Bontempo, John; Cesarz, David; Chandramouli, Nagarajan; Chen, Ru; Cheung, Min; Cornell-Kennon, Susan; Dean, Karl; Diamantidis, George; France, Dennis; Green, Michael A.; Howell, Kobporn Lulu; Kashi, Rina; Kwon, Paul; Lassota, Peter; Martin, Mary S.; Mou, Yin; Perez, Lawrence B.; Sharma, Sushil; Smith, Troy; Sorensen, Eric; Taplin, Francis; Trogani, Nancy; Versace, Richard; Walker, Heather; Weltchek-Engler, Susan; Wood, Alexander; Wu, Arthur; Atadja, Peter
Journal of Medicinal Chemistry, 2003 , vol. 46, # 21 p. 4609 - 4624 Title/Abstract Full Text View citing articles Show Details
Janssen; Prins; Meulemans; Lefebvre
British Journal of Pharmacology, 2002 , vol. 136, # 2 p. 321 - 329 Title/Abstract Full Text View citing articles Show Details
Zhang, Zhang-Jin; Trivedi, Bakula L.; De Paulis, Tomas; Schmidt, Dennis E.; Hewlett, William A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 2002 , vol. 365, # 2 p. 123 - 132 Title/Abstract Full Text View citing articles Show Details
Ito, Chika; Isobe, Yoshihiko; Kawamura, Reiko; Kiuchi, Yoichi; Tsuchida, Katsuharu; Higuchi, Shohei
Journal of Pharmacology and Experimental Therapeutics, 1997 , vol. 280, # 1 p. 67 - 72 Title/Abstract Full Text View citing articles Show Details
Amemiya, Norihito; Hatta, Shinichi; Takemura, Haruo; Ohshika, Hideyo
European Journal of Pharmacology, 1996 , vol. 318, # 2-3 p. 403 - 409 Title/Abstract Full Text View citing articles Show Details
Jayaprakasam, Bolleddula; Strasburg, Gale A.; Nair, Muraleedharan G.
Tetrahedron, 2004 , vol. 60, # 13 p. 3109 - 3121 Title/Abstract Full Text View citing articles Show Details
Dukat, Malgorzata; Smith, Carol; Herrick-Davis, Katharine; Teitler, Milt; Glennon, Richard A.
Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 10 p. 2545 - 2552 Title/Abstract Full Text View citing articles Show Details
Taylor, Mark S.; Jacobsen, Eric N.
Journal of the American Chemical Society, 2004 , vol. 126, # 34 p. 10558 - 10559 Title/Abstract Full Text View citing articles Show Details
Adams, David; Benardeau, Agnes; Bickerdike, Mike J.; Bentley, Jon M.; Bissantz, Caterina; Bourson, Anne; Cliffe, Ian A.; Hebeisen, Paul; Kennett, Guy A.; Knight, Antony R.; Malcolm, Craig S.; Mizrahi, Jacques; Plancher, Jean-Marc; Richter, Hans; Roever, Stephan; Taylor, Sven; Vickers, Steven P.
Chimia, 2004 , vol. 58, # 9 p. 613 - 620 Title/Abstract Full Text View citing articles Show Details
Domenech; Beleta; Palacios
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 356, # 3 p. 328 - 334 Title/Abstract Full Text View citing articles Show Details
Gurkan, A. Selen; Karabay, Arzu; Buyukbingol, Zeliha; Adejare, Adeboye; Buyukbingol, Erdem
Archiv der Pharmazie, 2005 , vol. 338, # 2-3 p. 67 - 73 Title/Abstract Full Text View citing articles Show Details
Holenz, Joerg; Merce, Ramon; Diaz, Jose Luis; Guitart, Xavier; Codony, Xavier; Dordal, Alberto; Romero, Gonzalo; Torrens, Antoni; Mas, Josep; Andaluz, Blas; Hernandez, Susana; Monroy, Xavier; Sanchez, Elisabeth; Hernandez, Enrique; Perez, Raquel; Cubi, Roger; Sanfeliu, Olga; Buschmann, Helmut
Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1781 - 1795 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Bioactivities present
Reference
Zlotos, Darius P.
Archiv der Pharmazie, 2005 , vol. 338, # 5-6 p. 229 - 247 Title/Abstract Full Text View citing articles Show Details
Kloda, Anna; Adams, David J.
British Journal of Pharmacology, 2005 , vol. 144, # 3 p. 323 - 330 Title/Abstract Full Text View citing articles Show Details
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Harada, Hiroshi; Hirokawa, Yoshimi; Suzuki, Kenji; Hiyama, Yoichi; Oue, Mayumi; Kawashima, Hitoshi; Kato, Hiroshi; Yoshida, Naoyuki; Furutani, Yasuji; Kato, Shiro
Chemical and Pharmaceutical Bulletin, 2005 , vol. 53, # 2 p. 184 - 198 Title/Abstract Full Text View citing articles Show Details
Ates-Alagoz; Buyukbingol; Buyukbingol, Erdem
Pharmazie, 2005 , vol. 60, # 9 p. 643 - 647
Title/Abstract Full Text View citing articles Show Details
Hirst, Warren D.; Abrahamsen, Bjarke; Blaney, Frank E.; Calver, Andrew R.; Aloj, Lucia; Price, Gary W.; Medhurst, Andrew D.
Molecular Pharmacology, 2003 , vol. 64, # 6 p. 1295 - 1308 Title/Abstract Full Text View citing articles Show Details
Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.
Molecular Pharmacology, 1998 , vol. 54, # 1 p. 94 - 104 Title/Abstract Full Text View citing articles Show Details
De Vries; Villalon; Heiligers; Saxena
Naunyn-Schmiedeberg's archives of pharmacology, 1997 , vol. 356, # 1 p. 90 - 99 Title/Abstract Full Text View citing articles Show Details
Cheve, Gwenael; Duriez, Patrick; Fruchart, Jean-Charles; Teissier, Elisabeth; Poupaert, Jacques; Lesieur, Daniel
Medicinal Chemistry Research, 2002 , vol. 11, # 7 p. 361 - 379 Title/Abstract Full Text View citing articles Show Details
Narimatsu, Shizuo; Yonemoto, Rei; Saito, Keita; Takaya, Kazuo; Kumamoto, Takuya; Ishikawa, Tsutomu; Asanuma, Masato; Funada, Masahiko; Kiryu, Kimio; Naito, Shinsaku; Yoshida, Yuzo; Yamamoto, Shigeo; Hanioka, Nobumitsu
Biochemical Pharmacology, 2006 , vol. 71, # 9 p. 1377 - 1385 Title/Abstract Full Text View citing articles Show Details
Iskander, Magdy N.; Leung, Lok M.; Buley, Trevor; Ayad, Fadi; Di Iulio, Juliana; Tan, Yean Y.; Coupar, Ian M.
European Journal of Medicinal Chemistry, 2006 , vol. 41, # 1 p. 16 - 26 Title/Abstract Full Text View citing articles Show Details
Chernov; Shul'ts; Shakirov; Tolstikov
Russian Journal of Organic Chemistry, 2006 , vol. 42, # 6 p. 828 - 838 Title/Abstract Full Text View citing articles Show Details
Ates-Alagoz, Zeynep; Coban, Tulay; Buyukbingol, Erdem
Archiv der Pharmazie, 2006 , vol. 339, # 4 p. 193 - 200 Title/Abstract Full Text View citing articles Show Details
Van Tilburg, Erica W.; Windhorst, Albert D.; Van Der Mey, Margreet; Herscheid, Jacobus D. M.
Journal of Labelled Compounds and Radiopharmaceuticals, 2006 , vol. 49, # 4 p. 321 - 330 Title/Abstract Full Text View citing articles Show Details
Venkatachalam; Salaskar; Chattopadhyay; Barik; Mishra; Gangabhagirathi; Priyadarsini
Bioorganic and Medicinal Chemistry, 2006 , vol. 14, # 18 p. 6414 - 6419 Title/Abstract Full Text View citing articles Show Details
Somei, Masanori; Iwaki, Takako; Yamada, Fumio; Tanaka, Yoshio; Shigenobu, Koki; Koike, Katsuo; Suzuki, Nobuo; Hattori, Atsuhiko
Heterocycles, 2006 , vol. 68, # 8 p. 1565 - 1569 Title/Abstract Full Text View citing articles Show Details
Costagli, Chiara; Galli, Alessandro
Biochemical Pharmacology, 1998 , vol. 55, # 10 p. 1733 - 1737 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 66, # 1 p. 171 - 176 Title/Abstract Full Text View citing articles Show Details
Enzensperger, Christoph; Kilian, Susann; Ackermann, Marit; Koch, Anne; Kelch, Kristin; Lehmann, Jochen
Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 5 p. 1399 - 1402 Title/Abstract Full Text View citing articles Show Details
Sogawa; Tagawa; Fujino; Ohyama; Asanuma; Funada; Kitayama
Toxicology Letters, 2007 , vol. 170, # 1 p. 75 - 82 Title/Abstract Full Text View citing articles Show Details
14 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Suckling, Colin J.; Murphy, John A.; Khalaf, Abedawn I.; Zhou, Sheng-ze; Lizos, Dimitris E.; van Nhien, Albert Nguyen; Yasumatsu, Hiroshi; McVie, Allan; Young, Louise C.; McCraw, Corinna; Waterman, Peter G.; Morris, Brian J.; Pratt, Judith A.; Harvey, Alan L.
Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 9 p. 2649 - 2655 Title/Abstract Full Text View citing articles Show Details
Vickery; Mai; Kaufman; Beattie; Pulido-Rios; O'Keefe; Humphrey; Smith
British Journal of Pharmacology, 2007 , vol. 150, # 6 p. 782 - 791 Title/Abstract Full Text View citing articles Show Details
Scott, William L.; Martynow, Jacek G.; Huffman, John C.; O'Donnell, Martin J.
Journal of the American Chemical Society, 2007 , vol. 129, # 22 p. 7077 - 7088 Title/Abstract Full Text View citing articles Show Details
Choo, Yeun-Mun; Hamann, Mark T.
Heterocycles, 2007 , vol. 71, # 2 p. 245 - 252 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007 , vol. 68, # 3 p. 927 - 941 Title/Abstract Full Text View citing articles Show Details
Trujillo, John I.; Meyers, Marvin J.; Anderson, David R.; Hegde, Shridhar; Mahoney, Matthew W.; Vernier, William F.; Buchler, Ingrid P.; Wu, Kun K.; Yang, Syaluan; Hartmann, Susan J.; Reitz, David B.
Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 16 p. 4657 - 4663 Title/Abstract Full Text View citing articles Show Details
Di Giacomo, Barbara; Bedini, Annalida; Spadoni, Gilberto; Tarzia, Giorgio; Fraschini, Franco; Pannacci, Marilou; Lucini, Valeria
Bioorganic and Medicinal Chemistry, 2007 , vol. 15, # 13 p. 4643 - 4650 Title/Abstract Full Text View citing articles Show Details
Bower, Kiowa S.; Price, Kerry L.; Sturdee, Laura E.C.; Dayrell, Mariza; Dougherty, Dennis A.; Lummis, Sarah C.R.
European Journal of Pharmacology, 2008 , vol. 580, # 3 p. 291 - 297 Title/Abstract Full Text View citing articles Show Details
Shestakov; Sidorenko; Shikhaliev; Pavlenko
Russian Journal of General Chemistry, 2007 , vol. 77, # 10 p. 1749 - 1760 Title/Abstract Full Text View citing articles Show Details
Baylor College of Medicine
Patent: US5424185 A1, 1995 ; Title/Abstract Full Text Show Details
Zisapel; Nava; Laudon; Moshe
Patent: US4880826 A1, 1989 ;
Title/Abstract Full Text Show Details
Instituto Farmacologico Lombardo-IFLO, S.a.S.
Patent: US5552428 A1, 1996 ; Title/Abstract Full Text Show Details
Sankyo Company, Limited
Patent: US6013663 A1, 2000 ; Title/Abstract Full Text Show Details
Raheem, Izzat T.; Thiara, Parvinder S.; Peterson, Emily A.; Jacobsen, Eric N.
Journal of the American Chemical Society, 2007 , vol. 129, # 44 p. 13404 - 13405 Title/Abstract Full Text View citing articles Show Details
Soriano-Agaton, Flor; Lagoutte, Delphine; Poupon, Erwan; Roblot, Francois; Fournet, Alain; Gantier, Jean-Charles; Hocquemiller, Reynald
Journal of Natural Products, 2005 , vol. 68, # 11 p. 1581 - 1587 Title/Abstract Full Text View citing articles Show Details
Shishido, Yuji; Jinno, Madoka; Ikeda, Takafumi; Ito, Fumitaka; Sudo, Masaki; Makita, Naoya; Ohta, Atsuko; Iki-Taki, Ayako; Ohmi, Takashi; Kanai, Yoshihito; Tamura, Tetsuya; Shimojo, Masato
Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 3 p. 1072 - 1078 Title/Abstract Full Text View citing articles Show Details
Sharma, Neera; Jain, Sapan K.; Rastogi, Ramesh C.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2008 , vol. 69, # 3 p. 748 - 756 Title/Abstract Full Text View citing articles Show Details
Passarella, Daniele; Belinghieri, Francesca; Scarpellini, Michele; Pratesi, Graziella; Zunino, Franco; Gia, Ornella Maria; Via, Lisa Dalla; Santoro, Giuseppe; Danieli, Bruno
Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 5 p. 2431 - 2438 Title/Abstract Full Text View citing articles Show Details
Mumford, Peter M.; Shiers, Jason J.; Tarver, Gary J.; Hayes, Jerome F.; Shipman, Michael
Tetrahedron Letters, 2008 , vol. 49, # 21 p. 3489 - 3491 Title/Abstract Full Text View citing articles Show Details
Lukehart; Raja
Inorganic Chemistry, 1982 , vol. 21, # 3 p. 1278 - 1280 Title/Abstract Full Text View citing articles Show Details
15 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
THE JOHNS HOPKINS UNIVERSITY
Patent: WO2008/124660 A2, 2008 ; Title/Abstract Full Text Show Details
NEURIM PHARMACEUTICALS (1991) LTD.
Patent: US2008/132559 A1, 2008 ; Title/Abstract Full Text Show Details
Gobbi, Luca; Knust, Henner; Malherbe, Parichehr; Nettekoven, Matthias; Pinard, Emmanuel; Roche, Olivier; Rogers-Evans, Mark
Patent: US2008/249125 A1, 2008 ; Title/Abstract Full Text Show Details
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Yerkes, Nancy; Wu, Jia Xin; McCoy, Elizabeth; Galan, M. Carmen; Chen, Shi; O'Connor, Sarah E.
Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 10 p. 3095 - 3098 Title/Abstract Full Text View citing articles Show Details
Kiviranta, Paeivi H.; Salo, Heikki S.; Leppaenen, Jukka; Rinne, Valtteri M.; Kyrylenko, Sergiy; Kuusisto, Erkki; Suuronen, Tiina; Salminen, Antero; Poso, Antti; Lahtela-Kakkonen, Maija; Wallen, Erik A.A.
Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 17 p. 8054 - 8062 Title/Abstract Full Text View citing articles Show Details
SEQUELLA, INC.
Patent: WO2005/34857 A2, 2005 ; Title/Abstract Full Text Show Details
Kulkarni, Aditya; Abid, Mohammed; Toeroek, Bela; Huang, Xudong
Tetrahedron Letters, 2009 , vol. 50, # 16 p. 1791 - 1794 Title/Abstract Full Text View citing articles Show Details
Klausen, Rebekka S.; Jacobsen, Eric N.
Organic Letters, 2009 , vol. 11, # 4 p. 887 - 890 Title/Abstract Full Text View citing articles Show Details
Delgado, Rieardo; Blakey, Simon B.
European Journal of Organic Chemistry, 2009 , # 10 p. 1506 - 1510 Title/Abstract Full Text View citing articles Show Details
Bou-Hamdan, Farhan R.; Leighton, James L.
Angewandte Chemie, International Edition, 2009 , vol. 48, # 13 p. 2403 - 2406 Title/Abstract Full Text View citing articles Show Details
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Australian Journal of Chemistry, 2009 , vol. 62, # 2 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
Chen, Zhuo; Hu, Gaoyun; Li, Dai; Chen, Jun; Li, Yuanjian; Zhou, Huayong; Xie, Ye
Bioorganic and Medicinal Chemistry, 2009 , vol. 17, # 6 p. 2351 - 2359 Title/Abstract Full Text View citing articles Show Details
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
European Journal of Medicinal Chemistry, 2009 , vol. 44, # 7 p. 2952 - 2959 Title/Abstract Full Text View citing articles Show Details
Alyab'ev; Kravchenko; Ivashchenko
Russian Journal of Organic Chemistry, 2009 , vol. 45, # 5 p. 719 - 724
Title/Abstract Full Text View citing articles Show Details
Luo, Xin-Feng; He, Ling; Yin, Hai-Bin; Zheng, Hu; Bei, Di; Deng, Jin-Jin; Huang, Wen-Cai
Synthetic Communications, 2009 , vol. 39, # 19 p. 3444 - 3452 Title/Abstract Full Text View citing articles Show Details
Aventis Pharma Limited
Patent: US6352977 B1, 2002 ; Title/Abstract Full Text Show Details
Schreiber, Stuart L.; Stavenger, Robert A.; Mitchison, Timothy J.; Maliga, Zoltan
Patent: US2004/59138 A1, 2004 ; Title/Abstract Full Text Show Details
WYETH
Patent: WO2004/24734 A1, 2004 ; Title/Abstract Full Text Show Details
The Procter and Gamble Company
Patent: US6784293 B1, 2004 ; Title/Abstract Full Text Show Details
16 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Neurim Pharmaceuticals (1991) Ltd.
Patent: US6858642 B1, 2005 ; Title/Abstract Full Text Show Details
Infinity Pharmaceuticals, Inc.
Patent: US2006/20004 A1, 2006 ; Title/Abstract Full Text Show Details
Miller, John F.; Turner, Elizabeth M.; Sherrill, Ronald G.; Gudmundsson, Kristjan; Spaltenstein, Andrew; Sethna, Phiroze; Brown, Kevin W.; Harvey, Robert; Romines, Karen R.; Golden, Pamela
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 1 p. 256 - 259 Title/Abstract Full Text View citing articles Show Details
Phutdhawong, Waya S.; Ruensamran, Wanwikar; Phutdhawong, Weerachai; Taechowisan, Thongchai
Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 19 p. 5753 - 5756 Title/Abstract Full Text View citing articles Show Details
Peng, Jiangnan; Kudrimoti, Sucheta; Prasanna, Sivaprakasam; Odde, Srinivas; Doerksen, Robert J.; Pennaka, Hari K.; Choo, Yeun-Mun; Rao, Karumanchi V.; Tekwani, Babu L.; Madgula, Vamsi; Khan, Shabana I.; Wang, Bin; Mayer, Alejandro M. S.; Jacob, Melissa R.; Tu, Lan Chun; Gertsch, Juerg; Hamann, Mark T.
Journal of Medicinal Chemistry, 2010 , vol. 53, # 1 p. 61 - 76 Title/Abstract Full Text View citing articles Show Details
White, James D.; Li, Yang; Ihle, David C.
Journal of Organic Chemistry, 2010 , vol. 75, # 11 p. 3569 - 3577 Title/Abstract Full Text View citing articles Show Details
LES LABORATOIRES SERVIER
Patent: US2010/204276 A1, 2010 ; Title/Abstract Full Text Show Details
Wu, Xiaoyu; Dai, Xiaoyang; Nie, Linlin; Fang, Huihui; Chen, Jie; Ren, Zhongjiao; Cao, Weiguo; Zhao, Gang
Chemical Communications, 2010 , vol. 46, # 16 p. 2733 - 2735 Title/Abstract Full Text View citing articles Show Details
Zhou, Yu; Zhai, Yun; Li, Jian; Ye, Deju; Jiang, Hualiang; Liu, Hong
Green Chemistry, 2010 , vol. 12, # 8 p. 1397 - 1404 Title/Abstract Full Text View citing articles Show Details
GRUeNENTHAL GMBH
Patent: WO2006/18184 A2, 2006 ; Title/Abstract Full Text Show Details
Bi, Wei; Bi, Yue; Xue, Ping; Zhang, Yanrong; Gao, Xiang; Wang, Zhibo; Li, Meng; Baudy-Floch, Michele; Ngerebara, Nathaniel; Gibson, K. Michael; Bi, Lanrong
Journal of Medicinal Chemistry, 2010 , vol. 53, # 18 p. 6763 - 6767 Title/Abstract Full Text View citing articles Show Details
Gastaminza, Pablo; Whitten-Bauer, Christina; Chisari, Francis V.
Proceedings of the National Academy of Sciences of the United States of America, 2010 , vol. 107, # 1 p. 291 - 296 Title/Abstract Full Text View citing articles Show Details
Barker, Emma; Jensen, Annika Jenmalm; Nordling, Erik; Proud, Andrew; Slater, Martin; Weber, Michael; Tedenborg, Lars
Patent: US2006/217375 A1, 2006 ; Title/Abstract Full Text Show Details
NEURIM PHARMACEUTICALS (1991) LTD.
Patent: WO2007/93880 A2, 2007 ; Title/Abstract Full Text Show Details
Holloway, Chloe A.; Muratore, Michael E.; Storer, R. Lan; Dixon, Darren J.
Organic Letters, 2010 , vol. 12, # 21 p. 4720 - 4723 Title/Abstract Full Text View citing articles Show Details
Defalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A.J.
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 23 p. 7076 - 7079 Title/Abstract Full Text View citing articles Show Details
Benkovics, Tamas; Guzei, Ilia A.; Yoon, Tehshik P.
Angewandte Chemie - International Edition, 2010 , vol. 49, # 48 p. 9153 - 9157 Title/Abstract Full Text View citing articles Show Details
Zhang, Shou-Hua; Wang, Chun-Ye; Jiang, Zhen-Zhou; Ni, Pei-Zhou; Zhou, Jin-Pei; Xi, Bao-Min; Chen, Wen-Hua
Chemical and Pharmaceutical Bulletin, 2011 , vol. 59, # 1 p. 96 - 99 Title/Abstract Full Text View citing articles Show Details
Fang, Huihui; Wu, Xiaoyu; Nie, Linlin; Dai, Xiaoyang; Chen, Jie; Cao, Weiguo; Zhao, Gang
Organic Letters, 2010 , vol. 12, # 23 p. 5366 - 5369 Title/Abstract Full Text View citing articles Show Details
Finlayson, Rhys; Brackovic, Amira; Simon-Levert, Annabel; Banaigs, Bernard; O'Toole, Ronan F.; Miller, Christopher H.; Copp, Brent R.
Tetrahedron Letters, 2011 , vol. 52, # 7 p. 837 - 840 Title/Abstract Full Text View citing articles Show Details
17 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
HERCULES TECHNOLOGY MANAGEMENT CO V, INC.; BLAGG, Julian
Patent: WO2011/47156 A1, 2011 ; Title/Abstract Full Text Show Details
Dai, Xiaoyang; Wu, Xiaoyu; Fang, Huihui; Nie, Linlin; Chen, Jie; Deng, Hongmei; Cao, Weiguo; Zhao, Gang
Tetrahedron, 2011 , vol. 67, # 17 p. 3034 - 3040 Title/Abstract Full Text View citing articles Show Details
DUKE UNIVERSITY
Patent: US2011/112073 A1, 2011 ; Title/Abstract Full Text Show Details
Duce, Sara; Pesciaioli, Fabio; Gramigna, Lucia; Bernardi, Luca; Mazzanti, Andrea; Ricci, Alfredo; Bartoli, Giuseppe; Bencivenni, Giorgio
Advanced Synthesis and Catalysis, 2011 , vol. 353, # 6 p. 860 - 864 Title/Abstract Full Text View citing articles Show Details
Nicolaou; Kiappes; Tian, Weiwei; Gondi, Vijaya B.; Becker, Jochen
Organic Letters, 2011 , vol. 13, # 15 p. 3924 - 3927 Title/Abstract Full Text View citing articles Show Details
Wu, Xiaoyu; Fang, Huihui; Liu, Qin; Nie, Linlin; Chen, Jie; Cao, Weiguo; Zhao, Gang
Tetrahedron, 2011 , vol. 67, # 38 p. 7251 - 7257 Title/Abstract Full Text View citing articles Show Details
Zhang, Pu Yong; Wan, Sheng Biao; Ren, Su Mei; Jiang, Tao
Chinese Chemical Letters, 2010 , vol. 21, # 11 p. 1307 - 1309 Title/Abstract Full Text View citing articles Show Details
Wu, Xiaoyu; Dai, Xiaoyang; Fang, Huihui; Nie, Linlin; Chen, Jie; Cao, Weiguo; Zhao, Gang
Chemistry - A European Journal, 2011 , vol. 17, # 38 p. 10510 - 10514 Title/Abstract Full Text View citing articles Show Details
Badillo, Joseph J.; Silva-Garcia, Abel; Shupe, Benjamin H.; Fettinger, James C.; Franz, Annaliese K.
Tetrahedron Letters, 2011 , vol. 52, # 43 p. 5550 - 5553 Title/Abstract Full Text View citing articles Show Details
Lallemand, Benjamin; Chaix, Fabien; Bury, Marina; Bruyere, Celine; Ghostin, Jean; Becker, Jean-Paul; Delporte, Cedric; Gelbcke, Michel; Mathieu, Veronique; Dubois, Jacques; Prevost, Martine; Jabin, Ivan; Kiss, Robert
Journal of Medicinal Chemistry, 2011 , vol. 54, # 19 p. 6501 - 6513 Title/Abstract Full Text View citing articles Show Details
PHARMA MAR, S.A.; MARTIN LOPEZ, M Jesus; FRANCESCH SOLLOSO, Andres; CUEVAS MARCHANTE, Maria del Carmen
Patent: WO2011/147828 A1, 2011 ; Title/Abstract Full Text Show Details
Shan, Wen-Jun; Huang, Ling; Zhou, Qi; Meng, Fan-Chao; Li, Xing-Shu
European Journal of Medicinal Chemistry, 2011 , vol. 46, # 12 p. 5885 - 5893 Title/Abstract Full Text View citing articles Show Details
Alam, Athar; Pal, Chinmay; Goyal, Manish; Kundu, Milan Kumar; Kumar, Rahul; Iqbal, Mohd Shameel; Dey, Sumanta; Bindu, Samik; Sarkar, Souvik; Pal, Uttam; Maiti, Nakul C.; Adhikari, Susanta; Bandyopadhyay, Uday
Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 24 p. 7365 - 7373 Title/Abstract Full Text View citing articles Show Details
Jiang, Huailei; Wang, Xu; Huang, Ling; Luo, Zonghua; Su, Tao; Ding, Ke; Li, Xingshu
Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 23 p. 7228 - 7235 Title/Abstract Full Text View citing articles Show Details
Teichert, Johannes F.; Fananas-Mastral, Martin; Feringa, Ben L.
Synthesis, 2012 , vol. 44, # 3 art. no. T104711SS, p. 409 - 416 Title/Abstract Full Text View citing articles Show Details
Klochkov; Afanas'eva; Ermatova; Chudinov
Chemistry of Natural Compounds, 2011 , vol. 47, # 5 p. 716 - 725 Title/Abstract Full Text View citing articles Show Details
Cuny, Gregory D.; Ulyanova, Natalia P.; Patnaik, Debasis; Liu, Ji-Feng; Lin, Xiangjie; Auerbach, Ken; Ray, Soumya S.; Xian, Jun; Glicksman, Marcie A.; Stein, Ross L.; Higgins, Jonathan M.G.
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 5 p. 2015 - 2019 Title/Abstract Full Text View citing articles Show Details
Huang, Dan; Xu, Fangxi; Lin, Xufeng; Wang, Yanguang
Chemistry - A European Journal, 2012 , vol. 18, # 11 p. 3148 - 3152 Title/Abstract Full Text View citing articles Show Details
Ascic, Erhad; Hansen, Casper L.; Le Quement, Sebastian T.; Nielsen, Thomas E.
Chemical Communications, 2012 , vol. 48, # 27 p. 3345 - 3347 Title/Abstract Full Text View citing articles Show Details
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
18 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
MacDonald, Jacob P.; Badillo, Joseph J.; Arevalo, Gary E.; Silva-Garcia, Abel; Franz, Annaliese K.
ACS Combinatorial Science, 2012 , vol. 14, # 4 p. 285 - 293
Title/Abstract Full Text View citing articles Show Details
Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 8 p. 2885 - 2888 Title/Abstract Full Text View citing articles Show Details
Dueckert, Heiko; Pries, Verena; Khedkar, Vivek; Menninger, Sascha; Bruss, Hanna; Bird, Alexander W.; Maliga, Zoltan; Brockmeyer, Andreas; Janning, Petra; Hyman, Anthony; Grimme, Stefan; Schuermann, Markus; Preut, Hans; Huebel, Katja; Ziegler, Slava; Kumar, Kamal; Waldmann, Herbert
Nature Chemical Biology, 2012 , vol. 8, # 2 p. 179 - 184 Title/Abstract Full Text View citing articles Show Details
Pal, Chinmay; Bindu, Samik; Dey, Sumanta; Alam, Athar; Goyal, Manish; Iqbal, Mohd Shameel; Sarkar, Souvik; Kumar, Rahul; Halder, Kamal Krishna; Debnath, Mita Chatterjee; Adhikari, Susanta; Bandyopadhyay, Uday
Journal of Biological Chemistry, 2012 , vol. 287, # 5 p. 3495 - 3509 Title/Abstract Full Text View citing articles Show Details
Jida, Mouhamad; Soueidan, Olivier-Mohamad; Deprez, Benoit; Laconde, Guillaume; Deprez-Poulain, Rebecca
Green Chemistry, 2012 , vol. 14, # 4 p. 909 - 911 Title/Abstract Full Text View citing articles Show Details
Zi, Weiwei; Xie, Weiqing; Ma, Dawei
Journal of the American Chemical Society, 2012 , vol. 134, # 22 p. 9126 - 9129 Title/Abstract Full Text View citing articles Show Details
Modha, Sachin G.; Vachhani, Dipak D.; Jacobs, Jeroen; Van Meervelt, Luc; Van Der Eycken, Erik V.
Chemical Communications, 2012 , vol. 48, # 52 p. 6550 - 6552 Title/Abstract Full Text View citing articles Show Details
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Klochkov; Afanas'eva; Pukhov
Chemistry of Heterocyclic Compounds, 2012 , vol. 48, # 2 p. 384 - 385 Title/Abstract Full Text View citing articles Show Details
Nirogi, Ramakrishna V.S.; Kambhampati, Ramasastri; Kothmirkar, Prabhakar; Konda, Jagadishbabu; Bandyala, Thrinath Reddy; Gudla, Parandhama; Arepalli, Sobhanadri; Gangadasari, Narasimhareddy P.; Shinde, Anil K.; Deshpande, Amol D.; Dwarampudi, Adireddy; Chindhe, Anil K.; Dubey, Pramod Kumar
Journal of Enzyme Inhibition and Medicinal Chemistry, 2012 , vol. 27, # 3 p. 443 - 450 Title/Abstract Full Text View citing articles Show Details
Liu, Lianzhu; Zhang, Liming
Angewandte Chemie - International Edition, 2012 , vol. 51, # 29 p. 7301 - 7304 Title/Abstract Full Text View citing articles Show Details
Albrecht, Anna; Morana, Fabio; Fraile, Alberto; Jørgensen, Karl Anker
Chemistry - A European Journal, 2012 , vol. 18, # 33 p. 10348 - 10354 Title/Abstract Full Text View citing articles Show Details
Perlovich, German L.; Proshin, Alexey N.; Volkova, Tatyana V.; Petrova, Ludmila N.; Bachurin, Sergey O.
Molecular Pharmaceutics, 2012 , vol. 9, # 8 p. 2156 - 2167 Title/Abstract Full Text View citing articles Show Details
CHEMILIA AB; HOeGBERG, Marita; DAHLSTEDT, Emma; SMITT, Olof; JOHANSSON, Tommy
Patent: WO2012/127032 A1, 2012 ; Title/Abstract Full Text Show Details
Dong, Guoqiang; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Yongqiang; Guo, Zizhao; Zhang, Wannian; Sheng, Chunquan
Journal of Medicinal Chemistry, 2012 , vol. 55, # 17 p. 7593 - 7613 Title/Abstract Full Text View citing articles Show Details
Gore, Sangram; Baskaran, Sundarababu; König, Burkhard
Organic Letters, 2012 , vol. 14, # 17 p. 4568 - 4571 Title/Abstract Full Text View citing articles Show Details
Zhu, Hai-Liang; Ling, Jun-Bing; Xu, Peng-Fei
Journal of Organic Chemistry, 2012 , vol. 77, # 17 p. 7737 - 7743,7 Title/Abstract Full Text Show Details
Patel, Paresh K.; Patel, Rahul V.; Mehta, Girish N.; Mahajan, Dharmesh H.; Parikh, Parimal A.; Chikhalia, Kishor H.
Medicinal Chemistry Research, 2012 , vol. 21, # 10 p. 3182 - 3194,13 Title/Abstract Full Text Show Details
Sanaboina, Chakrapani; Jana, Samaresh; Chidara, Sridhar; Patro, Balaram; Raolji, Gajendrasinh Balvantsinh; Eppakayala, Laxminarayana
Tetrahedron Letters, 2012 , vol. 53, # 37 p. 5027 - 5029,3 Title/Abstract Full Text Show Details
Kitson, Sean L.
Current Pharmaceutical Design, 2007 , vol. 13, # 25 p. 2621 - 2637 Title/Abstract Full Text View citing articles Show Details
19 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Anisimova; Spasov; Kosolapov; Tolpygin; Porotikov; Kucheryavenko; Sysoeva; Tibir'kova; El'tsova
Pharmaceutical Chemistry Journal, 2009 , vol. 43, # 9 p. 491 - 494 Title/Abstract Full Text View citing articles Show Details
Huang, Xi-Ping; Setola, Vincent; Yadav, Prem N.; Allen, John A.; Rogan, Sarah C.; Hanson, Bonnie J.; Revankar, Chetana; Robers, Matt; Doucette, Chris; Roth, Bryan L.
Molecular Pharmacology, 2009 , vol. 76, # 4 p. 710 - 722 Title/Abstract Full Text View citing articles Show Details
Zhou, Shu-Feng; Liu, Jun-Ping; Lai, Xin-Sheng
Current Medicinal Chemistry, 2009 , vol. 16, # 21 p. 2661 - 2805 Title/Abstract Full Text View citing articles Show Details
Miller, Keith J.; Wu, Ginger Y.; Varnes, Jeffrey G.; Levesque, Paul; Li, Julia; Li, Danshi; Robl, Jeffrey A.; Rossi, Karen A.; Wacker, Dean A.
Molecular Pharmacology, 2009 , vol. 76, # 6 p. 1211 - 1219 Title/Abstract Full Text View citing articles Show Details
Rosse, Gerard; Schaffhauser, Herve
Current Topics in Medicinal Chemistry, 2010 , vol. 10, # 2 p. 207 - 221 Title/Abstract Full Text View citing articles Show Details
Volk, Balazs; Nagy, Bence J.; Vas, Szilvia; Kostyalik, Diana; Simig, Gyula; Bagdy, Gyoergy
Current Topics in Medicinal Chemistry, 2010 , vol. 10, # 5 p. 554 - 578
Title/Abstract Full Text View citing articles Show Details
Hanna-Elias; Manallack; Berque-Bestel; Irving; Coupar; Iskander
Current Medicinal Chemistry, 2010 , vol. 17, # 25 p. 2775 - 2787 Title/Abstract Full Text View citing articles Show Details
Beckers, Daniel P.; Goldstin, Bella; Gullikson, Gary W.; Loeffler, Richard; Moormann, Alan; Moummi, Chaffiq; Nosal, Roger; Spangler, Dale; Villamil, Clara I.; Yang, Dai-C.; Zabrowski, Daniel L; Flynn, Daniel L.
Pharmacochemistry Library, 1996 , vol. 24, # C p. 99 - 120 Title/Abstract Full Text View citing articles Show Details
Klein, Michael T.; Dukat, Malgorzata; Glennon, Richard A.; Teitler, Milt
Journal of Pharmacology and Experimental Therapeutics, 2011 , vol. 337, # 3 p. 860 - 867 Title/Abstract Full Text View citing articles Show Details
Zhu, Hai-Liang; Ling, Jun-Bing; Xu, Peng-Fei
Journal of Organic Chemistry, 2012 , vol. 77, # 17 p. 7737 - 7743 Title/Abstract Full Text View citing articles Show Details
Wei, Yuhui; Xi, Lili; Yao, Xiaojun; Li, Jiazhong; Wu, Xinan
Archiv der Pharmazie, 2012 , vol. 345, # 10 p. 759 - 766 Title/Abstract Full Text View citing articles Show Details
Hayama, Tadashi; Sakaguchi, Yohei; Yoshida, Hideyuki; Itoyama, Miki; Todoroki, Kenichiro; Yamaguchi, Masatoshi; Nohta, Hitoshi
Analytical Chemistry, 2012 , vol. 84, # 19 p. 8407 - 8414 Title/Abstract Full Text View citing articles Show Details
Peshkov, Vsevolod A.; Pereshivko, Olga P.; Der Eycken, Erik V. Van
Advanced Synthesis and Catalysis, 2012 , vol. 354, # 14-15 p. 2841 - 2848 Title/Abstract Full Text View citing articles Show Details
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Engel-Andreasen, Jens; Shimpukade, Bharat; Ulven, Trond
Green Chemistry, 2013 , vol. 15, # 2 p. 336 - 340 Title/Abstract Full Text View citing articles Show Details
Chemilia AB; Högberg, Marita; Johansson, Tommy; Dahlstedt, Emma; Smitt, Olof
Patent: EP2502924 A1, 2012 ; Title/Abstract Full Text Show Details
Pharma Mar, S.A.; Martín López, Ma Jesús; Francesch Solloso, Andrés; Cuevas Marchante, Maria del Carmen
Patent: US2013/66067 A1, 2013 ; Title/Abstract Full Text Show Details
Eschenbrenner-Lux, Vincent; Dückert, Heiko; Khedkar, Vivek; Bruss, Hanna; Waldmann, Herbert; Kumar, Kamal
Chemistry - A European Journal, 2013 , vol. 19, # 7 p. 2294 - 2304 Title/Abstract Full Text View citing articles Show Details
Hong, Bor-Cherng; Liao, Wei-Kai; Dange, Nitin S.; Liao, Ju-Hsiou
Organic Letters, 2013 , vol. 15, # 3 p. 468 - 471 Title/Abstract Full Text View citing articles Show Details
INTELLECT NEUROSCIENCES, INC.; CHAIN, Daniel, G.
Patent: WO2013/63086 A1, 2013 ; Title/Abstract Full Text Show Details
20 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
NATREON, INC.; Ghosal, Shibnath; Veeraragavan, Muruganandam; Kalidindi, Sanyasi R.
Patent: US2013/115316 A1, 2013 ; Title/Abstract Full Text Show Details
Sun, Jing; Zhang, Li-Li; Yan, Chao-Guo
Tetrahedron, 2013 , vol. 69, # 26 p. 5451 - 5459 Title/Abstract Full Text View citing articles Show Details
Desroses, Matthieu; Koolmeister, Tobias; Jacques, Sylvain; Llona-Minguez, Sabin; Jacques-Cordonnier, Marie-Caroline; Cazares-Koerner, Armando; Helleday, Thomas; Scobie, Martin
Tetrahedron Letters, 2013 , vol. 54, # 27 p. 3554 - 3557 Title/Abstract Full Text View citing articles Show Details
Klochkov; Afanas'Eva; Bulychev, Yu. N.; Neganova; Shevtsova
Russian Chemical Bulletin, 2012 , vol. 61, # 2 p. 409 - 415 Title/Abstract Full Text View citing articles Show Details
Yin, Qin; Wang, Shou-Guo; You, Shu-Li
Organic Letters, 2013 , vol. 15, # 11 p. 2688 - 2691 Title/Abstract Full Text View citing articles Show Details
Aillaud, Isabelle; Barber, David M.; Thompson, Amber L.; Dixon, Darren J.
Organic Letters, 2013 , vol. 15, # 12 p. 2946 - 2949 Title/Abstract Full Text View citing articles Show Details
Taborsky; Delvigs; Page; Crawford
Journal of medicinal chemistry, 1965 , vol. 8, # 4 p. 60 - 66 Title/Abstract Full Text View citing articles Show Details
Daly; Creveling; Witkop
Journal of medicinal chemistry, 1966 , vol. 9, # 3 p. 273 - 280 Title/Abstract Full Text Show Details
De Bruyn, Tom; Van Westen, Gerard J.P.; IJzerman, Adriaan P.; Stieger, Bruno; De Witte, Peter; Augustijns, Patrick F.; Annaert, Pieter P.
Molecular Pharmacology, 2013 , vol. 83, # 6 p. 1257 - 1267 Title/Abstract Full Text View citing articles Show Details
Bennett Jr; Snyder
Molecular Pharmacology, 1976 , vol. 12, # 3 p. 373 - 389 Title/Abstract Full Text View citing articles Show Details
Davidson; Weidley
Life Sciences, 1976 , vol. 18, # 11 p. 1279 - 1284 Title/Abstract Full Text Show Details
Creese; Snyder
European journal of pharmacology, 1978 , vol. 49, # 2 p. 201 - 202 Title/Abstract Full Text Show Details
UNIVERSITY OF CALCUTTA; COUNCIL OF SCIENTIFIC and INDUSTRIAL RESEARCH; Bandyopadhyay, Uday; Pal, Chinmay; Bindu, Samik; Adhikari, Susanta Sekhar
Patent: US2013/197052 A1, 2013 ; Title/Abstract Full Text Show Details
Mori, Mattia; Tintori, Cristina; Christopher, Robert Selwyne Arul; Radi, Marco; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, Patrizia; DelleMonache, Simona; Angelucci, Adriano; Kissova, Miroslava; Crespan, Emmanuele; Maga, Giovanni; Botta, Maurizio
ChemMedChem, 2013 , vol. 8, # 3 p. 484 - 496 Title/Abstract Full Text View citing articles Show Details
Bockaert; Claeysen; Compan; Dumuis
Current drug targets. CNS and neurological disorders, 2004 , vol. 3, # 1 p. 39 - 51 Title/Abstract Full Text Show Details
Woolley, Marie L; Marsden, Charles A; Fone, Kevin C F
Current drug targets. CNS and neurological disorders, 2004 , vol. 3, # 1 p. 59 - 79 Title/Abstract Full Text Show Details
Zhu, Yan-Ping; Liu, Mei-Cai; Cai, Qun; Jia, Feng-Cheng; Wu, An-Xin
Chemistry - A European Journal, 2013 , vol. 19, # 31 p. 10132 - 10137 Title/Abstract Full Text View citing articles Show Details
Alebouyeh, Mahmoud; Takeda, Michio; Onozato, Maristela Lika; Tojo, Akihiro; Noshiro, Rie; Hasannejad, Habib; Inatomi, Jun; Narikawa, Shinichi; Huang, Xiu-Lin; Khamdang, Suparat; Anzai, Naohiko; Endou, Hitoshi
Journal of Pharmacological Sciences, 2003 , vol. 93, # 4 p. 430 - 436 Title/Abstract Full Text View citing articles Show Details
Leopoldo
Current Medicinal Chemistry, 2004 , vol. 11, # 5 p. 629 - 661 Title/Abstract Full Text View citing articles Show Details
Claeysen, Sylvie; Joubert, Lara; Sebben, Michele; Bockaert, Joel; Dumuis, Aline
The Journal of biological chemistry, 2003 , vol. 278, # 2 p. 699 - 702 Title/Abstract Full Text Show Details
Show next 20
21 of 239
Hide facts Comment (Pharmacological Data)
Bioactivities present
Reference
Ebersole, Barbara J.; Weinstein, Harel; Sealfon, Stuart C.
Journal of Biological Chemistry, 2002 , vol. 277, # 39 p. 36577 - 36584 Title/Abstract Full Text View citing articles Show Details
Teitler, Milt; Herrick-Davis, Katharine; Purohit, Anil
Current topics in medicinal chemistry, 2002 , vol. 2, # 6 p. 529 - 538 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A; Metwally, Kamel; Dukat, Malgorzata; Ismaiel, Abd M; De los Angeles, Joseph; Herndon, Jeffery; Teitler, Milt; Khorana, Nantaka
Current topics in medicinal chemistry, 2002 , vol. 2, # 6 p. 539 - 558 Title/Abstract Full Text View citing articles Show Details
Berger, Michael L
Neuroscience Letters, 2000 , vol. 296, # 1 p. 29 - 32 Title/Abstract Full Text View citing articles Show Details
Prins; Van Haselen; Lefebvre; Briejer; Akkermans; Schuurkes
British Journal of Pharmacology, 1999 , vol. 127, # 6 p. 1431 - 1437 Title/Abstract Full Text View citing articles Show Details
Prabhakar; Kumar, N. Vasanth; Reddy, M. Ravikanth; Sarma; Reddy, G. Om
Organic Process Research and Development, 1999 , vol. 3, # 3 p. 155 - 160 Title/Abstract Full Text View citing articles Show Details
Rubenstein, Lester A.; Lanzara, Richard G.
Journal of Molecular Structure: THEOCHEM, 1998 , vol. 430, # 1-3 p. 57 - 71 Title/Abstract Full Text View citing articles Show Details
Adham, Nika; Zgombick, John M.; Bard, Jonathan; Branchek, Theresa A.
Journal of Pharmacology and Experimental Therapeutics, 1998 , vol. 287, # 2 p. 508 - 514 Title/Abstract Full Text View citing articles Show Details
Hemedah; Coupar; Mitchelson
British Journal of Pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text Show Details
Boess, Frank G.; Monsma Jr., Frederick J.; Sleight, Andrew J.
Journal of Neurochemistry, 1998 , vol. 71, # 5 p. 2169 - 2177 Title/Abstract Full Text View citing articles Show Details
De Vries, Peter; Villalon, Carlos M.; Heiligers, Jan P. C.; Saxena, Pramod R.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 356, # 1 p. 90 - 99 Title/Abstract Full Text View citing articles Show Details
Pregenzer, Jeffrey F.; Alberts, Glen L.; Bock, Jeffrey H.; Slightom, Jerry L.; Bin Im, Wha
Neuroscience Letters, 1997 , vol. 235, # 3 p. 117 - 120 Title/Abstract Full Text View citing articles Show Details
Kaumann; Sanders; Brown; Murray
Naunyn-Schmiedeberg's archives of pharmacology, 1991 , vol. 344, # 2 p. 150 - 159 Title/Abstract Full Text Show Details
Blondel, Olivier; Gastineau, Monique; Dahmoune, Yamina; Langlois, Michel; Fischmeister, Rodolphe
Journal of Neurochemistry, 1998 , vol. 70, # 6 p. 2252 - 2261 Title/Abstract Full Text View citing articles Show Details
Terron, Jose A.
British Journal of Pharmacology, 1997 , vol. 121, # 3 p. 563 - 571 Title/Abstract Full Text View citing articles Show Details
Adham; Gerald; Schechter; Vaysse; Weinshank; Branchek
European journal of pharmacology, 1996 , vol. 304, # 1-3 p. 231 - 235 Title/Abstract Full Text Show Details
Parker, Eric M.; Izzarelli, Darcy G.; Lewis-Higgins, Lore; Palmer, Dawn; Shapiro, Robert A.
Journal of Neurochemistry, 1996 , vol. 67, # 5 p. 2096 - 2103
Title/Abstract Full Text View citing articles Show Details
Leung; Pulido-Rios; Bonhaus; Pekins; Zeitung; Hsu; Clark; Wong; Eglen
Naunyn-Schmiedeberg's archives of pharmacology, 1996 , vol. 354, # 2 p. 145 - 156 Title/Abstract Full Text Show Details
Leung; Walsh; Pulido-Rios; Eglen
British Journal of Pharmacology, 1996 , vol. 117, # 5 p. 926 - 930 Title/Abstract Full Text View citing articles Show Details
Budhoo; Harris; Kellum
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 137 - 144 Title/Abstract Full Text Show Details
22 of 239
23 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Pang; Tang; Song; Brown
Life Sciences, 1996 , vol. 58, # 13 p. 1047 - 1057 Title/Abstract Full Text Show Details
Sebben; Ansanay; Bockaert; Dumuis
NeuroReport, 1994 , vol. 5, # 18 p. 2553 - 2557 Title/Abstract Full Text Show Details
Pauwels; Colpaert
Biochemical Pharmacology, 1995 , vol. 50, # 10 p. 1651 - 1658 Title/Abstract Full Text Show Details
Waeber; Sebben; Grossman; Javoy-Agid; Bockaert; Dumuis
Neuroreport, 1993 , vol. 4, # 11 p. 1239 - 1242 Title/Abstract Full Text Show Details
Sugden; Chong; Lewis
British Journal of Pharmacology, 1995 , vol. 114, # 3 p. 618 - 623 Title/Abstract Full Text View citing articles Show Details
Pan; Galligan
European Journal of Pharmacology, 1995 , vol. 278, # 1 p. 67 - 74 Title/Abstract Full Text Show Details
To; Bonhaus; Eglen; Jakeman
British Journal of Pharmacology, 1995 , vol. 115, # 1 p. 107 - 116 Title/Abstract Full Text View citing articles Show Details
Johnson, Michael P.; Loncharich, Richard J.; Baez, Melvyn; Nelson, David L.
Molecular Pharmacology, 1994 , vol. 45, # 2 p. 277 - 286 Title/Abstract Full Text View citing articles Show Details
Gale; Grossman; Whitehead; Oxford; Bunce; Humphrey
British Journal of Pharmacology, 1994 , vol. 111, # 1 p. 332 - 338 Title/Abstract Full Text View citing articles Show Details
Schmuck; Ullmer; Engels; Lubbert
FEBS Letters, 1994 , vol. 342, # 1 p. 85 - 90 Title/Abstract Full Text Show Details
Schiavi; Brunet; Rizzi; Ladinsky
Neuropharmacology, 1994 , vol. 33, # 3-4 p. 543 - 549 Title/Abstract Full Text Show Details
Lee; Ueno; Sunagane; Sun
American Journal of Physiology - Heart and Circulatory Physiology, 1994 , vol. 266, # 3 35-3 p. H1000-H1006 Title/Abstract Full Text View citing articles Show Details
Schoeffter; Waeber
Naunyn-Schmiedeberg's Archives of Pharmacology, 1994 , vol. 350, # 4 p. 356 - 360 Title/Abstract Full Text Show Details
Wardle; Sanger
British Journal of Pharmacology, 1993 , vol. 110, # 4 p. 1593 - 1599 Title/Abstract Full Text View citing articles Show Details
Shen; Monsma Jr.; Metcalf; Jose; Hamblin; Sibley
Journal of Biological Chemistry, 1993 , vol. 268, # 24 p. 18200 - 18204 Title/Abstract Full Text Show Details
Bard; Zgombick; Adham; Vaysse; Branchek; Weinshank
Journal of Biological Chemistry, 1993 , vol. 268, # 31 p. 23422 - 23426 Title/Abstract Full Text Show Details
Ruat; Traiffort; Leurs; Tardivel-Lacombe; Diaz; Arrang -; Schwartz
Proceedings of the National Academy of Sciences of the United States of America, 1993 , vol. 90, # 18 p. 8547 - 8551 Title/Abstract Full Text Show Details
Becker; Gettys; Middleton; Olsen; Albers; Lee -; Fanburg; Raymond
Molecular Pharmacology, 1992 , vol. 42, # 5 p. 817 - 825 Title/Abstract Full Text Show Details
Zgombick; Schechter; Macchi; Hartig; Branchek; Weinshank
Molecular Pharmacology, 1992 , vol. 42, # 2 p. 180 - 185 Title/Abstract Full Text Show Details
Adham; Kao; Schechter; Bard; Olsen; Urquhart; Durkin; Hartig; Weinshank; Branchek
Proceedings of the National Academy of Sciences of the United States of America, 1993 , vol. 90, # 2 p. 408 - 412 Title/Abstract Full Text Show Details
Comment (Pharmacological Data)
Bioactivities present
Reference
Eglen; Alvarez; Johnson; Leung; Wong
British Journal of Pharmacology, 1993 , vol. 108, # 2 p. 376 - 382 Title/Abstract Full Text View citing articles Show Details
Monsma Jr.; Shen; Ward; Hamblin; Sibley
Molecular Pharmacology, 1993 , vol. 43, # 3 p. 320 - 327 Title/Abstract Full Text Show Details
Wainscott; Cohen; Schenck; Audia; Nissen; Baez; Kursar; Lucaites; Nelson
Molecular Pharmacology, 1993 , vol. 43, # 3 p. 419 - 426 Title/Abstract Full Text Show Details
Sweetnam; Caldwell; Lancaster; Bauer Jnr.; McMillan; Kinnier; Price
Journal of Natural Products (Lloydia), 1993 , vol. 56, # 4 p. 441 - 455 Title/Abstract Full Text Show Details
Foguet; Hoyer; Pardo; Parekh; Kluxen; Kalkman; Stuhmer; Lubbert
EMBO Journal, 1992 , vol. 11, # 9 p. 3481 - 3487 Title/Abstract Full Text Show Details
Eison; Wright; Freeman
Life sciences, 1992 , vol. 51, # 10 p. PL95-99 Title/Abstract Full Text Show Details
Rhodes; Colemann; Lattimer
Naunyn-Schmiedeberg's Archives of Pharmacology, 1992 , vol. 346, # 5 p. 496 - 503 Title/Abstract Full Text Show Details
Mourey; Dawson; Barrow; Enna; Snyder
Molecular pharmacology, 1992 , vol. 42, # 4 p. 619 - 626 Title/Abstract Full Text Show Details
Hamblin; Metcalf; McGuffin; Karpells
Biochemical and Biophysical Research Communications, 1992 , vol. 184, # 2 p. 752 - 759 Title/Abstract Full Text Show Details
Zgombick; Weinshank; Macchi; Schechter; Branchek; Hartig
Molecular Pharmacology, 1991 , vol. 40, # 6 p. 1036 - 1042 Title/Abstract Full Text Show Details
Schiavone; Giraldo; Giudici; Turconi; Sagrada
Life Sciences, 1992 , vol. 51, # 8 p. 583 - 592 Title/Abstract Full Text Show Details
Weinshank; Zgombick; Macchi; Branchek; Hartig
Proceedings of the National Academy of Sciences of the United States of America, 1992 , vol. 89, # 8 p. 3630 - 3634 Title/Abstract Full Text Show Details
Baines; Downer
Archives of insect biochemistry and physiology, 1991 , vol. 16, # 3 p. 153 - 163 Title/Abstract Full Text View citing articles Show Details
Hamblin; Metcalf
Molecular Pharmacology, 1991 , vol. 40, # 2 p. 143 - 148 Title/Abstract Full Text Show Details
Boulenguez; Chauveau; Segu; Morel; Lanoir; Delaage
European Journal of Pharmacology, 1991 , vol. 194, # 1 p. 91 - 98 Title/Abstract Full Text Show Details
Stankov; Cozzi; Lucini; Fumagalli; Scaglione; Fraschini
Neuroendocrinology, 1991 , vol. 53, # 3 p. 214 - 221 Title/Abstract Full Text Show Details
Glennon; Ismaiel; Chaurasia; Titeler
Drug Development Research, 1991 , vol. 22, # 1 p. 25 - 36 Title/Abstract Full Text View citing articles Show Details
Elswood; Bunce; Humphrey
European Journal of Pharmacology, 1991 , vol. 196, # 2 p. 149 - 155 Title/Abstract Full Text Show Details
Villalon; Den Boer; Heiligers; Saxena
British Journal of Pharmacology, 1991 , vol. 102, # 1 p. 107 - 112 Title/Abstract Full Text View citing articles Show Details
Eglen; Swank; Walsh; Whiting
British journal of pharmacology, 1990 , vol. 101, # 3 p. 513 - 520 Title/Abstract Full Text Show Details
24 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Sharif; Wong; Loury; Stefanich; Michel; Eglen; Whiting
British journal of pharmacology, 1991 , vol. 102, # 4 p. 919 - 925 Title/Abstract Full Text Show Details
Baxter; Craig; Clarke
Naunyn-Schmiedeberg's archives of pharmacology, 1991 , vol. 343, # 5 p. 439 - 446 Title/Abstract Full Text Show Details
Ivins; Molinoff
Molecular Pharmacology, 1990 , vol. 37, # 5 p. 622 - 630 Title/Abstract Full Text View citing articles Show Details
Lewis; Arendt; English
Journal of Pharmacology and Experimental Therapeutics, 1990 , vol. 252, # 1 p. 370 - 373 Title/Abstract Full Text View citing articles Show Details
Craig; Clarke
Journal of Pharmacology and Experimental Therapeutics, 1990 , vol. 252, # 3 p. 1378 - 1386 Title/Abstract Full Text View citing articles Show Details
Glennon; Chaurasia; Titeler
Journal of Medicinal Chemistry, 1990 , vol. 33, # 10 p. 2777 - 2784 Title/Abstract Full Text Show Details
Waeber; Schoeffter; Hoyer; Palacios
Neurochemical research, 1990 , vol. 15, # 6 p. 567 - 582 Title/Abstract Full Text Show Details
Dumuis; Bouhelal; Sebben; Cory; Bockaert
Molecular Pharmacology, 1988 , vol. 34, # 6 p. 880 - 887 Title/Abstract Full Text View citing articles Show Details
Glennon; Naiman; Pierson; Smith; Ismaiel; Titeler; Lyon
Journal of Medicinal Chemistry, 1989 , vol. 32, # 8 p. 1921 - 1926 Title/Abstract Full Text View citing articles Show Details
Dubocovich; Shankar; Mickel
European journal of pharmacology, 1989 , vol. 162, # 2 p. 289 - 299
Title/Abstract Full Text Show Details
Hoyer; Waeber; Schoeffter; Palacios; Dravid
Naunyn-Schmiedeberg's archives of pharmacology, 1989 , vol. 339, # 3 p. 252 - 258 Title/Abstract Full Text Show Details
Taylor; Nikam; Weck; Martin; Nelson
Life Sciences, 1987 , vol. 41, # 16 p. 1961 - 1969 Title/Abstract Full Text Show Details
Lyon; Titeler; Seggel; Glennon
European Journal of Pharmacology, 1988 , vol. 145, # 3 p. 291 - 297 Title/Abstract Full Text Show Details
Herrick-Davis; Titeler; Leonhardt; Struble; Price
Journal of neurochemistry, 1988 , vol. 51, # 6 p. 1906 - 1912 Title/Abstract Full Text Show Details
Hoyer; Neijt
Molecular Pharmacology, 1988 , vol. 33, # 3 p. 303 - 309 Title/Abstract Full Text View citing articles Show Details
Herrick-Davis; Titeler
Journal of Neurochemistry, 1988 , vol. 50, # 5 p. 1624 - 1631 Title/Abstract Full Text View citing articles Show Details
Hoyer
Trends in Pharmacological Sciences, 1988 , vol. 9, # 3 p. 89 - 94 Title/Abstract Full Text Show Details
Waeber; Schoeffter; Palacios; Hoyer
Naunyn-Schmiedeberg's Archives of Pharmacology, 1988 , vol. 337, # 6 p. 595 - 601 Title/Abstract Full Text Show Details
Duncan; Takahashi; Dubocovich
Endocrinology, 1988 , vol. 122, # 5 p. 1825 - 1833 Title/Abstract Full Text Show Details
Glennon
Journal of Medicinal Chemistry, 1987 , vol. 30, # 1 p. 1 - 12 Title/Abstract Full Text Show Details
25 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Heuring; Peroutka
The Journal of neuroscience : the official journal of the Society for Neuroscience, 1987 , vol. 7, # 3 p. 894 - 903 Title/Abstract Full Text Show Details
Hoyer; Vos; Closse; Pazos; Palacios; Davies
Naunyn-Schmiedeberg's archives of pharmacology, 1987 , vol. 335, # 3 p. 226 - 230 Title/Abstract Full Text Show Details
Dubocovich; Takahashi
Proceedings of the National Academy of Sciences of the United States of America, 1987 , vol. 84, # 11 p. 3916 - 3920 Title/Abstract Full Text Show Details
Lyon; Davis; Titeler
Molecular pharmacology, 1987 , vol. 31, # 2 p. 194 - 199 Title/Abstract Full Text Show Details
Schlegel; Peroutka
Biochemical Pharmacology, 1986 , vol. 35, # 12 p. 1943 - 1949 Title/Abstract Full Text Show Details
Peroutka
Journal of Neurochemistry, 1986 , vol. 47, # 2 p. 529 - 540 Title/Abstract Full Text View citing articles Show Details
Hoyer; Engel; Kalkman
European journal of pharmacology, 1985 , vol. 118, # 1-2 p. 1 - 12 Title/Abstract Full Text Show Details
Hall; el Mestikawy; Emerit; Pichat; Hamon; Gozlan
Journal of neurochemistry, 1985 , vol. 44, # 6 p. 1685 - 1696 Title/Abstract Full Text Show Details
Clancy; Maayani
Journal of Pharmacology and Experimental Therapeutics, 1985 , vol. 233, # 3 p. 761 - 769 Title/Abstract Full Text View citing articles Show Details
Branchek; Kates; Gershon
Brain Research, 1984 , vol. 324, # 1 p. 107 - 118 Title/Abstract Full Text Show Details
Dubocovich
Journal of Pharmacology and Experimental Therapeutics, 1985 , vol. 234, # 2 p. 395 - 401 Title/Abstract Full Text View citing articles Show Details
Gozlan; El Mestikawy; Pichat; Glowinski; Hamon
Nature, 1983 , vol. 305, # 5930 p. 140 - 142 Title/Abstract Full Text Show Details
Cascio; Kellar
European journal of pharmacology, 1983 , vol. 95, # 1-2 p. 31 - 39 Title/Abstract Full Text Show Details
Leysen; Gommeren; De Clerck
European journal of pharmacology, 1983 , vol. 88, # 1 p. 125 - 130 Title/Abstract Full Text Show Details
Weiss; Drummond
Molecular Pharmacology, 1981 , vol. 20, # 3 p. 592 - 597 Title/Abstract Full Text View citing articles Show Details
Liu, Song; Scotti, John S.; Kozmin, Sergey A.
Journal of Organic Chemistry, 2013 , vol. 78, # 17 p. 8645 - 8654 Title/Abstract Full Text View citing articles Show Details
Gregory, Alex W.; Jakubec, Pavol; Turner, Paul; Dixon, Darren J.
Organic Letters, 2013 , vol. 15, # 17 p. 4330 - 4333 Title/Abstract Full Text View citing articles Show Details
Kellar; Cascio
European journal of pharmacology, 1982 , vol. 78, # 4 p. 475 - 478 Title/Abstract Full Text Show Details
Leysen; Niemegeers; Van Nueten; Laduron
Molecular pharmacology, 1982 , vol. 21, # 2 p. 301 - 314 Title/Abstract Full Text Show Details
Middlemiss; Carroll; Fisher; Mounsey
European journal of pharmacology, 1980 , vol. 66, # 2-3 p. 253 - 254 Title/Abstract Full Text Show Details
26 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Peroutka; Snyder
Molecular Pharmacology, 1979 , vol. 16, # 3 p. 687 - 699 Title/Abstract Full Text View citing articles Show Details
Peroutka; Lebovitz; Snyder
Molecular Pharmacology, 1979 , vol. 16, # 3 p. 700 - 708 Title/Abstract Full Text View citing articles Show Details
Hwang; Van Woert
Journal of Pharmacology and Experimental Therapeutics, 1980 , vol. 213, # 2 p. 254 - 260 Title/Abstract Full Text View citing articles Show Details
Creese; Prosser; Snyder
Life Sciences, 1978 , vol. 23, # 5 p. 495 - 499 Title/Abstract Full Text Show Details
Northup; Mansour
Molecular Pharmacology, 1978 , vol. 14, # 5 p. 804 - 819 Title/Abstract Full Text View citing articles Show Details
Horn
Journal of Neurochemistry, 1973 , vol. 21, # 4 p. 883 - 888 Title/Abstract Full Text Show Details
Mellini, Paolo; Kokkola, Tarja; Suuronen, Tiina; Salo, Heikki S.; Tolvanen, Laura; Mai, Antonello; Lahtela-Kakkonen, Maija; Jarho, Elina M.
Journal of Medicinal Chemistry, 2013 , vol. 56, # 17 p. 6681 - 6695 Title/Abstract Full Text View citing articles Show Details
Aziz, Jessy; Brion, Jean-Daniel; Hamze, Abdallah; Alami, Mouad
Advanced Synthesis and Catalysis, 2013 , vol. 355, # 11-12 p. 2417 - 2429 Title/Abstract Full Text View citing articles Show Details
Wei, Qiang; Wang, Ya-Yi; Du, Yu-Liu; Gong, Liu-Zhu
Beilstein Journal of Organic Chemistry, 2013 , vol. 9, p. 1559 - 1564 Title/Abstract Full Text View citing articles Show Details
Zhang, Di-Han; Tang, Xiang-Ying; Wei, Yin; Shi, Min
Chemistry - A European Journal, 2013 , vol. 19, # 41 p. 13668 - 13673 Title/Abstract Full Text View citing articles Show Details
Ionescu, Alexandra; Cornut, Damien; Soriano, Sebastien; Guissart, Celine; Van Antwerpen, Pierre; Jabin, Ivan
Tetrahedron Letters, 2013 , vol. 54, # 45 p. 6087 - 6089 Title/Abstract Full Text View citing articles Show Details
Li, Zeng; Li, Jing; Yang, Nan; Chen, Ying; Zhou, Yu; Ji, Xun; Zhang, Lei; Wang, Jinfang; Xie, Xin; Liu, Hong
Journal of Organic Chemistry, 2013 , vol. 78, # 21 p. 10802 - 10811 Title/Abstract Full Text View citing articles Show Details
Baxter, Gordon Smith; Borman, Richard Anthony.
Patent: WO2001/8668 A2, 2001 ; Title/Abstract Full Text Show Details
Campbell, A. K.; Siddle, K.
Biochim. Biophys. Acta (G) [1963-], 1977 , vol. 497, # 1 p. 62 - 74 Title/Abstract Full Text Show Details
Gerald, Christophe; Hartig, Paul R.; Branchek, Theresa; Weinshank, Richard L.
Patent: US5766879 , 1998 ; Title/Abstract Full Text Show Details
Bard, Jonathan A.; Branchek, Theresa; Weinshank, Richard L.
Patent: US2003/166066 A1, 2003 ; Title/Abstract Full Text Show Details
Sibley, David R.; Monsma, Frederick J.; Hamblin, Mark
Patent: US2002/91235 A1, 2002 ; Title/Abstract Full Text Show Details
Weinshank; Richard L.; Branchek; Theresa; Hartig; Paul R.
Patent: US6475746 , 2002 ; Title/Abstract Full Text Show Details
Weinshank; Richard L.; Branchek; Theresa; Hartig; Paul R.
Patent: US6406859 , 2002 ; Title/Abstract Full Text Show Details
BISWAL, Shyam; SINGH, Anju; MALHOTRA, Deepti
Patent: WO2008/124660 A2, 2008 ; Title/Abstract Full Text Show Details
27 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Borman, Richard Anthony; Tilford, Nicholas Sean; Baxter, Gordon Smith.
Patent: WO2002/56010 , 2002 ; Title/Abstract Full Text Show Details
Blond, Aurelie; Dockerty, Paul; Alvarez, Raquel; Turcaud, Serge; Lecourt, Thomas; Micouin, Laurent
Journal of Organic Chemistry, 2013 , vol. 78, # 23 p. 12236 - 12242 Title/Abstract Full Text View citing articles Show Details
Liu, Yong; Wang, Qun; Zhang, Ying; Huang, Jianbiao; Nie, Linlin; Chen, Jie; Cao, Weiguo; Wu, Xiaoyu
Journal of Organic Chemistry, 2013 , vol. 78, # 23 p. 12009 - 12017 Title/Abstract Full Text View citing articles Show Details
Kuo, Ping-Chung; Li, Yue-Chiun; Hwang, Tsong-Long; Ma, Guo-Hao; Yang, Mei-Lin; Lee, E-Jian; Wu, Tian-Shung
Tetrahedron Letters, 2014 , vol. 55, # 1 p. 108 - 110 Title/Abstract Full Text View citing articles Show Details
Beasley, Benjamin O.; Alli-Balogun, Abimbola; Clarkson, Guy J.; Shipman, Michael
Tetrahedron Letters, 2014 , vol. 55, # 2 p. 541 - 543 Title/Abstract Full Text View citing articles Show Details
Winter, Evelyn; Lecerf-Schmidt, Florine; Gozzi, Gustavo; Peres, Basile; Lightbody, Mark; Gauthier, Charlotte; Ozvegy-Laczka, Csilla; Szakacs, Gergely; Sarkadi, Balazs; Creczynski-Pasa, Tainia B.; Boumendjel, Ahcene; Di Pietro, Attilio
Journal of Medicinal Chemistry, 2013 , vol. 56, # 24 p. 9849 - 9860 Title/Abstract Full Text View citing articles Show Details
TABORSKY; MCISAAC
Journal of medicinal chemistry, 1964 , vol. 7, p. 135 - 141 Title/Abstract Full Text View citing articles Show Details
Cathy D.Mahle; Katherine S.Takaki; A. John Watson
Annual reports in medicinal chemistry, 1997 , vol. 32, p. 31 - 40 Title/Abstract Full Text Show Details
J. E. Leysen; J. P. Tollenaere
Annual reports in medicinal chemistry, 1982 , vol. 17, p. 1 - 10 Title/Abstract Full Text Show Details
ROBERT G. TABORSKY; PETER DELVIGS; DJURO PALAIC; MERLIN BUMPUS
Journal of medicinal chemistry, 1967 , vol. 10, # 3 p. 403 - 407 Title/Abstract Full Text Show Details
BORMAN Richard Anthony; TILFORD Nicholas Sean; BAXTER Gordon Smith
Patent: WO2002/56010 A2, 2002 ; Title/Abstract Full Text Show Details
KETTLE, Anthony
Patent: WO2002/90575 A1, 2002 ; Title/Abstract Full Text Show Details
SATYA P. GUPTA; PRITHVI SINGH; MAHESH C. BINDAL
Chemical reviews, 1983 , vol. 83, # 6 p. 633 - 649 Title/Abstract Full Text Show Details
Richard L. Weinshank; Theresa Branchek; Paul R. Hartig
Patent: US5786155 A, 1998 ; Title/Abstract Full Text Show Details
V. A. Anisimova; N. I. Avdyunina; A. A. Spasov; I. A. Barchan
Pharm Chem J, 2002 , vol. 36, # 7 p. 377 - 381 Title/Abstract Full Text Show Details
Jonathan A. Bard; Theresa Branchek; Richard L. Weinshank
Patent: US5985585 A, 1999 ; Title/Abstract Full Text Show Details
Christophe Gerald; Paul R. Hartig; Theresa Branchek; Richard L. Weinshank
Patent: US6331401 B1, 2001 ; Title/Abstract Full Text Show Details
GERALD, Christophe; HARTIG, Paul; BRANCHEK, Theresa, A.; WEINSHANK, Richard, L.
Patent: WO1994/14957 A2, 1994 ; Title/Abstract Full Text Show Details
Anthony Kettle
Patent: US7108997 B2, 2006 ; Title/Abstract Full Text Show Details
Odagaki, Yuji; Kinoshita, Masakazu; Toyoshima, Ryoichi
European Journal of Pharmacology, 2014 , vol. 726, # 1 p. 109 - 115 Title/Abstract Full Text View citing articles Show Details
28 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Zhang, Lei; Chang, Lina; Hu, Hongwen; Wang, Huaqin; Yao, Zhu-Jun; Wang, Shaozhong
Chemistry - A European Journal, 2014 , vol. 20, # 10 p. 2925 - 2932 Title/Abstract Full Text View citing articles Show Details
Zimmerman, Sommer S.; Khatri, Alpa; Garnier-Amblard, Ethel C.; Mullasseril, Praseeda; Kurtkaya, Natalie L.; Gyoneva, Stefka; Hansen, Kasper B.; Traynelis, Stephen F.; Liotta, Dennis C.
Journal of Medicinal Chemistry, 2014 , vol. 57, # 6 p. 2334 - 2356 Title/Abstract Full Text View citing articles Show Details
Schuck, Desirée C.; Jordão, Alessandro K.; Nakabashi, Myna; Cunha, Anna C.; Ferreira, Vitor F.; Garcia, Célia R.S.
European Journal of Medicinal Chemistry, 2014 , vol. 78, p. 375 - 382 Title/Abstract Full Text View citing articles Show Details
López-Iglesias, Beatriz; Pérez, Concepción; Morales-García, José A.; Alonso-Gil, Sandra; Pérez-Castillo, Ana; Romero, Alejandro; López, Manuela G.; Villarroya, Mercedes; Conde, Santiago; Rodríguez-Franco, María Isabel
Journal of Medicinal Chemistry, 2014 , vol. 57, # 9 p. 3773 - 3785 Title/Abstract Full Text View citing articles Show Details
Ren, Jing; Li, Jian; Wang, Yueqin; Chen, Wuyan; Shen, Aijun; Liu, Hongchun; Chen, Danqi; Cao, Danyan; Li, Yanlian; Zhang, Naixia; Xu, Yechun; Geng, Meiyu; He, Jianhua; Xiong, Bing; Shen, Jingkang
Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 11 p. 2525 - 2529 Title/Abstract Full Text View citing articles Show Details
Nelson, Hosea M.; Reisberg, Solomon H.; Shunatona, Hunter P.; Patel, Jigar S.; Toste, F. Dean
Angewandte Chemie - International Edition, 2014 , vol. 53, # 22 p. 5600 - 5603 Angew. Chem., 2014 , vol. 126, # 22 p. 5706 - 5709,4 Title/Abstract Full Text View citing articles Show Details
Li, Yongzhen; Feng, Tingting; Liu, Peng; Liu, Chang; Wang, Xiao; Li, Dongsheng; Li, Ni; Chen, Minghua; Xu, Yanni; Si, Shuyi
ACS Medicinal Chemistry Letters, 2014 , vol. 5, # 8 p. 884 - 888 Title/Abstract Full Text View citing articles Show Details
Chojnacki, Jeremy E.; Liu, Kai; Yan, Xing; Toldo, Stefano; Selden, Tyler; Estrada, Martin; Rodríguez-Franco, María Isabel; Halquist, Matthew S.; Ye, Dexian; Zhang, Shijun
ACS Chemical Neuroscience, 2014 , vol. 5, # 8 p. 690 - 699 Title/Abstract Full Text View citing articles Show Details
Pathak, Ashish K.; Pathak, Vibha; Reynolds, Robert C.
ACS Combinatorial Science, 2014 , vol. 16, # 9 p. 485 - 493 Title/Abstract Full Text View citing articles Show Details
Blough, Bruce E.; Landavazo, Antonio; Partilla, John S.; Decker, Ann M.; Page, Kevin M.; Baumann, Michael H.; Rothman, Richard B.
Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 19 p. 4754 - 4758 Title/Abstract Full Text View citing articles Show Details
Abd Razik, Basma M.; Osman, Hasnah; Basiri, Alireza; Salhin, Abdussalam; Kia, Yalda; Ezzat, Mohammed Oday; Murugaiyah, Vikneswaran
Bioorganic Chemistry, 2014 , vol. 57, p. 162 - 168 Title/Abstract Full Text View citing articles Show Details
Ruchti, Jonathan; Carreira, Erick M.
Journal of the American Chemical Society, 2014 , vol. 136, # 48 p. 16756 - 16759 Title/Abstract Full Text View citing articles Show Details
Bedos, Philippe; Baltas, Michel
Patent: US2015/31740 A1, 2015 ; Title/Abstract Full Text Show Details
Dempsey, Daniel R.; Jeffries, Kristen A.; Bond, Jason D.; Carpenter, Anne-Marie; Rodriguez-Ospina, Santiago; Breydo, Leonid; Caswell, K. Kenneth; Merkler, David J.
Biochemistry, 2014 , vol. 53, # 49 p. 7777 - 7793 Title/Abstract Full Text View citing articles Show Details
Zhu, Dan; Sun, Jing; Yan, Chao-Guo
RSC Advances, 2014 , vol. 4, # 108 p. 62817 - 62826 Title/Abstract Full Text View citing articles Show Details
Tobisu, Mamoru; Takahira, Tsuyoshi; Ohtsuki, Akimichi; Chatani, Naoto
Organic Letters, 2015 , vol. 17, # 3 p. 680 - 683 Title/Abstract Full Text View citing articles Show Details
Haduch, Anna; Bromek, Ewa; Kot, Marta; Kamińska, Katarzyna; Gołembiowska, Krystyna; Daniel, Wladyslawa A.
Journal of Neurochemistry, 2015 , vol. 133, # 1 p. 83 - 92 Title/Abstract Full Text View citing articles Show Details
Zhao, Hai-Tao; Zhong, Shu-Ming; Qin, Jiang-Ke; Tang, Huang
Journal of the Serbian Chemical Society, 2015 , vol. 80, # 2 p. 127 - 136 Title/Abstract Full Text View citing articles Show Details
Bartolucci, Silvia; Mari, Michele; Bedini, Annalida; Piersanti, Giovanni; Spadoni, Gilberto
Journal of Organic Chemistry, 2015 , vol. 80, # 6 p. 3217 - 3222 Title/Abstract Full Text View citing articles Show Details
Liu, Chuan; Yin, Qin; Dai, Li-Xin; You, Shu-Li
Chemical Communications, 2015 , vol. 51, # 27 p. 5971 - 5974 Title/Abstract Full Text View citing articles Show Details
29 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Egea, Javier; Buendia, Izaskun; Parada, Esther; Navarro, Elisa; Rada, Patricia; Cuadrado, Antonio; López, Manuela G.; García, Antonio G.; León, Rafael
British Journal of Pharmacology, 2015 , vol. 172, # 7 p. 1807 - 1821 Title/Abstract Full Text View citing articles Show Details
Danda, Adithi; Kumar, Kamal; Waldmann, Herbert
Chemical Communications, 2015 , vol. 51, # 35 p. 7536 - 7539 Title/Abstract Full Text View citing articles Show Details
Dempsey, Daniel R.; Jeffries, Kristen A.; Handa, Sumit; Carpenter, Anne-Marie; Rodriguez-Ospina, Santiago; Breydo, Leonid; Merkler, David J.
Biochemistry, 2015 , vol. 54, # 16 p. 2644 - 2658 Title/Abstract Full Text View citing articles Show Details
VIRGINIA COMMONWEALTH UNIVERSITY; ZHANG, Shijun
Patent: WO2015/69970 A1, 2015 ; Title/Abstract Full Text Show Details
Haduch, Anna; Bromek, Ewa; Kot, Marta; Kamińska, Katarzyna; Gołembiowska, Krystyna; Daniel, Wladyslawa A.
Journal of neurochemistry, 2015 , vol. 133, # 1 p. 83 - 92 Title/Abstract Full Text Show Details
Kröger, Denis; Brockmeyer, Fabian; Kahrs, Christoph
Organic and Biomolecular Chemistry, 2015 , vol. 13, # 26 p. 7223 - 7229 Title/Abstract Full Text View citing articles Show Details
Zlotos, Darius P.; Riad, Noura M.; Osman, Mai B.; Dodda, Bala R.; Witt-Enderby, Paula A.
MedChemComm, 2015 , vol. 6, # 7 p. 1340 - 1344 Title/Abstract Full Text View citing articles Show Details
Nichols, David E.; Sassano, M. Flori; Halberstadt, Adam L.; Klein, Landon M.; Brandt, Simon D.; Elliott, Simon P.; Fiedler, Wolfgang J.
ACS Chemical Neuroscience, 2015 , vol. 6, # 7 p. 1165 - 1175 Title/Abstract Full Text View citing articles Show Details
Cheng, Shaobing; Zheng, Wei; Gong, Ping; Zhou, Qiang; Xie, Qiong; Yu, Lining; Zhang, Peiyi; Chen, Liangkang; Li, Juan; Chen, Jianxing; Chen, Hailin; Chen, Hongzhuan
Bioorganic and Medicinal Chemistry, 2015 , vol. 23, # 13 art. no. 12307, p. 3110 - 3118
Title/Abstract Full Text View citing articles Show Details
Xu, Wenqing; Wang, Wei; Wang, Xiang
Angewandte Chemie - International Edition, 2015 , vol. 54, # 33 p. 9546 - 9549 Angew. Chem., 2015 , vol. 127, p. 9682 - 9685 Title/Abstract Full Text View citing articles Show Details
Wang, Huifei; Liu, Dong; Chen, Huiyu; Li, Jing; Wang, David Zhigang
Tetrahedron, 2015 , vol. 71, # 38 p. 7073 - 7076 Title/Abstract Full Text View citing articles Show Details
Oda, Shingo; Fujiwara, Ryoichi; Kutsuno, Yuki; Fukami, Tatsuki; Itoh, Tomoo; Yokoi, Tsuyoshi; Nakajima, Miki
Drug Metabolism and Disposition, 2015 , vol. 43, # 6 p. 812 - 818 Title/Abstract Full Text View citing articles Show Details
Wang, Shengzheng; Fang, Kun; Dong, Guoqiang; Chen, Shuqiang; Liu, Na; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan
Journal of Medicinal Chemistry, 2015 , vol. 58, # 16 p. 6678 - 6696 Title/Abstract Full Text View citing articles Show Details
Luo, Xiao-Ting; Wang, Chun-Ming; Liu, Yun; Huang, Zhen-Guang
European Journal of Medicinal Chemistry, 2015 , vol. 103, p. 302 - 311 Title/Abstract Full Text View citing articles Show Details
Eagon, Scott; Anderson, Marc O.
European Journal of Organic Chemistry, 2014 , vol. 2014, # 8 p. 1653 - 1665 Title/Abstract Full Text Show Details
Jaswant S. Gidda; John M. Schaus
Patent: US5576352 A, 1996 ; Title/Abstract Full Text Show Details
Jaswant S. Gidda; John M. Schaus
Patent: US5594034 A, 1997 ; Title/Abstract Full Text Show Details
Gu, Jiaojiao; Jing, Lulu; Ma, Xiaotao; Zhang, Zhaofeng; Guo, Qianying; Li, Yong
Journal of Nutritional Biochemistry, 2015 , vol. 26, # 12 p. 1509 - 1519 Title/Abstract Full Text View citing articles Show Details
PHARMASYNTHESE; LE ROY, Pierre-Yves; LE GUEN, Yves
Patent: US2015/353469 A1, 2015 ; Title/Abstract Full Text Show Details
Sosi, Izidor; Anderluh, Marko; Sova, Matej; Gobec, Martina; Mlinari Raan, Irena; Derouaux, Adeline; Amoroso, Ana; Terrak, Mohammed; Breukink, Eefjan; Gobec, Stanislav
Journal of Medicinal Chemistry, 2015 , vol. 58, # 24 p. 9712 - 9721 Title/Abstract Full Text View citing articles Show Details
30 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
ELI LILLY AND COMPANY; Chen, Zhaogen; Cohen, Michael Philip; Fisher, Matthew Joseph; Gillig, James Ronald; McCowan, Jefferson Ray; Miller, Shawn Christopher; Schaus, John Mehnert; Giethlen, Bruno
Patent: EP1859798 B1, 2015 ; Title/Abstract Full Text Show Details
WEINSHANK Richard L.; BRANCHEK Theresa; HARTIG Paul R.
Patent: EP530265 B1, 1998 ; Title/Abstract Full Text Show Details
BARD Jonathan A.; WEINSHANK Richard L.; BRANCHEK Theresa
Patent: EP624100 B1, 2000 ; Title/Abstract Full Text Show Details
Theresa Branchek; Paul R. Hartig; Richard L. Weinshank
Patent: US2002/115149 A1, 2002 ; Title/Abstract Full Text Show Details
Richard L. Weinshank; Theresa Brancheck; Paul R. Hartig
Patent: US2003/8823 A1, 2003 ; Title/Abstract Full Text Show Details
Herington, Jennifer L.; Swale, Daniel R.; Brown, Naoko; Shelton, Elaine L.; Choi, Hyehun; Williams, Charles H.; Hong, Charles C.; Paria, Bibhash C.; Denton, Jerod S.; Reese, Jeff
PLoS ONE, 2015 , vol. 10, # 11 art. no. E0143243 Title/Abstract Full Text View citing articles Show Details
Liu, Chuan; Yi, Ji-Cheng; Zheng, Zhong-Bo; Tang, Yong; Dai, Li-Xin; You, Shu-Li
Angewandte Chemie - International Edition, 2016 , vol. 55, # 2 p. 751 - 754 Angew. Chem., 2016 , vol. 128, # 2 p. 761 - 764,4 Title/Abstract Full Text View citing articles Show Details
Tracy, Timothy S.; Chaudhry, Amarjit S.; Prasad, Bhagwat; Thummel, Kenneth E.; Schuetz, Erin G.; Zhong, Xiao-Bo; Tien, Yun-Chen; Jeong, Hyunyoung; Pan, Xian; Shireman, Laura M.; Tay-Sontheimer, Jessica; Lin, Yvonne S.
Drug Metabolism and Disposition, 2016 , vol. 44, # 3 p. 343 - 351 Title/Abstract Full Text View citing articles Show Details
Hényková, Eva; Vránová, Hana Přikrylová; Amakorová, Petra; Pospíšil, Tomáš; Žukauskaite, Asta; Vlčková, Magdaléna; Urbánek, Lubor; Novák, Ondřej; Mareš, Jan; Kaňovský, Petr; Strnad, Miroslav
Journal of Chromatography A, 2016 , vol. 1437, p. 145 - 157 Title/Abstract Full Text View citing articles Show Details
Hough; Segal
Neuroscience, 2016 , vol. 322, p. 178 - 194 Title/Abstract Full Text View citing articles Show Details
Algiert, Barbara; Rotsztejn, Helena; Mucha, Paulina; Trznadel-Grodzka, Ewa
Przeglad Dermatologiczny, 2016 , vol. 103, # 1 p. 71 - 76
Title/Abstract Full Text View citing articles Show Details
Majeed, Zana R.; Abdeljaber, Esraa; Soveland, Robin; Cornwell, Kristin; Bankemper, Aubrey; Koch, Felicitas; Cooper, Robin L.
Neural Plasticity, 2016 , vol. 2016, art. no. 7291438 Title/Abstract Full Text View citing articles Show Details
Hardeland, Rüdiger
Current Pharmaceutical Design, 2016 , vol. 22, # 8 p. 1086 - 1101 Title/Abstract Full Text View citing articles Show Details
Pacini, Nicola; Borziani, Fabio
International Journal of Molecular Sciences, 2016 , vol. 17, # 3 art. no. 341, p. 26 Title/Abstract Full Text View citing articles Show Details
Kirillova, Mariia S.; Muratore, Michael E.; Dorel, Ruth; Echavarren, Antonio M.
Journal of the American Chemical Society, 2016 , vol. 138, # 11 p. 3671 - 3674 Title/Abstract Full Text View citing articles Show Details
Zhao, Fei; Dai, Jiang-Kun; Liu, Dan; Wang, Shi-Jun; Wang, Jun-Ru
Molecules, 2016 , vol. 21, # 3 art. no. 390 Title/Abstract Full Text View citing articles Show Details
Zheng, Nan; Chang, Yuan-Yuan; Zhang, Li-Jie; Gong, Jian-Xian; Yang, Zhen
Chemistry - An Asian Journal, 2016 , vol. 11, # 3 p. 371 - 375 Title/Abstract Full Text View citing articles Show Details
Devaraj; Sollert; Juds; Gates; Pilarski
Chemical Communications, 2016 , vol. 52, # 34 p. 5868 - 5871 Title/Abstract Full Text View citing articles Show Details
Di Mascio, Paolo; Martinez, Glaucia R.; Miyamoto, Sayuri; Ronsein, Graziella E.; Medeiros, Marisa H.G.; Cadet, Jean
Archives of Biochemistry and Biophysics, 2016 , vol. 595, p. 161 - 175 Title/Abstract Full Text View citing articles Show Details
Zhao, Gaoyuan; Xie, Xingang; Sun, Haiyu; Yuan, Ziyun; Zhong, Zhuliang; Tang, Shouchu; She, Xuegong
Organic Letters, 2016 , vol. 18, # 10 p. 2447 - 2450 Title/Abstract Full Text View citing articles Show Details
31 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Wilke, Martin; Brand, Christian; Wilke, Josefin; Schmitt, Michael
Physical Chemistry Chemical Physics, 2016 , vol. 18, # 19 p. 13538 - 13545 Title/Abstract Full Text View citing articles Show Details
Marto, Joana; Ascenso, Andreia; Gonçalves, Lídia M.; Gouveia, Luís F.; Manteigas, Patrícia; Pinto, Pedro; Oliveira, Eduardo; Almeida, António J.; Ribeiro, Helena M.
Drug Delivery, 2016 , vol. 23, # 5 p. 1594 - 1607 Title/Abstract Full Text View citing articles Show Details
Erland, Lauren A. E.; Murch, Susan J.; Reiter, Russel J.; Saxena, Praveen K.
Plant Signaling and Behavior, 2015 , vol. 10, # 11 art. no. E1096469 Title/Abstract Full Text View citing articles Show Details
Byeon, Yeong; Back, Kyoungwhan
Applied Microbiology and Biotechnology, 2016 , vol. 100, # 15 p. 6683 - 6691 Title/Abstract Full Text View citing articles Show Details
Wang, Yi-Fu; Hsu, Yu-Juei; Wu, Hsu-Feng; Lee, Guan-Lin; Yang, Ya-Sung; Wu, Jing-Yiing; Yet, Shaw-Fang; Wu, Kenneth K.; Kuo, Cheng-Chin
Circulation Research, 2016 , vol. 119, # 2 p. 222 - 236 Title/Abstract Full Text View citing articles Show Details
Letra-Vilela, Ricardo; Sánchez-Sánchez, Ana María; Rocha, Ana Maia; Martin, Vanesa; Branco-Santos, Joana; Puente-Moncada, Noelia; Santa-Marta, Mariana; Outeiro, Tiago Fleming; Antolín, Isaac; Rodriguez, Carmen; Herrera, Federico
Molecular and Cellular Endocrinology, 2016 , vol. 434, p. 238 - 249 Title/Abstract Full Text View citing articles Show Details
Spindler, Anna; Stefan, Katja; Wiese, Michael
Journal of Medicinal Chemistry, 2016 , vol. 59, # 13 p. 6121 - 6135 Title/Abstract Full Text View citing articles Show Details
Yan, Shihan; Wei, Dongshan; Tang, Mingjie; Shi, Changcheng; Zhang, Mingkun; Yang, Zhongbo; Du, Chunlei; Cui, Hong-Liang
IEEE Transactions on Terahertz Science and Technology, 2016 , vol. 6, # 4 art. no. 7497010, p. 532 - 540 Title/Abstract Full Text View citing articles Show Details
NATIONAL HEALTH RESEARCH INSTITUTES; KUO, Cheng-Chin; WU, Kenneth Kun-Yu
Patent: WO2016/115188 A1, 2016 ; Title/Abstract Full Text Show Details
Wang, Jin; Wang, Zhi-Min; Li, Xue-Mei; Li, Fan; Wu, Jia-Jia; Kong, Ling-Yi; Wang, Xiao-Bing
Bioorganic and Medicinal Chemistry, 2016 , vol. 24, # 18 p. 4324 - 4338 Title/Abstract Full Text View citing articles Show Details
Yokoo, Hidetomo; Ohsaki, Ayumi; Kagechika, Hiroyuki; Hirano, Tomoya
Tetrahedron, 2016 , vol. 72, # 39 p. 5872 - 5879 Title/Abstract Full Text Show Details
Martínez-Guerrero, Lucy J.; Morales, Mark; Ekins, Sean; Wright, Stephen H.
Molecular Pharmacology, 2016 , vol. 90, # 3 p. 254 - 264 Title/Abstract Full Text Show Details
Jiang, Yan-Hong; Yan, Chao-Guo
Synthesis (Germany), 2016 , vol. 48, # 18 art. no. SS-2016-H0064-OP, p. 3057 - 3064 Title/Abstract Full Text Show Details
Toselli, Francesca; Dodd, Peter R.; Gillam, Elizabeth M. J.
Drug Metabolism Reviews, 2016 , vol. 48, # 3 p. 379 - 404 Title/Abstract Full Text Show Details
Shmatova, Olga I.; Khrustalev, Victor N.; Nenajdenko, Valentine G.
Organic Letters, 2016 , vol. 18, # 18 p. 4494 - 4497 Title/Abstract Full Text Show Details
People's Liberation Army Second Military Medical University; Sheng, Chunquan; Zhang, Wannian; Dong, Guoqiang; Chen, Shuqiang; Li, Zhengang; Mou, Zhenyuan; Yao, Jianzhong; Liu, Na; Wu, Shanchao; Fang, Kun
Patent: CN105418610 A, 2016 ; Title/Abstract Full Text Show Details
Institute of Chemistry Chinese Academy of Sciences; Shi, Yian; Li, Jing; Liu, Mao; Tian, Hua
Patent: CN105566347 A, 2016 ; Title/Abstract Full Text Show Details
Zulfiker, Abu Hasanat Md; Sohrabi, Mohsen; Qi, Ji; Matthews, Ben; Wei, Ming Q; Grice, I. Darren
Journal of Pharmaceutical and Biomedical Analysis, 2016 , vol. 129, p. 260 - 272 Title/Abstract Full Text Show Details
Adamska, Iwona; Lewczuk, Bogdan; Markowska, Magdalena; Majewski, Pawel M.
Journal of Photochemistry and Photobiology B: Biology, 2016 , vol. 164, p. 335 - 343 Title/Abstract Full Text Show Details
Saya, Jordy M.; Oppelaar, Barry; Cioc, RǍzvan C.; Van Der Heijden, Gydo; Vande Velde, Christophe M. L.; Orru, Romano V. A.; Ruijter, Eelco
Chemical Communications, 2016 , vol. 52, # 84 p. 12482 - 12485 Title/Abstract Full Text Show Details
32 of 239
Comment (Pharmacological Data)
Bioactivities present
Reference
Back, Kyoungwhan; Tan, Dun-Xian; Reiter, Russel J.
Journal of Pineal Research, 2016 , vol. 61, # 4 p. 426 - 437 Title/Abstract Full Text Show Details
Sawant, Rajiv T.; Stevens, Marc Y.; Sköld, Christian; Odell, Luke R.
Organic Letters, 2016 , vol. 18, # 20 p. 5392 - 5395 Title/Abstract Full Text Show Details
Yang, Yajun; Zhu, Cuiju; Zhang, Min; Huang, Shijun; Lin, Jingjing; Pan, Xiandao; Su, Weiping
Chemical Communications, 2016 , vol. 52, # 87 p. 12869 - 12872 Title/Abstract Full Text Show Details
Faulkner, Katherine C.; Hurley, Katherine A.; Weibel, Douglas B.
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 22 p. 5539 - 5544 Title/Abstract Full Text Show Details
Benchekroun, Mohamed; Romero, Alejandro; Egea, Javier; León, Rafael; Michalska, Patrycja; Buendía, Izaskun; Jimeno, María Luisa; Jun, Daniel; Janockova, Jana; Sepsova, Vendula; Soukup, Ondrej; Bautista-Aguilera, Oscar M.; Refouvelet, Bernard; Ouari, Olivier; Marco-Contelles, José; Ismaili, Lhassane
Journal of Medicinal Chemistry, 2016 , vol. 59, # 21 p. 9967 - 9973 Title/Abstract Full Text Show Details
SIGNUM BIOSCIENCES, INC.; Vafai, Scott; Voronkov, Michael; Stock, Maxwell; Stock, Jeffry B.; Lee, Seung-Yub; Li, Zhu; Gu, Haoming
Patent: US9486441 B2, 2016 ; Title/Abstract Full Text Show Details
Hanbat National University Academic Cooperation; Park, Jung Ho; Jang, Mi; Kim, Jae Kwan
Patent: KR2016/46450 A, 2016 ; Title/Abstract Full Text Show Details
Horton, William; Sood, Abha; Peerannawar, Swarada; Kugyela, Nandor; Kulkarni, Aditya; Tulsan, Rekha; Tran, Chris D.; Soule, Jessica; LeVine, Harry; Török, Béla; Török, Marianna
Bioorganic and Medicinal Chemistry Letters, 2017 , vol. 27, # 2 p. 232 - 236 Title/Abstract Full Text Show Details
Setyaningsih, Widiastuti; Saputro, Irfan E.; Carrera, Ceferino A.; Palma, Miguel; Barroso, Carmelo G.
Food Chemistry, 2017 , vol. 225, p. 1 - 9 Title/Abstract Full Text Show Details
Ramos, Eva; Patiño, Paloma; Reiter, Russel J.; Gil-Martín, Emilio; Marco-Contelles, José; Parada, Esther; los Rios, Cristobal de; Romero, Alejandro; Egea, Javier
Free Radical Biology and Medicine, 2017 , vol. 104, p. 32 - 53 Title/Abstract Full Text Show Details
Brandt, Simon D.; Kavanagh, Pierce V.; Dowling, Geraldine; Talbot, Brian; Westphal, Folker; Meyer, Markus R.; Maurer, Hans H.; Halberstadt, Adam L. Drug Testing and Analysis, 2017 , vol. 9, # 1 p. 115 - 126 Title/Abstract Full Text Show Details
Pietri, Jose E.; Pakpour, Nazzy; Napoli, Eleonora; Song, Gyu; Pietri, Eduardo; Potts, Rashaun; Cheung, Kong W.; Walker, Gregory; Riehle, Michael A.; Starcevich, Hannah; Giulivi, Cecilia; Lewis, Edwin E.; Luckhart, Shirley
Biochemical Journal, 2016 , vol. 473, # 20 p. 3487 - 3503 Title/Abstract Full Text Show Details
Aguer, Céline; Piccolo, Brian D.; Fiehn, Oliver; Adams, Sean H.; Harper, Mary-Ellen
FASEB Journal, 2017 , vol. 31, # 2 p. 814 - 827 Title/Abstract Full Text Show Details
Sanz Sharley, Daniel D.; Williams, Jonathan M. J.
Chemical Communications, 2017 , vol. 53, # 12 p. 2020 - 2023 Title/Abstract Full Text Show Details
Sun Yat-Sen University; Pi, Rongbiao; Yang, Xiaohong; Liu, Xingguo; Chen, Ziwei; Wang, Shengnan
Patent: CN105906608 A, 2016 ; Title/Abstract Full Text Show Details
Fujinoki, Masakatsu; Takei, Gen L.
Journal of Reproduction and Development, 2017 , vol. 63, # 1 p. 67 - 74 Title/Abstract Full Text Show Details
Geffard, Michel; Mangas, Arturo; Coveñas, Rafael
Biomedical Reports, 2017 , vol. 6, # 3 p. 307 - 313 Title/Abstract Full Text Show Details
Lee, Hyoung Yool; Back, Kyoungwhan
Journal of Pineal Research, 2017 , vol. 62, # 2 art. no. E12379 Title/Abstract Full Text Show Details
Barbanti, Piero; Aurilia; Egeo; Fofi; Palmirotta
Expert Opinion on Investigational Drugs, 2017 , vol. 26, # 3 p. 269 - 277 Title/Abstract Full Text Show Details
33 of 239
Comment (Pharmacological Data)
physiological behaviour discussed
34 of 239
35 of 239
36 of 239
37 of 239
38 of 239
39 of 239
40 of 239
41 of 239
Reference
Letra-Vilela, Ricardo; Sánchez-Sánchez, Ana María; Rocha, Ana Maia; Martin, Vanesa; Branco-Santos, Joana; Puente-Moncada, Noelia; Santa-Marta, Mariana; Outeiro, Tiago Fleming; Antolín, Isaac; Rodriguez, Carmen; Herrera, Federico
Molecular and Cellular Endocrinology, 2016 , vol. 434, p. 238 - 249 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Martínez-Guerrero, Lucy J.; Morales, Mark; Ekins, Sean; Wright, Stephen H.
Molecular Pharmacology, 2016 , vol. 90, # 3 p. 254 - 264 Title/Abstract Full Text Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Faulkner, Katherine C.; Hurley, Katherine A.; Weibel, Douglas B.
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 22 p. 5539 - 5544 Title/Abstract Full Text Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Oda, Shingo; Fujiwara, Ryoichi; Kutsuno, Yuki; Fukami, Tatsuki; Itoh, Tomoo; Yokoi, Tsuyoshi; Nakajima, Miki
Drug Metabolism and Disposition, 2015 , vol. 43, # 6 p. 812 - 818 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Herington, Jennifer L.; Swale, Daniel R.; Brown, Naoko; Shelton, Elaine L.; Choi, Hyehun; Williams, Charles H.; Hong, Charles C.; Paria, Bibhash C.; Denton, Jerod S.; Reese, Jeff
PLoS ONE, 2015 , vol. 10, # 11 art. no. E0143243 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Odagaki, Yuji; Kinoshita, Masakazu; Toyoshima, Ryoichi
European Journal of Pharmacology, 2014 , vol. 726, # 1 p. 109 - 115 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Blough, Bruce E.; Landavazo, Antonio; Partilla, John S.; Decker, Ann M.; Page, Kevin M.; Baumann, Michael H.; Rothman, Richard B.
Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 19 p. 4754 - 4758 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D18-LR of rat
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
192 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D18-LR of rat
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.0005
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
42 of 239
43 of 239
44 of 239
45 of 239
46 of 239
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D18-LR of rat
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
0.09 pmol*min/pmol
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D18-LR of rat
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D2-HR of rat
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
45 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D2-HR of rat
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.0062
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D2-HR of rat
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type
0.28 pmol*min/pmol
(Pharmacological Data)
47 of 239
48 of 239
49 of 239
50 of 239
51 of 239
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D2-HR of rat
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D4-LR of rat
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
82 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D4-LR of rat
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.0011
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D4-LR of rat
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
0.09 pmol*min/pmol
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D4-LR of rat
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59
Title/Abstract Full Text View citing articles Show Details
52 of 239
53 of 239
54 of 239
55 of 239
56 of 239
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
20 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
35 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
3.3514
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
7.29
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
maximal velocity (Vmax)
57 of 239
58 of 239
59 of 239
60 of 239
61 of 239
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
117.3 pmol*min/pmol
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
145.8 pmol*min/pmol
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-HR of human
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-LR of human
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
57 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-LR of human
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.4489
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-LR of human
62 of 239
63 of 239
64 of 239
65 of 239
66 of 239
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
25.59 pmol*min/pmol
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
CYP2D6-LR of human
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
brain microsomes of rat
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
250 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
brain microsomes of rat
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.0016
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
brain microsomes of rat
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
0.39 pmol*min/mg
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
67 of 239
68 of 239
69 of 239
70 of 239
71 of 239
Species or Test-System (Pharmacological Data)
brain microsomes of rat
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes allelic variant 2D6*4*4 of human
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
412 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes allelic variant 2D6*4*4 of human
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
0.1184
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes allelic variant 2D6*4*4 of human
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
48.79 pmol*min/mg
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes allelic variant 2D6*4*4 of human
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of human
72 of 239
73 of 239
74 of 239
75 of 239
76 of 239
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
61 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of human
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
4.7951
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of human
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
292.5 pmol*min/mg
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of human
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of rat
Further Details (Pharmacological Data)
Michaelis constant (Km)
Type (Pharmacological Data)
Km
Value of Type (Pharmacological Data)
31 μmol/l
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
77 of 239
78 of 239
79 of 239
80 of 239
81 of 239
Species or Test-System (Pharmacological Data)
liver microsomes of rat
Further Details (Pharmacological Data)
intrinsic clearance (CL)
Type (Pharmacological Data)
CL
Value of Type (Pharmacological Data)
1.3016
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of rat
Further Details (Pharmacological Data)
maximal velocity (Vmax)
Type (Pharmacological Data)
Vmax
Value of Type (Pharmacological Data)
40.35 pmol*min/mg
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
pharmacokinetics
Species or Test-System (Pharmacological Data)
liver microsomes of rat
Metabolite (Pharmacological Data)
3-(2-aminoethyl)-1H-indol-5-ol [Reaxys RN: 143524]
Reference
Haduch, Anna; Bromek, Ewa; Sadakierska-Chudy, Anna; Wójcikowski, Jacek; Daniel, Władysława A.
Pharmacological Research, 2013 , vol. 67, # 1 p. 53 - 59 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
De Bruyn, Tom; Van Westen, Gerard J.P.; IJzerman, Adriaan P.; Stieger, Bruno; De Witte, Peter; Augustijns, Patrick F.; Annaert, Pieter P.
Molecular Pharmacology, 2013 , vol. 83, # 6 p. 1257 - 1267 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme activity; inhibition of
Species or Test-System (Pharmacological Data)
acetylcholinesterase of electric eel
Concentration (Pharmacological Data)
0.001 mol/l
Kind of Dosing (Pharmacological Data)
title compound dissolved in buffer containing not more than 10percent MeOH
Further Details (Pharmacological Data)
inhibition rate of comparative compound at 3.4E-4 M: 100percent
Results
molecular target: acetylcholinesterase
Reference
Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 8 p. 2885 - 2888 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme activity; inhibition of
Species or Test-System (Pharmacological Data)
acetylcholinesterase of electric eel
Concentration (Pharmacological Data)
0.001 mol/l
Kind of Dosing
title compound dissolved in buffer containing not more than 10percent MeOH
(Pharmacological Data)
82 of 239
83 of 239
84 of 239
85 of 239
Further Details (Pharmacological Data)
inhibition rate of comparative compound at 3.4E-4 M: 100percent
Type (Pharmacological Data)
inhibition rate
Value of Type (Pharmacological Data)
7.19 percent
Reference
Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 8 p. 2885 - 2888 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme activity; inhibition of
Species or Test-System (Pharmacological Data)
recombinant acetylcholinesterase of human
Concentration (Pharmacological Data)
0.001 mol/l
Kind of Dosing (Pharmacological Data)
title compound dissolved in buffer containing not more than 10percent MeOH
Results
molecular target: human acetylcholinesterase
Reference
Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 8 p. 2885 - 2888 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme activity; inhibition of
Species or Test-System (Pharmacological Data)
recombinant acetylcholinesterase of human
Concentration (Pharmacological Data)
0.001 mol/l
Kind of Dosing (Pharmacological Data)
title compound dissolved in buffer containing not more than 10percent MeOH
Type (Pharmacological Data)
inhibition rate
Value of Type (Pharmacological Data)
14.68 percent
Reference
Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk
Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 8 p. 2885 - 2888 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
brain membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
in presence of 30 μmol/l spermine; radioligand binding assay ; radioligand: [3H]MK-801
Results
molecular target: NMDA receptor
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
brain membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
in presence of 30 μmol/l spermine; radioligand binding assay ; radioligand: [3H]MK-801; IC50 related to: NMDA receptor
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
179 μmol/l
86 of 239
87 of 239
88 of 239
89 of 239
90 of 239
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
brain membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]MK-801
Results
molecular target: NMDA receptor
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
brain membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]MK-801; IC50 related to: NMDA receptor
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
19.2 μmol/l
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
hippocampal CA1 + dentate gyrus membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]-OH-DPAT
Results
molecular target: 5-HT1A receptor
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
hippocampal CA1 + dentate gyrus membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]-OH-DPAT; IC50 related to: 5-HT1A receptor
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
0.0049 - 0.0068 μmol/l
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
prefrontal cortex membranes of Wistar rat
91 of 239
92 of 239
93 of 239
94 of 239
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]ketanserin
Results
molecular target: 5-HT2A receptor
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
prefrontal cortex membranes of Wistar rat
Sex
male
Further Details (Pharmacological Data)
radioligand binding assay; radioligand: [3H]ketanserin; IC50 related to: 5-HT2A receptor
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
10.8 μmol/l
Reference
Berger; Palangsuntikul; Rebernik; Wolschann; Berner
Current Medicinal Chemistry, 2012 , vol. 19, # 18 p. 3044 - 3057 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
menthol-stimulated 45Ca2+ influx; inhibition of
Species or Test-System (Pharmacological Data)
T-REx-293 cells; genetically modified/infected with: pcDNA5TO-hTRPM8
Further Details (Pharmacological Data)
hTRPM8: human transient receptor potential melastatin 8
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
12.4 μmol/l
Location
supporting information
Reference
Defalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A.J.
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 23 p. 7076 - 7079 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
menthol-stimulated 45Ca2+ influx; inhibition of
Species or Test-System (Pharmacological Data)
T-REx-293 cells; genetically modified/infected with: pcDNA5TO-hTRPM8
Further Details (Pharmacological Data)
hTRPM8: human transient receptor potential melastatin 8
Results
molecular target: TRPM8
Location
supporting information
Reference
Defalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A.J.
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 23 p. 7076 - 7079 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
icilin-stimulated 45Ca2+ influx; inhibition of
Species or Test-System (Pharmacological Data)
T-REx-293 cells; genetically modified/infected with: pcDNA5TO-hTRPM8
Further Details (Pharmacological Data)
hTRPM8: human transient receptor potential melastatin 8
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
11.6 μmol/l
Location
supporting information
Reference
Defalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A.J.
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 23 p. 7076 - 7079 Title/Abstract Full Text View citing articles Show Details
95 of 239
96 of 239
97 of 239
98 of 239
99 of 239
Effect (Pharmacological Data)
icilin-stimulated 45Ca2+ influx; inhibition of
Species or Test-System (Pharmacological Data)
T-REx-293 cells; genetically modified/infected with: pcDNA5TO-hTRPM8
Further Details (Pharmacological Data)
hTRPM8: human transient receptor potential melastatin 8
Results
molecular target: TRPM8
Location
supporting information
Reference
Defalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A.J.
Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 23 p. 7076 - 7079 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4b receptor
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM
Results
molecular target: human 5-HT4b receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4b receptor
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; displacement rate (title comp.): 99percent at 1 μM
Results
molecular target: human 5-HT4b receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4b receptor
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; displacement rate (title comp.): 99percent at 1 μM; pKi related to: human 5-HT4b receptor
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
6.83
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4b receptor
100 of 239
101 of 239
102 of 239
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; pKi related to: human 5-HT4b receptor
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
6.83
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4d receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM
Results
molecular target: human 5-HT4d receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: h5-HT4d receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; rate of displacement related to: human 5-HT4d receptor
Type (Pharmacological Data)
rate of displacement
Value of Type (Pharmacological Data)
100 percent
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4b receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM
Results
molecular target: human 5-HT4b receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
103 of 239
104 of 239
105 of 239
106 of 239
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4b receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; rate of displacement related to: human 5-HT4b receptor
Type (Pharmacological Data)
rate of displacement
Value of Type (Pharmacological Data)
100 percent
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4g receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM
Results
molecular target: human 5-HT4g receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4g receptor
Concentration (Pharmacological Data)
1 μmol/l
Kind of Dosing (Pharmacological Data)
comparative comp. dissolved in phosphate buffered saline (PBS) and DMSO (max. conc. 1percent v/v)
Further Details (Pharmacological Data)
radioligand: [3H]-GR113808 at 0.25 nM; rate of displacement related to: human 5-HT4g receptor
Type (Pharmacological Data)
rate of displacement
Value of Type (Pharmacological Data)
100 percent
Reference
Hanna-Elias, Amir; Manallack, David T.; Levit, Alla; Nguyen, William; Ayad, Fadi; Perera, Glen; Shapiro, Marina; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Medicinal Chemistry, 2010 , vol. 6, # 6 p. 344 - 354 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: 5-HT4b receptor splice variant
Concentration (Pharmacological Data)
1e-6 mol/l
Kind of Dosing (Pharmacological Data)
dissolved in phosphate buffered saline (PBS) and DMSO
Further Details (Pharmacological Data)
[3H]-GR113808 displacement related to: 5-HT4b receptor
107 of 239
108 of 239
109 of 239
110 of 239
Type (Pharmacological Data)
[3H]-GR113808 displacement
Value of Type (Pharmacological Data)
100 percent
Reference
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Australian Journal of Chemistry, 2009 , vol. 62, # 2 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: 5-HT4b receptor splice variant
Concentration (Pharmacological Data)
1e-6 mol/l
Kind of Dosing (Pharmacological Data)
dissolved in phosphate buffered saline (PBS) and DMSO
Results
molecular target: 5-HT4b receptor
Reference
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
Australian Journal of Chemistry, 2009 , vol. 62, # 2 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4b receptor splice variant
Concentration (Pharmacological Data)
1 - 100 μmol/l
Kind of Dosing (Pharmacological Data)
title compound dissolved in phosphate buffered saline
Further Details (Pharmacological Data)
[3H]-GR113808 [(1-(2-(methylsulphonyl)amino)ethyl-4-piperidinyl)methyl-1-methyl-1H-indole-3-carboxylate] as radioligand; inhibition constant (Ki); Ki related to: human 5-HT4b receptor
Type (Pharmacological Data)
log Ki
Value of Type (Pharmacological Data)
-7.57
Reference
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
European Journal of Medicinal Chemistry, 2009 , vol. 44, # 7 p. 2952 - 2959 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor binding affinity
Species or Test-System (Pharmacological Data)
COS-7 cell membranes; genetically modified/infected with: human 5-HT4b receptor splice variant
Concentration (Pharmacological Data)
1 - 100 μmol/l
Kind of Dosing (Pharmacological Data)
title compound dissolved in phosphate buffered saline
Further Details (Pharmacological Data)
[3H]-GR113808 [(1-(2-(methylsulphonyl)amino)ethyl-4-piperidinyl)methyl-1-methyl-1H-indole-3-carboxylate] as radioligand
Results
molecular target: human 5-HT4b receptor splice variant
Reference
Hanna-Elias, Amir; Manallack, David T.; Berque-Bestel, Isabelle; Irving, Helen R.; Coupar, Ian M.; Iskander, Magdy N.
European Journal of Medicinal Chemistry, 2009 , vol. 44, # 7 p. 2952 - 2959 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
human embryonic kidney 293 cells
Method (Pharmacological Data)
competitive binding assay; cell membranes incubated in HEPES buffer containing <3H>granisetron and title comp. at 4 deg C, 1 h; reaction terminated by vaccum filtration; radioactivity detd. by using SC; binding affinity to 5-HT3A receptor detd.
Further Details (Pharmacological Data)
SC: scintillation counter; ref. comp.: 5-hydroxytrptamine, m-chlorophenylbiguanide and tryptamine
Type (Pharmacological
Ki
Data)
111 of 239
112 of 239
Value of Type (Pharmacological Data)
34.9 μmol/l
Reference
Bower, Kiowa S.; Price, Kerry L.; Sturdee, Laura E.C.; Dayrell, Mariza; Dougherty, Dennis A.; Lummis, Sarah C.R.
European Journal of Pharmacology, 2008 , vol. 580, # 3 p. 291 - 297 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
human embryonic kidney 293 cells
Method (Pharmacological Data)
competitive binding assay; cell membranes incubated in HEPES buffer containing <3H>granisetron and title comp. at 4 deg C, 1 h; reaction terminated by vaccum filtration; radioactivity detd. by using SC; binding affinity to 5-HT3AB receptor detd.
Further Details (Pharmacological Data)
SC: scintillation counter; ref. comp.: 5-hydroxytrptamine, m-chlorophenylbiguanide and tryptamine
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
21.7 μmol/l
Reference
Bower, Kiowa S.; Price, Kerry L.; Sturdee, Laura E.C.; Dayrell, Mariza; Dougherty, Dennis A.; Lummis, Sarah C.R.
European Journal of Pharmacology, 2008 , vol. 580, # 3 p. 291 - 297 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
Nrf2 activity; inhibition of
Species or Test-System (Pharmacological Data)
lung adenocarcinoma cells transfected with ARE-luciferase reporter vector
Method (Pharmacological Data)
Example 2 A Novel Assay for Nrf2 Inhibitors A high throughput approach to screen compounds was developed. A cell based reporter assay was used to identify agents that can inhibit Nrf2 mediated transcription. Lung adenocarcinoma cells that are stably transfected with ARE-luciferase reporter vector were plated on to 96 well plates. After overnight incubation, cells were pretreated with 12-16 hours with candidate Nrf2 modulators. Luciferase activity was measured after 6 hours of treatment using a luciferase assay system. The decrease in luciferase activity correlates with degree of Nrf2 inhibition.The compounds identified using this assay are identified in Figure 16:Table 5. The known use of each compound is identified in the middle column and the percent luciferase activity is identified in the right hand column.
Results
title compound treatment showed inhibited luciferase activity of 63percent
Location
Page/Page column 9; 57; 16/28-22/28
Reference
THE JOHNS HOPKINS UNIVERSITY
Patent: WO2008/124660 A2, 2008 ; Title/Abstract Full Text Show Details
113 of 239
114 of 239
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
56 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Thr mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
115 of 239
116 of 239
117 of 239
118 of 239
Value of Type (Pharmacological Data)
21 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Asp mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
13.1 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Ser mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
21 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Cys mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
22 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Met mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
119 of 239
120 of 239
121 of 239
122 of 239
Value of Type (Pharmacological Data)
4.5 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Tyr175Phe mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
26 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala169Ile mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
6.6 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Thr439Val mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
28 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Thr439Ser mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
123 of 239
124 of 239
125 of 239
126 of 239
Value of Type (Pharmacological Data)
25 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Thr439Ala mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
2.55 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Tyr176Phe mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
47 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
5-HT uptake; inhibition of
Species or Test-System (Pharmacological Data)
HEK-293 MSR cells transfected with hSERT, Ala173Leu mutant
Method (Pharmacological Data)
inhibition of <3H>-5-HT uptake assayed; cells preincubated with title comp. for 30 min in PBSCM pH 7.4; uptake initiated by addition of <3H>-5-HT (50-100 nM) and continued for 10 min; cells lysed, radiolabeled 5-HT quantified by scintillation counting
Further Details (Pharmacological Data)
hSERT: human serotonin transporter
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
4.6 μmol/l
Reference
Celik, Leyla; Sinning, Steffen; Severinsen, Kasper; Hansen, Carsten G.; Moller, Maria S.; Bols, Mikael; Wiborg, Ove; Schiott, Birgit
Journal of the American Chemical Society, 2008 , vol. 130, # 12 p. 3853 - 3865 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
transport; inhibition of
Species or Test-System (Pharmacological Data)
COS-7 cells
Concentration (Pharmacological Data)
Ca. 1 - 500 μmol/l
Method (Pharmacological Data)
cells expressing rSERT incubated with <3H>5-HT in presence of title comp. for 10 min at 37 deg C; radioactivity extracted with NaOH; measured by liquid scintillation spectrometry
Further Details (Pharmacological Data)
rSERT: rat serotonin transporter; 5-HT: serotonin; cocaine used as positive control (IC50 = 0.64 μmol/l)
127 of 239
128 of 239
129 of 239
130 of 239
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
35.9 μmol/l
Reference
Sogawa; Tagawa; Fujino; Ohyama; Asanuma; Funada; Kitayama
Toxicology Letters, 2007 , vol. 170, # 1 p. 75 - 82 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
membrane currents; inhibition of
Species or Test-System (Pharmacological Data)
Xenopus laevis oocyte
Concentration (Pharmacological Data)
Ca. 0.001 - 10 mmol/l
Method (Pharmacological Data)
oocytes expressing rat NMDA receptor subunits NR1a+2B; Ca(2+)- and Mg(2+)-free solution at 18 deg C; two-electrode voltage clamp at -70 mV; bath application of title comp.; inhibition of currents induced by 100 μmol/l glutamate and 10 μmol/l glycine
Further Details (Pharmacological Data)
NMDA: N-methyl-D-aspartate; further studies using 0.1 or 0.3 mmol/l Mg(2+)
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
18 μmol/l
Results
title comp. concentration-dependently inhibited glutamate-induced currents; co-application of Mg(2+) attenuated effect of title comp. (table, figure)
Reference
Kloda, Anna; Adams, David J.
British Journal of Pharmacology, 2005 , vol. 144, # 3 p. 323 - 330 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
membrane currents; inhibition of
Species or Test-System (Pharmacological Data)
Xenopus laevis oocyte
Method (Pharmacological Data)
oocytes expressing rat NMDA receptor subunits NR1a+2B; Ca(2+)- and Mg(2+)-free solution at 18 deg C; two-electrode voltage clamp at -120 mV; bath application of title comp.; inhibition of currents induced by 100 μmol/l glutamate and 10 μmol/l glycine
Further Details (Pharmacological Data)
NMDA: N-methyl-D-aspartate
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
3.6 μmol/l
Results
title comp. concentration-dependently inhibited glutamate-induced currents
Reference
Kloda, Anna; Adams, David J.
British Journal of Pharmacology, 2005 , vol. 144, # 3 p. 323 - 330 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2C receptors
Method (Pharmacological Data)
in vitro; fluorimetric imaging plate reader assay
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
3 nmol/l
Results
relative efficacy at 1 μmol/l dose: 87 percent
Reference
Adams, David; Benardeau, Agnes; Bickerdike, Mike J.; Bentley, Jon M.; Bissantz, Caterina; Bourson, Anne; Cliffe, Ian A.; Hebeisen, Paul; Kennett, Guy A.; Knight, Antony R.; Malcolm, Craig S.; Mizrahi, Jacques; Plancher, Jean-Marc; Richter, Hans; Roever, Stephan; Taylor, Sven; Vickers, Steven P.
Chimia, 2004 , vol. 58, # 9 p. 613 - 620 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
131 of 239
132 of 239
133 of 239
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2A receptors
Method (Pharmacological Data)
in vitro; fluorimetric imaging plate reader assay
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
6 nmol/l
Reference
Adams, David; Benardeau, Agnes; Bickerdike, Mike J.; Bentley, Jon M.; Bissantz, Caterina; Bourson, Anne; Cliffe, Ian A.; Hebeisen, Paul; Kennett, Guy A.; Knight, Antony R.; Malcolm, Craig S.; Mizrahi, Jacques; Plancher, Jean-Marc; Richter, Hans; Roever, Stephan; Taylor, Sven; Vickers, Steven P.
Chimia, 2004 , vol. 58, # 9 p. 613 - 620 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2B receptors
Method (Pharmacological Data)
in vitro; fluorimetric imaging plate reader assay
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
2 nmol/l
Reference
Adams, David; Benardeau, Agnes; Bickerdike, Mike J.; Bentley, Jon M.; Bissantz, Caterina; Bourson, Anne; Cliffe, Ian A.; Hebeisen, Paul; Kennett, Guy A.; Knight, Antony R.; Malcolm, Craig S.; Mizrahi, Jacques; Plancher, Jean-Marc; Richter, Hans; Roever, Stephan; Taylor, Sven; Vickers, Steven P.
Chimia, 2004 , vol. 58, # 9 p. 613 - 620 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
rat brain membranes
Concentration (Pharmacological Data)
0.01 - 10 μmol/l
Method (Pharmacological Data)
competition experiment: membranes incub. with title comp.+0.1 nmol/l <125I>DAIZAC at room temp.; bound and free radioligand separated by vacuum filtration, analysis by gamma spectrometry
Further Details (Pharmacological Data)
DAIZAC: (S)-5-chloro-3-iodo-2-methoxy-N-(1-azabicyclo<2.2.2>oct-3-yl)benzamide; title comp. effect on binding of <125I>DAIZAC to 5-HT3 receptors studied; pKi estimated using IC50 by the Cheng-Prusoff equation, Ki in mol/l
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
7.39 dimensionless
Reference
Zhang, Zhang-Jin; Trivedi, Bakula L.; De Paulis, Tomas; Schmidt, Dennis E.; Hewlett, William A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 2002 , vol. 365, # 2 p. 123 - 132 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
mouse neuroblastoma*chinese hamster hybrid NCB20 cells
Concentration (Pharmacological Data)
0.01 - 10 μmol/l
Method (Pharmacological Data)
competition experiment: cells incub. with title comp.+0.1 nmol/l <125I>DAIZAC at room temp.; bound and free radioligand separated by vacuum filtration, analysis by gamma spectrometry
Further Details (Pharmacological Data)
DAIZAC: (S)-5-chloro-3-iodo-2-methoxy-N-(1-azabicyclo<2.2.2>oct-3-yl)benzamide; title comp. effect on binding of <125I>DAIZAC to 5-HT3 receptors studied; pKi estimated using IC50 by the Cheng-Prusoff equation, Ki in mol/l
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
6.05 dimensionless
Reference
Zhang, Zhang-Jin; Trivedi, Bakula L.; De Paulis, Tomas; Schmidt, Dennis E.; Hewlett, William A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 2002 , vol. 365, # 2 p. 123 - 132 Title/Abstract Full Text View citing articles Show Details
134 of 239
135 of 239
136 of 239
137 of 239
Effect (Pharmacological Data)
vasoconstrictive
Species or Test-System (Pharmacological Data)
mongrel dog
Sex
male and female
Route of Application
intraarterial
Concentration (Pharmacological Data)
1 - 100 μg/min
Method (Pharmacological Data)
dogs (15-30 kg) anaesthetized (sodium pentobarbitone); bilateral cervical vagosympathectomy; 1 min intracarotid infusion of title comp.
Further Details (Pharmacological Data)
internal carotid blood flow; antagonists: GR127935 (30 μg/kg), ritanserin (100 μg/kg); 5-HT1B/1D and 5-HT2A receptors
Results
dose-response curve of internal carotid blood flow (diagram); effect of antagonists (diagrams)
Reference
Centurion, David; Ortiz, Mario I; Sanchez-Lopez, Araceli; De Vries, Peter; Saxena, Pramod R; Villalon, Carlos M
British Journal of Pharmacology, 2001 , vol. 132, # 5 p. 983 - 990 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
guinea pig distal colon longitudinal muscle strips
Method (Pharmacological Data)
in vitro; effect on 5-HT4 receptor-mediated contraction evaluated; strips vertically suspended in organ bath filled with Krebs' solution; 95 percent O2/5 percent CO2; 37 deg C; increasing conc. of title comp. added at 15 min intervals
Further Details (Pharmacological Data)
contractile responses recorded isometrically; responses expressed as percent of max. 5-HT (EC50: 6.3 nmol/l)-evoked contraction
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
20.8 nmol/l
Results
intrinsic activity of title comp. was 1.03
Reference
Suzuki; Ohuchi; Asanuma; Kaneko; Yokomori; Ito; Isobe; Muramatsu
Chemical and Pharmaceutical Bulletin, 2001 , vol. 49, # 1 p. 29 - 39 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Hartley guinea pig ileal longitudinal muscle strips
Sex
male
Method (Pharmacological Data)
in vitro; ability to restore twitch response to that obtained at supramaximal voltage (serotonin 5-HT4 receptor agonist activity) evaluated; tissue vertically suspended in organ bath filled with Krebs' solution under resting tension of 0.8 g
Further Details (Pharmacological Data)
95 percent O2/5 percent CO2; 32 deg C; twitch responses evoked by transmural electrical stimulation of enteric cholinergic nerves; then voltage reduced to obtain stable submaximal response and title comp. added
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
19.5 nmol/l
Reference
Suzuki; Ohuchi; Asanuma; Kaneko; Yokomori; Ito; Isobe; Muramatsu
Chemical and Pharmaceutical Bulletin, 2001 , vol. 49, # 1 p. 29 - 39 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
DNA; examination of
Species or Test-System (Pharmacological Data)
DNA plasmid pBR322
Concentration (Pharmacological Data)
0.05 - 2.5 mmol/l
Method (Pharmacological Data)
in vitro; inhibition of peroxynitrite-induced plasmid DNA strand scission detected by electrophoresis; PBS; three forms of plasmid: supercoiled, open-circular, and linear detected with UV luminometer
Results
electrophoresis pattern; partly inhibited DNA strand breakage
138 of 239
139 of 239
140 of 239
Reference
Nakagawa, Hidehiko; Sumiki, Erika; Takusagawa, Mitsuko; Ikota, Nobuo; Matsushima, Yoshikazu; Ozawa, Toshihiko
Chemical and Pharmaceutical Bulletin, 2000 , vol. 48, # 2 p. 261 - 265 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
hypotensive
Species or Test-System (Pharmacological Data)
Sprague-Dawley rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
< 0.01 - 0.06 μmol/kg
Kind of Dosing (Pharmacological Data)
dissolved in 0.1 ml of alcoholic saline (1 percent EtOH in 0.9 percent NaCl); cumulative doses of title comp. injected via external jugular vein at stable mean arterial blood pressure
Method (Pharmacological Data)
rat weight 260-280 g; 10 rats/group; housed at 21 deg C and 12/12 hr light/dark cycle; maintained on standard rodent chow and water ad lib.; blood pressure measured in left carotid artery; cumulative effect of title comp. accounted
Results
very potent effect at low doses; gentle decrease of blood pressure at higher doses; dose-response curve of the hypotensive effect of title comp. (figure)
Reference
Wang, Hexiang; Ng, Tzi Bun
Pharmacology and Toxicology, 2000 , vol. 86, # 3 p. 125 - 128 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
5-HT6 receptors
Method (Pharmacological Data)
receptors stably transfected to human embryonic kidney 293 cells; binding activity of title comp. determined in competition with 2 nmol/l <3H>lysergic acid diethylamide in Tris buffer (pH 7.4) at 37 deg C for 60 min; liquid scintillation
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
90 nmol/l
Reference
Lee; Rangisetty; Dukat; Slassi; Maclean; Glennon
Medicinal Chemistry Research, 2000 , vol. 10, # 4 p. 230 - 242 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
displacing of 125I-DAIZAC
Species or Test-System (Pharmacological Data)
whole brain membrane of Sprague-Dawley rat
Sex
male
Concentration (Pharmacological Data)
3 - 30 μmol/l
Method (Pharmacological Data)
cell membranes suspn. incubated with title compd. in presence of 3 nM of 125I-DAIZAC; anal. (gamma spectrometry)
Further Details (Pharmacological Data)
125I-DAIZAC - desamino-3-(125)iodo-(S)-zacopride
Results
2 percent displacement of specifically bound 125I-DAIZAC
Reference
Hewlett, William A.; Trivedi, Bakula L.; Zhang, Zhang-Jin; De Paulis, Tomas; Schmidt, Dennis E.; Lovinger, David M.; Ansari, M. Sib; Ebert, Michael H. Journal of Pharmacology and Experimental Therapeutics, 1999 , vol. 288, # 1 p. 221 - 231 Title/Abstract Full Text View citing articles Show Details
141 of 239
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
prolonged decrease in diastolic blood pressure
Species or Test-System (Pharmacological Data)
fawn-hooded rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
142 of 239
143 of 239
144 of 239
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-350 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Comment (Pharmacological Data)
No effect
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
prolonged decrease in diastolic blood pressure
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-300 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
56 nmol/kg
Results
title comp.-induced maximum decrease in diastolic blood pressure was 66 mmHg
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
increase in systolic blood pressure
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-300 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
227 nmol/kg
Results
title comp.-induced maximum increase in systolic blood pressure was 75 mmHg
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
increase in systolic blood pressure
Species or Test-System (Pharmacological Data)
fawn-hooded rat
145 of 239
146 of 239
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-350 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
62 nmol/kg
Results
title comp.-induced maximum increase in systolic blood pressure was 57 mmHg
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
decrease in heart rate
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-300 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Further Details (Pharmacological Data)
estimation of the effect of title comp. on heart rate
Comment (Pharmacological Data)
No effect
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
cardiovascular
Endpoint of Effect (Pharmacological Data)
decrease in heart rate
Species or Test-System (Pharmacological Data)
fawn-hooded rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-350 g rats; title comp. was injected via femoral vein; arterial blood flow was monitored at the left carotid artery with continuous display of the heart rate using a rate-meter
Further Details (Pharmacological Data)
estimation of the effect of title comp. on heart rate
Comment (Pharmacological Data)
No effect
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
147 of 239
148 of 239
149 of 239
Effect (Pharmacological Data)
secretion stimulant
Endpoint of Effect (Pharmacological Data)
change in potential difference in proximal colon
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-300 g rats; 3-cm segment of PC of anesth. rats was tied at the distal end and filled with 154 nM NaCl; title comp. was injected via femoral vein; potential difference across each loop was measured between 2 salt-bridge electrodes
Further Details (Pharmacological Data)
proximal colon (PC); estimation of title comp. effect on transepithelial electrical activity
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
192 nmol/kg
Results
maximum response induced by title comp. was equal to 4.1 +/- 0.5; graphic representation
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
secretion stimulant
Endpoint of Effect (Pharmacological Data)
change in potential difference in proximal colon
Species or Test-System (Pharmacological Data)
fawn-hooded rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-350 g rats; 3-cm segment of PC of anesth. rats was tied at the distal end and filled with 154 nM NaCl; title comp. was injected via femoral vein; potential difference across each loop was measured between 2 salt-bridge electrodes
Further Details (Pharmacological Data)
proximal colon (PC); estimation of title comp. effect on transepithelial electrical activity
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
204 nmol/kg
Results
maximum response induced by title comp. was equal to 7.0 +/- 0.8; graphic representation
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
secretion stimulant
Endpoint of Effect (Pharmacological Data)
change in potential difference in mid-small intestine
Species or Test-System (Pharmacological Data)
fawn-hooded rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-09 mol/kg
150 of 239
151 of 239
152 of 239
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-350 g rats; 3-cm segment of MSI of anesth. rats was tied at the distal end and filled with 154 nM NaCl; title comp. was injected via femoral vein; potential difference across each loop was measured between 2 salt-bridge electrodes
Further Details (Pharmacological Data)
mid-small intestine (MSI); estimation of title comp. effect on transepithelial electrical activity
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
70 nmol/kg
Results
maximum response induced by title comp. was equal to 4.1 +/- 0.3; graphic representation
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
secretion stimulant
Endpoint of Effect (Pharmacological Data)
change in potential difference in mid-small intestine
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
Ca. 1E-09 - 1E-06 mol/kg
Kind of Dosing (Pharmacological Data)
bolus injection
Method (Pharmacological Data)
250-300 g rats; 3-cm segment of MSI of anesth. rats was tied at the distal end and filled with 154 nM NaCl; title comp. was injected via femoral vein; potential difference across each loop was measured between 2 salt-bridge electrodes
Further Details (Pharmacological Data)
mid-small intestine (MSI); estimation of title comp. effect on transepithelial electrical activity
Type (Pharmacological Data)
ED50
Value of Type (Pharmacological Data)
59 nmol/kg
Results
maximum response induced by title comp. was equal to 3.3 +/- 0.3; graphic representation
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1999 , vol. 51, # 12 p. 1415 - 1421 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
jejunum of Wistar rat
Sex
not specified
Method (Pharmacological Data)
isolated rat jejunum, 3 - 4 cm length; gassed Krebs-Henseleit solution, 37 deg C, title comp. in increasing concn. at 10 min intervals; isotonic transducer, contractions measured; control acetylcholine (1 μmol/l)
Further Details (Pharmacological Data)
experiment was carried out in the presence of ondansetrom (1 μmol/l) - blockade of 5HT3 receptors
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
5.33 dimensionless
Reference
Hemedah; Coupar; Mitchelson
British journal of pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
homogenate of guinea-pig ileum
Sex
not specified
153 of 239
154 of 239
155 of 239
Kind of Dosing (Pharmacological Data)
title comp. used in the concn. range of -10 to -6 log mol/l
Method (Pharmacological Data)
phosphate buffer (50 mmol/l) with <3H>-mesulergine (10 nmol/l) and title comp. (at least 5 different concn., quadruplicate) incubated for 10 min at 37 deg C; homogenate added; incubation 60 min at 37 deg C; filtration; LSC of filter
Further Details (Pharmacological Data)
5-HT7 receptor assay; other receptors blocked by masking drugs added prior to first incubation: cinanserin (30 nmol/l), RS 102221 (3 μmol/l), raclopride (1 μmol/l), prazosin (0.1 μmol/l), and yohimbine (0.1 μmol/l)
Results
inhibition of <3H>-mesulergine binding (diagram); pKi = 7.7 to 9.6 (table)
Reference
Hemedah; Coupar; Mitchelson
British journal of pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
membranes of Wistar rats whole brain minus cerebellum
Sex
not specified
Kind of Dosing (Pharmacological Data)
title comp. used in the concn. range ca. -10 to -4.5 log mol/l
Method (Pharmacological Data)
homogenized brain, membrane isolated; phosphate buffer (50 mmol/l) with <3H>-mesulergine (10 nmol/l) and title comp. (13 concn., duplicates) incub. for 10 min at 37 deg C; membrane homogenate added; incub. 60 min at 37 deg C; filtration; LSC of filter
Further Details (Pharmacological Data)
5-HT7 receptor assay; other receptors blocked by masking drugs added prior to first incubation; cinanserin (30 nmol/l), RS 102221 (3 μmol/l), raclopride (1 μmol/l), prazosin (0.1 μmol/l), and yohimbine (0.1 μmol/l)
Results
inhibition of <3H>-mesulergine binding (diagram); pKi = 6.2 to 9.2 (table)
Reference
Hemedah; Coupar; Mitchelson
British journal of pharmacology, 1999 , vol. 126, # 1 p. 179 - 188 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
rat jejunum
Sex
male
Concentration (Pharmacological Data)
100 μmol/l
Exposure Period (Pharmacological Data)
10 min
Method (Pharmacological Data)
desensitization; Wistar rats, 230-250 g body wt., anaesthetized with 60 mg/kg i.p. sodium pentobarbitone; potential difference (PD), short-circuit current (SCC) and tissue resistance measured across paired sheets of intact and stripped proximal jejunum
Further Details (Pharmacological Data)
37 deg C, 5-HT - 5-hydroxytryptamine
Results
second application of title compound failed to elicit an increase in SCC either in intact or stripped sheets; desensitization to title compound abolished 5-HT response in stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1998 , vol. 50, # 5 p. 539 - 547 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
rat jejunum
Sex
male
Concentration (Pharmacological Data)
100 μmol/l
Kind of Dosing (Pharmacological Data)
jejunum treated with combination of title compound and 1-phenylbiguanide, 100 μM
Exposure Period (Pharmacological Data)
10 min
Method (Pharmacological Data)
desensitization; Wistar rats, 230-250 g body wt., anaesthetized with 60 mg/kg i.p. sodium pentobarbitone; potential difference (PD), short-circuit current (SCC) and tissue resistance measured across paired sheets of intact and stripped proximal jejunum
Further Details (Pharmacological Data)
37 deg C, 5-HT - 5-hydroxytryptamine
156 of 239
157 of 239
158 of 239
159 of 239
Results
reduced 5-HT-induced increase in SCC in intact sheets and eliminated it in stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1998 , vol. 50, # 5 p. 539 - 547 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
rat jejunum
Sex
male
Concentration (Pharmacological Data)
1E-08 - 0.0001 mol/l
Exposure Period (Pharmacological Data)
10 min
Method (Pharmacological Data)
in vitro; Wistar rats, 230-250 g body wt., anaesthetized with 60 mg/kg i.p. sodium pentobarbitone; potential difference (PD), short-circuit current (SCC) and tissue resistance measured across paired sheets of intact and stripped proximal jejunum
Further Details (Pharmacological Data)
37 deg C
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
6.3 - 11 μmol/l
Results
induced conc.-dependent increases in SCC, 18.3 μA/cm2 in stripped sheets, 25.1 μA/cm2 in intact sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1998 , vol. 50, # 5 p. 539 - 547 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
intracellular cAMP stimulation
Species or Test-System (Pharmacological Data)
murine fibroblasts (LMtk-) cell line
Concentration (Pharmacological Data)
1E-09 - 1E-05 mol/l
Exposure Period (Pharmacological Data)
10 min
Method (Pharmacological Data)
cell line membrane preincubated (HEPES-buffered saline, pH 7.4, 37 deg C, 30 min), then incubated in presence of title compd.
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
129 nmol/l
Results
affinity const. Ki = 2.2 nM; concn.-dependent stimulation given (diagram)
Reference
Adham, Nika; Zgombick, John M.; Bard, Jonathan
Journal of Pharmacology and Experimental Therapeutics, 1998 , vol. 287, # 2 p. 508 - 514 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antioxidant
Species or Test-System (Pharmacological Data)
deoxyribose
Concentration (Pharmacological Data)
0.1 - 10 mmol/l
Method (Pharmacological Data)
deoxyribose (dRib) incub. without/with title comp.+FeCl3+H2O2 in phosphate buffer (pH 7.4; 37 deg C; 1 h); thiobarbituric acid reactive products (oxidative degradation of dRib) detected by spectrophotometry
Further Details (Pharmacological Data)
title comp. effect on dRib degradation studied
Results
conc.-dependent inhibition of dRib degradation (graph)
Reference
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antidote
160 of 239
161 of 239
162 of 239
Species or Test-System (Pharmacological Data)
Balb/C mice
Sex
female
Route of Application
subcutaneous
Concentration (Pharmacological Data)
4.9 mg/kg
Kind of Dosing (Pharmacological Data)
single dose
Method (Pharmacological Data)
18-20 g mice inj. with 160 μg i.p. E. coli lipopolysaccharide (LPS) simultaneously with title comp.; survival rate (SR) assessed daily for 4 d
Further Details (Pharmacological Data)
title comp. effect on SR studied
Results
SR significantly improved (graph)
Reference
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antagonist
Species or Test-System (Pharmacological Data)
CD-1 mice
Sex
male
Route of Application
subcutaneous
Concentration (Pharmacological Data)
0.02 nmol/kg
Kind of Dosing (Pharmacological Data)
single dose
Method (Pharmacological Data)
18-20 g mice; 30 min after title comp. inj. with 160 μg i.p. E. coli lipopolysaccharide (LPS); serum tumor necrosis factor (TNF measured by ELISA
Further Details (Pharmacological Data)
title comp.effect on LPS-induced TNF studied
Results
LPS-induced TNF inhibited (diagram)
Reference
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antagonist
Species or Test-System (Pharmacological Data)
human peripheral blood mononuclear cells
Concentration (Pharmacological Data)
1E-09 - 1E-05 mol/l
Kind of Dosing (Pharmacological Data)
single dose
Method (Pharmacological Data)
cells incub. with title comp.+10 ng/ml E. coli lipopolysaccharide (LPS) in RPMI 1640 (4 h); tumor necrosis factor (TNF) in supernatant measured by ELISA
Further Details (Pharmacological Data)
title comp. effect on LPS-induced TNF studied
Results
LPS-induced TNF conc.-dependently inhibited (diagram)
Reference
Sacco, Silvano; Aquilini, Luciano; Ghezzi, Pietro; Pinza, Mario; Guglielmotti, Angelo
European Journal of Pharmacology, 1998 , vol. 343, # 2-3 p. 249 - 255 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Chinese hamster ovary FA4 cells
Concentration (Pharmacological Data)
3 μmol/l
Method (Pharmacological Data)
ability of title comp. to activate PLC-mediated IP accumulation studied; cells labeled with 1 μCi/ml myo-<3H>inositol (24 h, 37 deg C) incubated with title comp. for 10 min; mono-, di-, triphosphates of inositol separated by ion exchange chromatography
163 of 239
164 of 239
165 of 239
166 of 239
167 of 239
Further Details (Pharmacological Data)
radioactivity counted by liquid scintillation; cells expressing human 5-HT2A receptors; 5-HT: 5-hydroxytryptamine; PLC: phospholipase C; IP: inositol phosphates; 5-HT used as reference comp.; Emax: maximal response
Results
Emax title comp./Emax 5-HT ca. 0.85 (figure)
Reference
Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.
Molecular Pharmacology, 1998 , vol. 54, # 1 p. 94 - 104 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Chinese hamster ovary FA4 cells
Concentration (Pharmacological Data)
3 μmol/l
Method (Pharmacological Data)
ability of title comp. to activate PLA2-mediated arachidonic acid release studied; cells labeled with 0.1 μCi/ml <14C>arachidonic acid (4 h, 37 deg C) incubated with title comp. for 10 min; radioactivity measured by liquid scintillation counting
Further Details (Pharmacological Data)
cells expressing human 5-HT2A receptors; 5-HT: 5-hydroxytryptamine; PLA2: phospholipase A2; 5-HT used as reference comp.; Emax: maximal response
Results
Emax title comp./Emax 5-HT ca. 1.30 (figure)
Reference
Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.
Molecular Pharmacology, 1998 , vol. 54, # 1 p. 94 - 104 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Chinese hamster ovary FA4 cells
Concentration (Pharmacological Data)
3 μmol/l
Method (Pharmacological Data)
ability of title comp. to increase Ca(2+) conc. studied; cells loaded with Fura-2; intracellular Ca(2+) conc. determined by measuring fluorescence (340/380 nm)
Further Details (Pharmacological Data)
cells expressing human 5-HT2A receptors; 5-HT: 5-hydroxytryptamine; 5-HT used as reference comp.; Emax: maximal response
Results
Emax title comp./Emax 5-HT ca. 0.80 (figure)
Reference
Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.
Molecular Pharmacology, 1998 , vol. 54, # 1 p. 94 - 104 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
inhibition of 2-<125I>-iodomelatonin binding in membrane preparations of rat testes, IC50>100000 nmol/L
Reference
Vera; Tijmes; Valladares
Steroids, 1997 , vol. 62, # 2 p. 226 - 229 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
acetylcholine release
Species or Test-System (Pharmacological Data)
guinea-pig ileum
Sex
male and female
Concentration (Pharmacological Data)
1E-07 - 0.0001 mol/l
Exposure Period (Pharmacological Data)
15 min
Method (Pharmacological Data)
longitudinal muscle-myenteric plexus preparation; incubation with <3H>choline (7 μCi/ml); superfusion; depolarization with 50 mM KCl at 12 and 45 min after beginning sample collection; drug addition at 30 min; measuring tritium content in superfusate
Further Details (Pharmacological Data)
Tyrode's solution containing 1 μM hemicholinum-3 and 1 μM methysergide; at 37 deg C; 95 percent O2/5 percent CO2
Results
enhancement of <3H>acetyl choline release in concentration-dependent manner
Reference
Ramirez; Garcia-Garayoa; Romero; Monge; Roca; Del Rio; Lasheras
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 1 p. 58 - 65 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antagonist
168 of 239
169 of 239
170 of 239
Endpoint of Effect (Pharmacological Data)
inhibition of increase in neurogenic twitch response
Species or Test-System (Pharmacological Data)
guinea-pig ileum
Sex
male and female
Concentration (Pharmacological Data)
5e-07 mol/l
Exposure Period (Pharmacological Data)
30 min
Method (Pharmacological Data)
longitudinal muscle-myenteric plexus preparation; electrical field stimulation (0.2 Hz, 60 percent maximal voltage); incubation with test compound; treatment with VB20B7 (50 μM); contractions recorded isometrically
Further Details (Pharmacological Data)
in physiological solution (pH 7.4) containing 1 μM methysergide; at 37 deg C; 95 percent O2/5 percent CO2; under 0.5-g tension
Results
inhibited contraction elicited by VB20B7 by 75 percent
Reference
Ramirez; Garcia-Garayoa; Romero; Monge; Roca; Del Rio; Lasheras
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 1 p. 58 - 65 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle relaxant
Endpoint of Effect (Pharmacological Data)
relaxation of carbachol-induced tone
Species or Test-System (Pharmacological Data)
Wistar rat oesophageal tunica muscularis mucosae
Sex
male
Method (Pharmacological Data)
contracting rat oesophagus with carbachol (3 μM, 20 min); cumulative addition of test agonist; isometrical recording of response; cumulative concentration-effect curve
Further Details (Pharmacological Data)
in Tyrode's solution (pH 7.4) containing 0.1 mM pargyline, 30 μM cocaine, 30 μM corticosterone and 1 μM methysergide; at 37 deg C; 95 percent O2/5 percent CO2
Results
pEC50 8.08; intrinsic activity (relative to maximal response to 5-HT) 1.20; equipotent concentration ratio (=IC40 test agonist/IC40 5-HT) 0.26
Reference
Ramirez; Garcia-Garayoa; Romero; Monge; Roca; Del Rio; Lasheras
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 1 p. 58 - 65 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Concentration (Pharmacological Data)
1E-08 - 0.0001 mol/l
Kind of Dosing (Pharmacological Data)
at desensitization assay: two consecutive application at concn. of 100 μM with 10 min interval
Method (Pharmacological Data)
rats of 230-250 g; paired sheets of intact and stripped ileum; effect of title comp. on potential difference (PD), short-circuit current (SCC) and tissue resistance generated in intact and stripped sheets; repeated application to assess desensitization
Further Details (Pharmacological Data)
incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; title comp. adding to serosal fluid; serosal fluid contained 10 mM glucose, mucosal fluid contained 10 mM mannitol
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
3.3 - 20 μmol/l
Results
dose-dependent increase in SCC with maximum of 43.9 and 28.6 μA cm-2 in intact and stripped sheets, resp.; higher affect in stripped sheets; loss of response at 2nd application in stripped sheets, but SCC increase in intact sheets to 45 percent 1st response
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
Beagle dog colon longitudinal muscle
171 of 239
172 of 239
173 of 239
Sex
male and female
Concentration (Pharmacological Data)
Ca. 1E-07 - 0.0001 mol/l
Method (Pharmacological Data)
dogs (7-14kg) decerebrated, a piece of midcolon ca. 5 cm dissected, luminal contents removed; mucosa, submucosa and mesenterium dissected, strips of longitudinal muscle prepared; in the presence of (10nM) SB 204070
Further Details (Pharmacological Data)
pEC50 = -log (effective concentration 50)
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
5.7 mol/l
Reference
Prins, Nicolaas H.; Briejer, Michel R.; Schuurkes, Jan A.J.
British Journal of Pharmacology, 1997 , vol. 120, # 4 p. 714 - 720 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
Beagle dog colon longitudinal muscle
Sex
male and female
Concentration (Pharmacological Data)
Ca. 1E-07 - 0.0001 mol/l
Method (Pharmacological Data)
dogs (7-14kg) decerebrated, a piece of midcolon ca. 5 cm dissected, luminal contents removed; mucosa, submucosa and mesenterium dissected, strips of longitudinal muscle prepared
Further Details (Pharmacological Data)
concentration-response curve in the presence of 10 nM SB 204070
Results
concentration-dependent contraction: title compound concentration (logM), ca. contraction percent: -7, 10; -6, 30; -5, 70; -4, 75; slope of concentration-response curve = 0.7+/-0.2
Reference
Prins, Nicolaas H.; Briejer, Michel R.; Schuurkes, Jan A.J.
British Journal of Pharmacology, 1997 , vol. 120, # 4 p. 714 - 720 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Albino rabbit retina membranes
Method (Pharmacological Data)
ML1 melatonine presynaptic heteroreceptors binding study; membranes suspension (80-100 μg protein/tube) incubated with 2-<125I>-iodomelatonin (80 pmol/l) and title comp. at 25 deg C for 1.5 h
Further Details (Pharmacological Data)
filters counted in a γ-counter; Ki value calculated from IC50 obtained from concentration effects curves; Ki: dissociation constant;
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
27390 nmol/l
Reference
Dubocovich, Margarita L.; Masana, Monica I.; Iacob, Stanca; Sauri, Daniel M.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 355, # 3 p. 365 - 375 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
COS-7 cells expressing human Mel1b receptors
Method (Pharmacological Data)
COS-7 cells transiently transfected with the human Mel1b cDNAs, then cells were lysed; final suspension concentration: 20-35 μg protein/tube; lysate incubated with 2<125I>-iodomelatonin (80 pmol/l) and title comp. (25 deg C, 1.5 h)
Further Details (Pharmacological Data)
filters counted in a γ-counter; Ki value calculated from IC50 obtained from concentration effects curves; Ki: dissociation constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
254000 nmol/l
Reference
Dubocovich, Margarita L.; Masana, Monica I.; Iacob, Stanca; Sauri, Daniel M.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 355, # 3 p. 365 - 375 Title/Abstract Full Text View citing articles Show Details
174 of 239
175 of 239
176 of 239
177 of 239
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
COS-7 cells expressing human Mel1a receptors
Method (Pharmacological Data)
COS-7 cells transiently transfected with the human Mel1a cDNAs, then cells were lysed; final suspension concentration: 20-35 μg protein/tube; lysate incubated with 2<125I>-iodomelatonin (80 pmol/l) and title comp. (25 deg C, 1.5 h)
Further Details (Pharmacological Data)
filters counted in a γ-counter; Ki value calculated from IC50 obtained from concentration effects curves; Ki: dissociation constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
244000 nmol/l
Reference
Dubocovich, Margarita L.; Masana, Monica I.; Iacob, Stanca; Sauri, Daniel M.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1997 , vol. 355, # 3 p. 365 - 375 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
hypotensive
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
1.7 - 5260 nmol/kg
Kind of Dosing (Pharmacological Data)
title comp. dissolved in saline, administered after raised BP had become stable; each dose of title comp. admin. as single bolus in 1 ml/kg
Method (Pharmacological Data)
in vivo; normotensive rats (350-450 g) anesthet., pithed, artificially respired, bilaterally vagotomized; catheters placed in the left femoral vein (ME infusion), the right femoral vein (title comp. admin.) and the left carotid artery (pressure record.)
Further Details (Pharmacological Data)
diastolic blood pressure (BP), heart rate measured; i.v. 0.18 μmol/kg ketanserin admin. and 10 min later contin. infusion of 60-80 nmol/kg/min methoxamine (ME), BP raised to 110 mm Hg; dose response curve to title comp.; ED50 in mol/kg
Type (Pharmacological Data)
-log ED50
Value of Type (Pharmacological Data)
7.38 dimensionless
Results
title comp. produced clear hypotensive responses, dose-dependent decreases in diastolic BP observed; biphasic hypotensive pattern; initial pressor responses to title comp. were inhibited by increasing conc. of ketanserin to 3.2 μmol/kg (diagram)
Reference
Terron
British journal of pharmacology, 1997 , vol. 121, # 3 p. 563 - 571 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
Accumulation
Species or Test-System (Pharmacological Data)
Hartley guinea pig ileum
Sex
male
Concentration (Pharmacological Data)
10 μmol/l
Method (Pharmacological Data)
pigs (250-300 g) sacrificed by asphyxiation with CO2, ilea dissected, longitudinal muscle removed; incubation with title comp. at 37 degC for 10 min; cAMP accumulation determined by measuring incorporation of (3H)adenine into (3H)ATP
Further Details (Pharmacological Data)
cAMP = cyclic AMP; inhibition by oxotremorine-M further studied
Results
title comp. caused a 1.25-fold increase in cAMP levels compared with control
Reference
Ostrom, Rennolds S.; Ehlert, Frederick J.
Journal of Pharmacology and Experimental Therapeutics, 1997 , vol. 280, # 1 p. 189 - 199 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Wistar rat distal colonic mucosa
Sex
male
178 of 239
179 of 239
180 of 239
181 of 239
Concentration (Pharmacological Data)
3E-07 - 0.0003 mol/l
Method (Pharmacological Data)
in vitro; short-circuit current (Isc) responses evaluated; preparations mounted in Ussing chamber, bathed on both sides with Krebs-bicarbonate solution equilibrated with 95 percent O2/5 percent CO2 at 37 deg C, short-circuited, and Isc recorded continuously
Further Details (Pharmacological Data)
5-HT used as reference comp.
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
1.2E-5 mol/l
Results
title comp. conc.-dependently increased Isc and max. response was 80.8 percent of that to 5-HT
Reference
Kiso, Tetsuo; Ito, Hiroyuki; Miyata, Keiji
European Journal of Pharmacology, 1997 , vol. 320, # 2-3 p. 187 - 192 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
peristaltic stimulant
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
subcutaneous
Concentration (Pharmacological Data)
3 - 10 mg/kg
Kind of Dosing (Pharmacological Data)
title comp. suspended in a 5 percent arabic gum solution
Method (Pharmacological Data)
feces discharged by three rats 180-210 g collected and weighed 1 hr after administration of title comp.
Further Details (Pharmacological Data)
title comp. affects 5-HT4, 5-HT1-like and 5-HT2 receptors but not 5-HT3 receptors
Results
title comp. dose-dependently increased the fecal pellet output, at 3 mg/kg fecal pellet output (g/3 rats/hr) ca. 1, at 10 mg/kg ca. 1.5, control ca. 0.5
Reference
Ito, Chika; Isobe, Yoshihiko; Kawamura, Reiko; Kiuchi, Yoichi; Tsuchida, Katsuharu; Higuchi, Shohei
Journal of Pharmacology and Experimental Therapeutics, 1997 , vol. 280, # 1 p. 67 - 72 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
hypotensive
Species or Test-System (Pharmacological Data)
Wistar rat
Sex
male
Route of Application
intravenous
Concentration (Pharmacological Data)
1 - 30 μg/kg
Kind of Dosing (Pharmacological Data)
used as hydrochloride; dissolved in physiological saline; dose refers to free base
Method (Pharmacological Data)
vagosympathectomized, anaesthetized rats treated with title comp.; BP measured from right carotid artery using pressure transducer; HR measured with tachograph triggered from electrocardiogram signals; BP and HR recorded on polygraph
Further Details (Pharmacological Data)
BP: blood pressure; HR: heart rate
Results
title comp. dose-dependently decreased mean arterial BP, effect lasted for 5-10 min
Reference
De Vries; Villalon; Heiligers; Saxena
Naunyn-Schmiedeberg's archives of pharmacology, 1997 , vol. 356, # 1 p. 90 - 99 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
binding at human 5-HT1A, 5-HT1Dβ and 5-HT1Dα receptors
Reference
Glennon, Richard A.; Hong, Seoung-Soo; Bondarev, Mikhail; Law, Ho; Dukat, Malgorzata; Rakhit, Suman; Power, Patricia; Fan, Ermei; Kinneau, Diana; Kamboj, Rajender; Teitler, Milt; Herrick-Davis, Katharine; Smith, Carol
Journal of Medicinal Chemistry, 1996 , vol. 39, # 1 p. 314 - 322 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
intrinsic activity and agonist potency in the isolated rat oesophageal tunica muscularis mucosae 1.2 and pEC 50 = 8.1, resp.
182 of 239
183 of 239
184 of 239
185 of 239
Reference
Lasheras, Berta; Berjon, Angel; Montanes, Rafael; Roca, Joan; Romero, Gonzalo; Ramirez, Maria J.; Del Rio, Joaquin
Arzneimittel-Forschung/Drug Research, 1996 , vol. 46, # 4 p. 401 - 406 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
vasodilator, peripheral
Species or Test-System (Pharmacological Data)
jugular vein of Cynomolgus monkey
Sex
not specified
Method (Pharmacological Data)
weight 4-7 kg; endothelium denuded rings; pre-contraction with 10 nM U46619; after 60 min incubation in presence of ketanserin (0.1 μM), pindolol (3 μM), ondansetron (1 μM), GR 113808 (1 μM), phentolamine (1 mM)
Further Details (Pharmacological Data)
pEC50=agonist potency; n=4
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
5.7 dimensionless
Results
max. relaxation 54.5 percent of U46619-induced tone; conc.-dependent relaxation
Reference
Leung; Walsh; Pulido-Rios; Eglen
British Journal of Pharmacology, 1996 , vol. 117, # 5 p. 926 - 930 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
vasoconstrictive
Species or Test-System (Pharmacological Data)
jugular vein of Cynomolgus monkey
Sex
not specified
Concentration (Pharmacological Data)
1 - 32000 nmol/l
Method (Pharmacological Data)
weight 4-7 kg; endothelium denuded rings; in absence of spasmogen; in presence of ketanserin (0.1 μM), pindolol (3 μM), ondansetron (1 μM), GR 113808 (1 μM), phentolamine (1 mM)
Comment (Pharmacological Data)
No effect
Reference
Leung; Walsh; Pulido-Rios; Eglen
British Journal of Pharmacology, 1996 , vol. 117, # 5 p. 926 - 930 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
effect on 5-HT levels
Species or Test-System (Pharmacological Data)
rat hippocampus
Sex
female
Concentration (Pharmacological Data)
10 μmol/l
Method (Pharmacological Data)
in vivo study; Wistar rats (150-250 g) anaesthetized, cannulae stereotaxically inserted in cerebral cortex overlaying the hippocampus; after 14 d microdialysis probe inplanted
Further Details (Pharmacological Data)
baseline dialysate 5-HT levels analyzed, title comp. adm. via the microdialysis probe; dialyzate 5-HT levels quantified immediately by HPLC-electrochemical detection; in the continued presence of, and 80 min following methysergide (10 μM) pindolol
Results
enhanced extracellular levels of 5-HT (figure given) approx. 450 percent
Reference
Ge, Jian; Barnes, Nicholas M.
British Journal of Pharmacology, 1996 , vol. 117, # 7 p. 1475 - 1480 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Hartley guinea-pig brain slices
Sex
male
Method (Pharmacological Data)
in vitro; slices in Krebs buffer contng. <3H>-5-HT (100 nmol/l for mesencephalic raphe, 20 nmol/l for hippocampus and frontal cortex); 37 deg C, 95 percent O2, 5 percent CO2; electrical stimulation; tritium release by liquid scintillation spectrometry
Further Details (Pharmacological Data)
effect of title comp. (5-HT1D/1B receptor agonist) on the modulation of 5-HT release in mesencephalic raphe, hippocampus and frontal cortex
186 of 239
187 of 239
188 of 239
189 of 239
Results
title comp. inhibited the electrically evoked release of tritium in a concentration-dependent manner
Reference
El Mansari; Blier
British Journal of Pharmacology, 1996 , vol. 118, # 3 p. 681 - 689 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK 293 cells transfected with 5-HT3R-As cDNA
Kind of Dosing (Pharmacological Data)
as hydrochloride
Method (Pharmacological Data)
assay tubes containing 100 μl 3H-granisetron, 100 μl of title comp. and 50 μl of membrane homogenate, total reaction volume 1 ml (37 deg C, 60 min); bound and free radioligand separated by addn. of 3 ml ice cold buffer and immediate vacuum filtration
Results
specific binding remaining in the presence of title comp. = 74+/-2 percent
Reference
Hope, Anthony G.; Peters, John A.; Brown, Angus M.; Lambert, Jeremy J.; Blackburn, Thomas P.
British Journal of Pharmacology, 1996 , vol. 118, # 5 p. 1237 - 1245 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
human detrusor muscle
Concentration (Pharmacological Data)
10 - 30000 nmol/l
Method (Pharmacological Data)
in vitro; muscular strips in organ bath; isometric transducer; electrical field stimulation (5 Hz for 5 s every min, 0.1 ms pulse duration, 60 V); presence of methylsergide (1 μmol/l) and ondasetron (3 μmol/l); cumulative admin. of title comp.
Further Details (Pharmacological Data)
potentiation of the contractile responses to el. stimulation by title comp. (5-HT4 receptor agonist)
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
6.02 dimensionless
Results
concn.-response curve for title comp. (Fig. 2)
Reference
Candura; Messori, Eliana; Franceschetti; D'Agostino; Vicini; Tagliani, Monica; Tonini
British Journal of Pharmacology, 1996 , vol. 118, # 8 p. 1965 - 1970 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rats
Sex
male
Method (Pharmacological Data)
whole brain dissected from animals (150-200 g), disrupted, centrifuged, freezed; binding assay at 0, 10, 20, 25, 30, 35 deg C according to Nelson and Thomas method with displacement of <3H>BRL 43694
Further Details (Pharmacological Data)
Ki = inhibitory constant obtained by displacement of 0.6 nM <3H>BRL 43694 from the same receptor
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
6360 - 31810 nmol/l
Results
Ki values (at K):31810 (273), 22730 (283), 12720 (293), 9120 (298), 8180 (303), 6360 (308); thermodynamic data for the binding equilibrium given (Γ0, ΔH0, ΔS0)
Reference
Borea, Pier Andrea; Dalpiaz, Alessandro; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 298, # 3 p. 329 - 334 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
stripped rat distal colon (Wistar)
Concentration (Pharmacological Data)
0.1 - 100 μmol/l
Method
rats killed by CO2-induced narcosis; distal colon excised and prepared by stripping the muscularis propria and neural ganglia; mounted in Ussing chambers in Krebs
190 of 239
191 of 239
192 of 239
(Pharmacological Data)
soln. pH 7.4, 37 deg C, connected to voltage clamps, subjected to short circuit condition
Further Details (Pharmacological Data)
pretreated with 0.2 μM tetrodotoxin and with tropisetron (0.3,0, and 3 μM) 20 min prior to addition of various concns. of title comp.; title comp.-induced Cl- secretion registered as changes in short circuit current (ΔIsc)
Type (Pharmacological Data)
pA2
Value of Type (Pharmacological Data)
6.4 dimensionless
Results
tropisetron produced dextral shifts in title comp.-induced response curves; at all concns. of tropisetron significant shifts in EC50; Schild plot slope 0.8
Reference
Budhoo, Misra R.; Harris, R. Paul; Kellum, John M.
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 137 - 140 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
stripped rat distal colon (Wistar)
Concentration (Pharmacological Data)
0.01 - 100 μmol/l
Method (Pharmacological Data)
rats killed by CO2-induced narcosis; distal colon excised and prepared by stripping the muscularis propria and neural ganglia; mounted in Ussing chambers in Krebs soln. pH 7.4, 37 deg C, connected to voltage clamps, subjected to short circuit condition
Further Details (Pharmacological Data)
pretreated with 0.2 μM tetrodotoxin 20 min prior to addition of title comp. or 5-hydroxytryptamine (5-HT control); title comp.-induced Cl- secretion registered as changes in short circuit current (ΔIsc)
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
12.0 μmol/l
Results
title comp.-induced a concn.-dependent changes in Isc; maximum response was 99 percent of the 5-HT-induced change in Isc
Reference
Budhoo, Misra R.; Harris, R. Paul; Kellum, John M.
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 137 - 140 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
cells from colliculi neurons of Swiss mouse embryos
Concentration (Pharmacological Data)
1E-9 - 1E-4 log M
Method (Pharmacological Data)
cells were generated from colliculi of 14-15-day-old Swiss mouse embryos; membrane suspension prepared (pH 7.4, 5 mg protein/ml soln.), incubated with various concns. of title comp. in presence of 0.2 nM (3H)GR 113808 for 30 min at 37 deg C
Further Details (Pharmacological Data)
competition binding expressed as percent of the specific binding in the absence of title comp.; IC50 value required to displace 50 percent of (3H)GR 113808 binding converted to Kd
Type (Pharmacological Data)
pKd
Value of Type (Pharmacological Data)
6.28 dimensionless
Reference
Ansanay; Sebben; Bockaert; Dumuis
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 165 - 174 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
cells from colliculi neurons of Swiss mouse embryos
Concentration (Pharmacological Data)
1E-9 - 1E-4 log M
Method (Pharmacological Data)
cells were generated from colliculi of 14-15-day-old Swiss mouse embryos; incubated with increasing concns. of title comp. conversion of (3H)ATP to (3H)cAMP detn. after 5 min at 37 deg C; results expressed as the percent stimulation over basal conversion
Further Details (Pharmacological Data)
EC50 corresponded to the concn. of title comp. required to obtain a half-maximal stimulation of adenylyl cyclase
Type (Pharmacological Data)
pEC50
Value of Type
7 dimensionless
(Pharmacological Data)
193 of 239
194 of 239
195 of 239
196 of 239
Reference
Ansanay; Sebben; Bockaert; Dumuis
European Journal of Pharmacology, 1996 , vol. 298, # 2 p. 165 - 174 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
vasodilator, coronary
Species or Test-System (Pharmacological Data)
coronary artery smooth muscle of dog
Concentration (Pharmacological Data)
1E-07 - 0.001 mol/l
Kind of Dosing (Pharmacological Data)
cumulative doses into organ bath
Method (Pharmacological Data)
precontraction with 2 μM prostaglandin F2α, application of title comp.; measurement of force
Further Details (Pharmacological Data)
mongrel dogs of either sex (weight 15-25 kg); killed; coronary arteries washed, freed of endothelium; segments of arteries 4 mm lengths in Krebs bicarbonate solution stretched to tension of 10 g over 10 min, tested by contraction with 40 μM KCl
Type (Pharmacological Data)
pD2
Value of Type (Pharmacological Data)
4.42 dimensionless
Results
small vasoconstriction at low doses, relaxation at higher doses; pD2 4.58; effects unaltered by pretreatment with 5-HT1D receptor antagonist GR127935
Reference
Terron, Jose A.
British Journal of Pharmacology, 1996 , vol. 118, # 6 p. 1421 - 1428 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Siberian hamster tissue, melatonin ML2 receptors
Method (Pharmacological Data)
membrane pellets from whole brain or testes incubated in Tris-HCl buffer with 7 conc.s of title comp. at 4 deg C, pH 7.4, for 1 h, competing for binding with 2<125I>MCA-NAT (50 pM)
Further Details (Pharmacological Data)
Ki values from IC50 obtained from competition curves, method Cheng and Prusoff
Results
Ki (nM): 2-<125I>MCA-NAT: brain 641, testes 1926
Reference
Molinari; North; Dubocovich
European Journal of Pharmacology, 1996 , vol. 301, # 1-3 p. 159 - 168 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
h5-HT1Dβ L929sA cells
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>5-alniditan (2 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
47 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
h5-HT1Dβ L929sA cells
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>5-HT (4 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
197 of 239
198 of 239
199 of 239
200 of 239
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
9.4 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
h5-HT1Dα C6 glioma cells
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>5-HT (4 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
3.2 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
h5-HT1Dα C6 glioma cells
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>alniditan (2 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
36 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
5-HT1D calf substantia nigra
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>alniditan (2 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
9.6 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
5-HT1D calf substantia nigra
Method (Pharmacological Data)
radioligand assay; incubation at 37 deg C, for 30 min; radioactivity measured by scintillation; in presence of <3H>5-HT (4 nM)
Further Details (Pharmacological Data)
Ki = apparent equilibrium inhibition constant
201 of 239
202 of 239
203 of 239
204 of 239
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
3.2 nmol/l
Reference
Leysen; Gommeren; Heylen; Luyten; Van De Weyer; Vanhoenacker; Haegeman; Schotte; Van Gompel; Wouters; Lesage
Molecular Pharmacology, 1996 , vol. 50, # 6 p. 1567 - 1580 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Y-1 adrenocortical tumor cells
Method (Pharmacological Data)
recombinant human 5-HT1Dβ receptor subtype stably expressed in cells; potency to inhibit forskolin-stimulated cAMP accumulation; radioimmunoassay
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
8.1 nmol/l
Reference
Zgombick, John M.; Schechter, Lee E.; Adham, Nika; Kucharewicz, Stefan A.; Weinshank, Richard L.; Branchek, Theresa A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 354, # 3 p. 226 - 236 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
NIH-3T3 fibroblast
Method (Pharmacological Data)
recombinant human 5-HT1Dα receptor subtype stably expressed in fibroblasts; potency to inhibit forskolin-stimulated cAMP accumulation; radioimmunoassay
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
1.0 nmol/l
Reference
Zgombick, John M.; Schechter, Lee E.; Adham, Nika; Kucharewicz, Stefan A.; Weinshank, Richard L.; Branchek, Theresa A.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 354, # 3 p. 226 - 236 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
monkey kidney cells
Method (Pharmacological Data)
membranes harvested from cells (Cos-7) transiently expressing gene encoding rabbit 5-HT1Dα (A) or 5-HT1Dβ (B) receptor subtypes; radioligand binding assay; competition experiments with <3H>5-hydroxytryptamine at 37 deg C for 30 min
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
7.58 - 7.81 dimensionless
Results
pKi for A 7.81, for B 7.58
Reference
Bard, Jonathan A.; Kucharewicz, Stefan A.; Zgombick, John M.; Weinshank, Richard L.; Branchek, Theresa A.; Cohen, Marlene L.
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 354, # 3 p. 237 - 244 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
rat cortex membranes
Method (Pharmacological Data)
membranes incub. with title comp.+<3H>8-hydroxy-N,N-dipropyl-2-aminotetralin in Tris-HCl-containing buffer (pH 7.7; 0-35 deg C; 20-60 min); inhibition of radioligand binding determined by liquid scintillation
Further Details (Pharmacological Data)
parameter of competitive binding (inhibitory binding const., Ki) calculated from IC50 (title comp. conc. displacing 50 percent of radioligand) values; thermodynamic parameters of binding (ΔG0, ΔH0, ΔS0 for 298.15 K) also determined
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
1.62 - 29 nmol/l
205 of 239
206 of 239
207 of 239
208 of 239
Results
single-site binding; ΔG0=-44.6 KJ/mol; ΔH0=-65 KJ/mol; ΔS0=-67 J/T(K)*mol
Reference
Dalpiaz, Alessandro; Borea, Pier Andrea; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 312, # 1 p. 107 - 114 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
vasoconstrictive
Species or Test-System (Pharmacological Data)
jejunum from Hooded Wister rat
Concentration (Pharmacological Data)
0.003 - 100 μmol/l
Method (Pharmacological Data)
tissue from 200-250 g male rats incub. with title comp.+tetrodotoxin in Krebs-Henseleit sol. (O2:CO2=95:5; 37 deg C; 10 min); isotonic contractions measured with transducer
Further Details (Pharmacological Data)
conc.-response curve (CRC) obtained cumulatively; Emax: max. response expressed as percent of max. response to 1 μM acetylcholine; pEC50=-logEC50: potency
Results
conc.-dependent contractions with monophasic CRC; Emax=83.2 percent; pEC50=6.95 (graph)
Reference
McLean, Peter G.; Coupar, Ian M.
European Journal of Pharmacology, 1996 , vol. 312, # 2 p. 215 - 225 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of binding to receptor
Species or Test-System (Pharmacological Data)
human 5-HT1B receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pcDNA3/5-HT1B plasmid; cellular membranes prepared; radioligand binding with 0.5 nM <3H>-5carboxamidotryptamine in presence of title comp., 25 deg C, 30 min
Further Details (Pharmacological Data)
5-HT=serotonin
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
2.18 nmol/l
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of nucleotide formation
Species or Test-System (Pharmacological Data)
human 5-HT1B receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pcDNA3/5-HT1B plasmid; incub. with 100 μM forskolin plus title comp., 37 deg C, 5 min; cellular cAMP content by radioimunoassay
Further Details (Pharmacological Data)
EC50: conc. of title comp. yielding 50 percent of the inhibition by 1 μM serotonin (5-HT)
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
21.00 nmol/l
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of nucleotide formation
Species or Test-System (Pharmacological Data)
human 5-HT1D receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pRcRSV/5-HT1D plasmid; incub. with 100 μM forskolin plus title comp., 37 deg C, 5 min; cellular cAMP content by radioimunoassay
Further Details (Pharmacological Data)
EC50: conc. of title comp. yielding 50 percent of the inhibition by 1 μM serotonin (5-HT)
Type (Pharmacological Data)
EC50
Value of Type
0.97 nmol/l
(Pharmacological Data)
209 of 239
210 of 239
211 of 239
212 of 239
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of nucleotide formation
Species or Test-System (Pharmacological Data)
human 5-HT1D receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pcDNA3/5-HT1D plasmid; incub. with 100 μM forskolin plus title comp., 37 deg C, 5 min; cellular cAMP content by radioimunoassay
Further Details (Pharmacological Data)
EC50: conc. of title comp. yielding 50 percent of the inhibition by 1 μM serotonin (5-HT)
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
4.90 nmol/l
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of binding to receptor
Species or Test-System (Pharmacological Data)
human 5-HT1D receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pcDNA3/5-HT1D plasmid; cellular membranes prepared; radioligand binding with 3 nM <3H>-sumatriptan in presence of title comp., 25 deg C, 30 min
Further Details (Pharmacological Data)
5-HT=serotonin
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
1.65 nmol/l
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of binding to receptor
Species or Test-System (Pharmacological Data)
human 5-HT1D receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pcDNA3/5-HT1D plasmid; cellular membranes prepared; radioligand binding with 0.5 nM <3H>-5carboxamidotryptamine (5-CT) in presence of title comp., 25 deg C, 30 min
Further Details (Pharmacological Data)
5-HT=serotonin
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
1.33 nmol/l
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
inhibition of binding to receptor
Species or Test-System (Pharmacological Data)
human 5-HT1D receptor
Method (Pharmacological Data)
C6-glial cells (CCL 107, rat), ATCC, stably transfected with pRcRSV/5-HT1D plasmid; cellular membranes prepared; radioligand binding with <3H>-5carboxamidotryptamine in presence of title comp., 25 deg C, 30 min
Further Details (Pharmacological Data)
5-HT=serotonin
Type (Pharmacological Data)
Ki
1.38 nmol/l
Value of Type (Pharmacological Data)
213 of 239
214 of 239
215 of 239
216 of 239
Reference
Pauwels; Palmier; Wurch; Colpaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 2 p. 144 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antagonist
Species or Test-System (Pharmacological Data)
rat Cos-7 cells
Concentration (Pharmacological Data)
1E-09 - 0.0001 mol/l
Method (Pharmacological Data)
the affinity of title comp. that compete for <3H>GR113808 binding at the cloned 5-HT4L receptor was measured; membranes were incubated with 0.4 nmol/l <3H>GR113808 for 30 min at 37 deg C
Further Details (Pharmacological Data)
affinity values are given as Kis, were determined from IC50 values
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
401 nmol/l
Reference
Adham, Nika; Gerald, Christophe; Schechter, Lee; Vaysse, Pierre; Weinshank, Richard; Branchek, Theresa
European Journal of Pharmacology, 1996 , vol. 304, # 1-3 p. 231 - 235 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
antagonist
Species or Test-System (Pharmacological Data)
rat Cos-7 cells
Concentration (Pharmacological Data)
1E-08 - 1E-05 mol/l
Method (Pharmacological Data)
the affinity of title comp. that compete for <3H>5-HT binding at the cloned 5-HT4L receptor was measured; membranes were incubated with 10 nmol/l <3H>5-HT for 30 min at 37 deg C
Further Details (Pharmacological Data)
affinity values are given as Kis, were determined from IC50 values
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
112 nmol/l
Reference
Adham, Nika; Gerald, Christophe; Schechter, Lee; Vaysse, Pierre; Weinshank, Richard; Branchek, Theresa
European Journal of Pharmacology, 1996 , vol. 304, # 1-3 p. 231 - 235 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
Wistar rat stomach
Sex
male
Concentration (Pharmacological Data)
1E-09 - 1E-05 mol/l
Kind of Dosing (Pharmacological Data)
title comp. was dissolved in Tyrode solution
Method (Pharmacological Data)
stomach fundus strips incubated with <M-3H>CC for 60 min and then superfused (1 ml/min) with Tyrode containing H-3; title comp. added 5 min after start; superfusates collected; radioactivity determined by LSS; contractility recorded isometrically
Further Details (Pharmacological Data)
contractile activity and <3H> outflow determined simultaneously; H-3: hemicholinium-3; <M-3H>CC: <methyl-3H>choline chloride; LSS: liquid scintillation spectrometer; further investigations with tetrodotoxin, atropine or SDZ 205-557
Results
title comp. increased contractions in conc.-dependent manner and evoked <3H>acetylcholine release in a 'bell-shaped' manner with maximum stimulation at 1E-7 mol/l; effects were decreased by tetrodotoxin and SDZ 205-557; atropine inhibited contraction
Reference
Amemiya, Norihito; Hatta, Shinichi; Takemura, Haruo; Ohshika, Hideyo
European Journal of Pharmacology, 1996 , vol. 318, # 2-3 p. 403 - 409 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System
Wistar rat stomach
(Pharmacological Data)
217 of 239
218 of 239
219 of 239
220 of 239
Sex
male
Concentration (Pharmacological Data)
1E-09 - 1E-05 mol/l
Kind of Dosing (Pharmacological Data)
title comp. was dissolved in Tyrode solution
Method (Pharmacological Data)
stomach fundus strips placed in organ bath with Tyrode; tension 2 g applied to strips; 60 min later pretreatment with 1 μmol/l atropine for 5 min; incubation with title comp. for 10 min in presence of atropine; contractility recorded isometrically
Results
contractile response to title comp. (1E-8 - 1E-6) was reduced in presence of atropine
Reference
Amemiya, Norihito; Hatta, Shinichi; Takemura, Haruo; Ohshika, Hideyo
European Journal of Pharmacology, 1996 , vol. 318, # 2-3 p. 403 - 409 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
Wistar rat stomach
Sex
male
Concentration (Pharmacological Data)
0.1 μmol/l
Kind of Dosing (Pharmacological Data)
title comp. was dissolved in Tyrode solution
Method (Pharmacological Data)
stomach fundus strips placed in organ bath with Tyrode; tension 2 g applied; 60 min later 1 μmol/l atropine (ATR) added for 5 min; incubation with title comp. for 10 min in presence of atropine; contractility recorded isometrically
Further Details (Pharmacological Data)
further invest. with (1 μmol/l each) ATR/tetrodotoxin (TTX), ATR/SDZ 205-557 (SDZ, 5-HT4 receptor antagonist), ATR/TTX/SDZ, ATR/yohimbine (YOH, 5-HT2B receptor antagonist), ATR/TTX/YOH or ATR/SDZ/YOH
Results
contractile response to title comp. was reduced in presence of ATR, ATR/TTX, ATR/SDZ or ATR/YOH but in presence of TTX contraction was further inhibited by YOH but not SDZ; title comp. as believe involves ATR-sensitive and ATR-resistant components
Reference
Amemiya, Norihito; Hatta, Shinichi; Takemura, Haruo; Ohshika, Hideyo
European Journal of Pharmacology, 1996 , vol. 318, # 2-3 p. 403 - 409 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
Wistar rat stomach
Sex
male
Concentration (Pharmacological Data)
0.1 μmol/l
Kind of Dosing (Pharmacological Data)
title comp. was dissolved in Tyrode solution
Method (Pharmacological Data)
stomach fundus strips placed in organ bath with Tyrode; tension 2 g applied; electrical stimulation (ES) for 4 min; SDZ added for 10 min; incubation with title comp. for 10 min in presence of SDZ; ES repeated; contractility recorded isometrically
Further Details (Pharmacological Data)
ES: 45 V, 5 Hz, 5-ms pulse duration, for 5 s, intervals 30 s; SDZ: SDZ 205-557, 1 μmol/l (SDZ, 5-HT4 receptor antagonist); further invest. with 1 μmol/l yohimbine (YOH, 5-HT2B receptor antagonist)
Results
title comp. alone enhanced electrically evoked contractions by 40 percent of control but this stimulatory effect was antagonized by SDZ and YOH
Reference
Amemiya, Norihito; Hatta, Shinichi; Takemura, Haruo; Ohshika, Hideyo
European Journal of Pharmacology, 1996 , vol. 318, # 2-3 p. 403 - 409 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
effect on the transintestinal electrical activity of rat small intestine and colon in-vivo
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1995 , vol. 47, # 9 p. 744 - 749 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle relaxant
Species or Test-System (Pharmacological Data)
Dunkin-Hartley guinea-pig ileum
Sex
male
Method
250-350 g pigs killed, ileal segments suspended in Krebs solution + (μM) cocaine 10, corticosterone 10, pargyline 5, indomethacin 1, atropine 1 at 37 deg C, pH 7.4;
(Pharmacological Data)
H: without/with desensitization by 60 min equilibr. with 3 μM 5-carboxamidotryptamine
Further Details (Pharmacological Data)
contractions induced by 1 μM histamine (H) or 30 nM substance P (SP) for 30 s, 5 min dose-cycle; when stable contractions, title comp. added 3 min before spasmogen; change in isometric tension recorded
Results
concentration-dependent relaxation; contraction by H: pEC50: < 4.5; desens.: no effect; SP: pEC50: 5.7, relaxation: 43 percent
Reference
Carter; Champney; Hwang; Eglen
European Journal of Pharmacology, 1995 , vol. 280, # 3 p. 243 - 250 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
electrophysiological
Species or Test-System (Pharmacological Data)
neurons of guinea pig ileum
Sex
male
Concentration (Pharmacological Data)
0.1 - 3 μmol/l
Method (Pharmacological Data)
small piece longitudinal muscle-myenteric plexus pinned out flat and superfused with oxygenated Krebs-bicarbonate solution with 1 μM nifedipine and 1 μM scopolamine; Grass S44 stimulator; intracellular recordings obtained using amplifier Axoclamp 2A
Further Details (Pharmacological Data)
glass electrode filled with Krebs solution was used to evoke slow excitatory postsynaptic potentials (EPSP); stimulating electrode positioned on an interganglionic nerve strand; cumulative addition of title compound
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
0.4 μmol/l
Results
caused concentration-dependent membrane depolarization in 6 of 9 neurons; conc.-dependent inhibition of spike afterhyperpolarization
Reference
Pan, Hui; Galligan, James J.
European Journal of Pharmacology, 1995 , vol. 278, # 1 p. 67 - 74 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
calf striatum homogenate
Exposure Period (Pharmacological Data)
30 min
Method (Pharmacological Data)
radioligand binding assay; 37 deg C; liquid scintillation counter analysis in ecoscint cocktail
Further Details (Pharmacological Data)
affinity to bovine 5-HT1D receptors
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
4.1 nmol/l
Reference
Hong, Seoung-Soo; Dukat, Malgorzata; Teitler, Milt; Herrick-Davis, Kathy; McCallum, Kirk; et al.
Medicinal Chemistry Research, 1995 , vol. 5, # 9 p. 690 - 699 Title/Abstract Full Text Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
human 5-HT1Dβ receptors, cloned
Exposure Period (Pharmacological Data)
30 min
Method (Pharmacological Data)
radioligand binding assay; membrane homogenates from cells transfected with human 5-HT1Dβ genes; receptors labeled with 2 nM (3H)serotonin; 37 deg C
Further Details (Pharmacological Data)
liquid scintillation counter analysis in ecoscint cocktail
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
3.5 nmol/l
Reference
Hong, Seoung-Soo; Dukat, Malgorzata; Teitler, Milt; Herrick-Davis, Kathy; McCallum, Kirk; et al.
Hide facts 221 of 239
222 of 239
223 of 239
Medicinal Chemistry Research, 1995 , vol. 5, # 9 p. 690 - 699 Title/Abstract Full Text Show Details
224 of 239
225 of 239
226 of 239
227 of 239
228 of 239
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
human 5-HT1A receptors, cloned
Exposure Period (Pharmacological Data)
30 min
Method (Pharmacological Data)
radioligand binding assay; membrane homogenates from cells transfected with human 5-HT1A genes; receptors labeled with 0.2 nM (3H)-8-OH DPAT; 37 deg C
Further Details (Pharmacological Data)
liquid scintillation counter analysis in ecoscint cocktail
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
3.2 nmol/l
Reference
Hong, Seoung-Soo; Dukat, Malgorzata; Teitler, Milt; Herrick-Davis, Kathy; McCallum, Kirk; et al.
Medicinal Chemistry Research, 1995 , vol. 5, # 9 p. 690 - 699 Title/Abstract Full Text Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
guinea-pig ileum
Sex
male
Method (Pharmacological Data)
Hartley guinea-pig, distal ileum isolated, mucosal segments prepared, tissues bathed in Ussing system for measurement of short-circuit current, title comp., methysergide and 5-HT added, concentration-response curve measured
Results
title comp. alone stimulatd short-circuit current; title comp. mimicked only the high potency 5-HT response in the presence of methysergide
Reference
Leung; Blissard; Jett; Eglen
Naunyn-Schmiedeberg's Archives of Pharmacology, 1995 , vol. 351, # 6 p. 596 - 602 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
rat C6-glial cells expressing human 5-HT1Dβ receptor
Concentration (Pharmacological Data)
1E-10 - 1E-05 mol/l
Method (Pharmacological Data)
in vitro; inhibition of forskolin-stimulated cAMP formation evaluated; 100 μmol/l forskolin; 1 mmol/l isobutylmethylxanthine; controlled salt solution, pH 7.4; humidified 95 percent air/5 percent CO2; 37 deg C; incubated for 5 min
Further Details (Pharmacological Data)
cellular cAMP content assayed using RIA; EC50: conc. yielding 50 percent of inhibition of forskolin-induced cAMP formation produced by 1 μmol/l 5-HT; Emax: max. percent inhibition of forskolin-induced cAMP formation vs. that obtained with 1 μmol/l 5-HT
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
21.0 nmol/l
Results
Emax: 99 percent (conc.-response curve)
Reference
Pauwels, Petrus J.; Colpaert, Francis C.
Biochemical Pharmacology, 1995 , vol. 50, # 10 p. 1651 - 1658 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
affinity and selectivity in 5-HT2A and 5-HT2C serotonin receptor binding
Reference
Glennon; Dukat; El-Bermawy; Law; De los Angeles; Teitler; King; Herrick-Davis
Journal of Medicinal Chemistry, 1994 , vol. 37, # 13 p. 1929 - 1935 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
antifouling activity
Reference
Kon-Ya, Kazumi; Shimidzu, Nobuyoshi; Miki, Wataru; Endo, Mamoru
Bioscience, Biotechnology, and Biochemistry, 1994 , vol. 58, # 12 p. 2178 - 2181 Title/Abstract Full Text Show Details
229 of 239
230 of 239
231 of 239
232 of 239
233 of 239
234 of 239
235 of 239
236 of 239
237 of 239
238 of 239
239 of 239
Comment (Pharmacological Data)
receptor binding affinities (pKl) for 6 subtypes of serotonin/tryptamin receptors: 5-HT1A: 8.42; 5-HT1B: 7.98; 5-HT1C: 8.15; 5-HT1D: 8.30; 5-HT2: 5.77; 5-HT3: 5.40; tryptamine: 6.48.
Reference
Dijkstra, Gerard D. H.; Tulp, Martin Th. M.; Hermkens, Pedro H. H.; Maarseveen, Jan H. van; Scheeren, Hans W.; Kruse, Chris G.
Recueil des Travaux Chimiques des Pays-Bas, 1993 , vol. 112, # 2 p. 131 - 136 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
binding activity at 5-HT2 type receptors, IC50: 11 (5-HT1A), 49 (5-HT1D), 250 (5-HT1C), 130 (5-HT2(DOI)), 1800 (5-HT2(ket)) nM
Reference
Macor; Fox; Johnson; Koe; Lebel; Zorn
Journal of Medicinal Chemistry, 1992 , vol. 35, # 20 p. 3625 - 3632 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
binding affinities at <3H>ketanserin- or <3H>-DOB-labeled 5-HT2 serotonin receptors in brains of male Sprauge-Dawley rats: Ki
Reference
Glennon, Richard A.; Chaurasia, Chandra; Titeler, Milt
Journal of Medicinal Chemistry, 1990 , vol. 33, # 10 p. 2777 - 2784 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Serotonergic agonist of central serotonin (5-HT) binding sites.
Reference
Glennon; Titeler; Lyon; Slusher
Journal of Medicinal Chemistry, 1988 , vol. 31, # 4 p. 867 - 870 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
ability to display <3H>ketanserin and <3H>serotonin from rat brain frontal cortex homogenate as an indication of affinity for 5-HT2 and 5HT1B receptors, (pKi = 5.99; 8.19), respectively
Reference
Nichols; Lloyd; Johnson; Hoffman
Journal of Medicinal Chemistry, 1988 , vol. 31, # 7 p. 1406 - 1412 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
hypoglycemic activity: dose 300 mg/kg (rat, orally)
Reference
Grin, L. M.; Khlaponina, L. N.; Pivnenko, N. S.; Selichenko, A. G.; Brutov, V. D.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 7 p. 476 - 479 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 7 p. 819 - 822 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Ld 50: 102.5 mg/kg, intravenously (mouse); spasmogenic activity (isolated uterus horn of rat); hypertensic activity; causes contraction of the third eyelid, constricts the ear vessels (rabbit)
Reference
Partsvaniya, D. A.; Akhvlediani, R. N.; Gordeev, E. N.; Vigdorchik, M. M.; Kuleshova, L. N.; et al.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 12 p. 833 - 838 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 12 p. 1454 - 1459 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
causes flabbiness, hyperthermia, tremor, and diarrhea, intensify the activity of hexenal, and weaken the hyperthermic activity of phenamine, subcutaneously (mouse); prolongation of the duration of the soporific activity of hexenal
Reference
Partsvaniya, D. A.; Akhvlediani, R. N.; Gordeev, E. N.; Vigdorchik, M. M.; Kuleshova, L. N.; et al.
Pharmaceutical Chemistry Journal, 1986 , vol. 20, # 12 p. 833 - 838 Khimiko-Farmatsevticheskii Zhurnal, 1986 , vol. 20, # 12 p. 1454 - 1459 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
LD50=2.3 mM, Rhopalosiphum maidis
Reference
Corcuera, Luis J.
Phytochemistry (Elsevier), 1984 , vol. 23, # 3 p. 539 - 542 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
inhib. of pituitary and hypothalamic progesterone 5α-reductase activity of female Holtzman rat
Reference
Krause; Halls; Karavolas
Steroids, 1980 , vol. 36, # 3 p. 305 - 320 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Zum Metabolismus in vitro durch Rattenleber-homogenate
Reference
Iskric; Kveder
Croatica Chemica Acta, 1965 , vol. 37, p. 233 Full Text Show Details
Ecotoxicology (2)
1 of 2
2 of 2
Effect (Ecotoxicology)
enzyme; inhibition of
Species or Test-System (Ecotoxicology)
purified AChE of Electrophorus electricus, electric eel
Method (Ecotoxicology)
substrate (o-NAA) was incub. at 37 deg C, 1 h in potassium phosphate buffer (0.1 mol/l), pH 8.0, containing 0.15-0.25 U of AChE in presence of title comp.; reaction stopped; AChE associated AAA activity was measured by spectrophotometer at 410 nm
Further Details (Ecotoxicology)
AAA: aryl acylamidase; AChE: acetylcholineesterase; o-NAA: 2'-nitroacetanilide
Type (Ecotoxicology)
IC50
Value of Type (Ecotoxicology)
> 1000 μmol/l
Reference
Costagli, Chiara; Galli, Alessandro
Biochemical Pharmacology, 1998 , vol. 55, # 10 p. 1733 - 1737 Title/Abstract Full Text View citing articles Show Details
Effect (Ecotoxicology)
receptor; binding activity
Species or Test-System (Ecotoxicology)
quail (Coturnix coturnix)
Sex
male and female
Exposure Period (Ecotoxicology)
50 min
Method (Ecotoxicology)
quails, 8-10 week old, decapitated; hearts dissected; fresh heart tissues homogenized in Tris-HCl; 2.0-2.5 mg/ml heart membrane incubated with 22-30 pM <125I>iodomelatonin and title comp. at 37 deg C
Further Details (Ecotoxicology)
radioligand binding assay; radioactivity was determined by gamma counter; Ki: inhibition constant
Type (Ecotoxicology)
Ki
Value of Type (Ecotoxicology)
> 10000 nmol/l
Reference
Pang; Tang; Song; Brown
Life Sciences, 1996 , vol. 58, # 13 p. 1047 - 1057 Title/Abstract Full Text View citing articles Show Details
Other Data Use (6) Laboratory Use and Handling
Use Pattern
Reference
active ingredient of a liposomal topical formulation
GUILFORD, F., Timothy
Patent: WO2008/36979 A2, 2008 ;
itching
GUILFORD, F., Timothy
Patent: WO2008/36979 A2, 2008 ;
Title/Abstract Full Text Show Details
Title/Abstract Full Text Show Details
histamine and non-histamine related inflammatory skin changes
GUILFORD, F., Timothy
Patent: WO2008/36979 A2, 2008 ;
Comparative compound for investigation of inhibition of lipid peroxidation
Board of Trustees of Michigan State University
Patent: US2005/59727 A1, 2005 ;
used as inhibitor in reaction of peroxidation of 1-stearoyl 2-linoleoyl sn-glycerol 3phosphocholine induced by FeCl2*4H2O
Jayaprakasam, Bolleddula; Strasburg, Gale A.; Nair, Muraleedharan G.
Tetrahedron, 2004 , vol. 60, # 13 p. 3109 - 3121 Title/Abstract Full Text View citing articles Show Details
inhibitory activity on nitration (IC50 0.44 mM) of L-tyrosine to 3-nitrotyrosine (37 deg C, 10 min, pH 7.4); enhancement of oxidation of L-tyrosine to 2,2'-dityrosine
Nakagawa, Hidehiko; Sumiki, Erika; Takusagawa, Mitsuko; Ikota, Nobuo; Matsushima, Yoshikazu; Ozawa, Toshihiko
Chemical and Pharmaceutical Bulletin, 2000 , vol. 48, # 2 p. 261 - 265 Title/Abstract Full Text View citing articles Show Details
Reaxys Registry Number: 25679244
Title/Abstract Full Text Show Details
Title/Abstract Full Text Show Details
no reactions.
Bioactivity (1)
2
CAS Registry Number: 137375-67-8 Molecular Formula: C11H14N2O*H Linear Structure Formula: C11H14N2O*H(1+)
Molecular Weight: 191.253
InChI Key: JTEJPPKMYBDEMY-UHFFFAOYSA-O
2
Synthesize | Hide Details Find similar
Bioactivity Pharmacological Data (1) 1 of 1
Comment (Pharmacological Data)
Bioactivities present
Reference
Vermeulen, Erik S.; Schmidt, Anne W.; Sprouse, Jeffrey S.; Wikstroem, Hakan V.; Grol, Cor J.
Journal of Medicinal Chemistry, 2003 , vol. 46, # 25 p. 5365 - 5374 Title/Abstract Full Text View citing articles Show Details
Pratuangdejkul; Schneider; Jaudon; Rosilio; Baudoin; Loric; Conti; Launay; Manivet
Current Medicinal Chemistry, 2005 , vol. 12, # 20 p. 2393 - 2410 Title/Abstract Full Text View citing articles Show Details
Chemical Name: 5-methoxytryptamine-α,α,β,β-d4
3
Reaxys Registry Number: 482899
CAS Registry Number: 96236-05-4 Type of Substance: heterocyclic Molecular Formula: C11H14N2O Linear Structure Formula: C11H10D4N2O Molecular Weight: 194.213
InChI Key: JTEJPPKMYBDEMY-CQOLUAMGSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine-α,α,β,β-d4, 5-Methoxy-(α,α,β,β-2H(4))-tryptamin, 5-Methoxy-(α,α,β,β-D4)-tryptamin Identification Substance Label (3) Label
Reference
2-d&4%
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
5
Beck; Bosin
Biomedical Mass Spectrometry, 1979 , vol. 6, p. 19,20 Full Text Show Details
7
Shaw; Wright; Milne
Biomedical mass spectrometry, 1977 , vol. 4, # 6 p. 348 - 353 Title/Abstract Full Text View citing articles Show Details
Derivative (2)
5 prep out of 5 reactions.
Identification Physical Data (2) Spectra (3)
3
Comment (Derivative)
Reference
Pentafluorpropionylderivat: MS
Beck; Bosin
Biomedical Mass Spectrometry, 1979 , vol. 6, p. 19,20 Full Text Show Details
Hydrochlorid: F:235-240grad
Shaw; Wright; Milne
Biomedical mass spectrometry, 1977 , vol. 4, # 6 p. 348 - 353 Title/Abstract Full Text View citing articles Show Details
Physical Data Melting Point (2) Melting Point
Reference
118 - 121 °C
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
246 - 248 °C
Beck; Bosin
Biomedical Mass Spectrometry, 1979 , vol. 6, p. 19,20 Full Text Show Details
Spectra Mass Spectrometry (3) Description (Mass Spectrometry)
Reference
spectrum electron impact (EI)
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
spectrum chemical ionization (CI)
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Shaw; Wright; Milne
Biomedical mass spectrometry, 1977 , vol. 4, # 6 p. 348 - 353 Title/Abstract Full Text View citing articles Show Details
Chemical Name: 5-methoxytryptamine hydrochloride
4
Reaxys Registry Number: 3717598
CAS Registry Number: 66-83-1 Type of Substance: heterocyclic Molecular Formula: C11H14N2O*ClH Linear Structure Formula: C11H14N2O*ClH Molecular Weight: 226.706
InChI Key: TXVAYRSEKRMEIF-UHFFFAOYSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine hydrochloride, 2-(5-methoxy-1H-indol-3-yl)ethylamine hydrochloride, 5-Methoxytryptamine hydrochloride, 5Methoxytryptamine HCl, 5-methoxytryptamine hydrochloric acid, 3-methoxytryptamine hydrochloride, o-methylserotonin hydrochloride Identification Substance Label (14) Label
Reference
2
Megyesi, Rita; Forró, Enikő; Fülöp, Ferenc
ChemistryOpen, 2016 , vol. 5, # 3 p. 254 - 260 Title/Abstract Full Text View citing articles Show Details
2 prep out of 137 reactions.
Identification Physical Data (4) Spectra (4) Bioactivity (45)
114
10
Chen, Jing; Tao, Ling-Xue; Xiao, Wei; Ji, Sha-Sha; Wang, Jian-Rong; Li, Xu-Wen; Zhang, Hai-Yan; Guo, Yue-Wei
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 15 p. 3765 - 3769 Title/Abstract Full Text View citing articles Show Details
5-MT
Odagaki; Fuxe
Journal of Pharmacology and Experimental Therapeutics, 1995 , vol. 274, # 1 p. 337 - 344 Title/Abstract Full Text View citing articles Show Details
Davison, Emma K.; Sperry, Jonathan
Organic and Biomolecular Chemistry, 2015 , vol. 13, # 29 p. 7911 - 7914 Title/Abstract Full Text View citing articles Show Details
A43
Vendrell-Navarro, Glòria; Rúa, Federico; Bujons, Jordi; Brockmeyer, Andreas; Janning, Petra; Ziegler, Slava; Messeguer, Angel; Waldmann, Herbert
ChemBioChem, 2015 , vol. 16, # 11 p. 1580 - 1587 Title/Abstract Full Text View citing articles Show Details
15
Liew, Lydia P.P.; Fleming, Jessica M.; Longeon, Arlette; Mouray, Elisabeth; Florent, Isabelle; Bourguet-Kondracki, Marie-Lise; Copp, Brent R.
Tetrahedron, 2014 , vol. 70, # 33 p. 4910 - 4920 Title/Abstract Full Text View citing articles Show Details
KD30
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ; Title/Abstract Full Text Show Details
1
Schott, Yvonne; Decker, Michael; Rommelspacher, Hans; Lehmann, Jochen
Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 22 p. 5840 - 5843 Title/Abstract Full Text View citing articles Show Details
5-MeOT
Berner Hansen
Pharmacology and Toxicology, 1995 , vol. 76, # 2 p. 136 - 140 Title/Abstract Full Text View citing articles Show Details
Steward; Ge Jian; Stowe; Brown; Bruton; Stokes; Barnes
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 55 - 62 Title/Abstract Full Text View citing articles Show Details
Chesnoy-Marchais; Barthe
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 133 - 141 Title/Abstract Full Text View citing articles Show Details
Briejer, Michel R.; Akkermans, Louis M. A.; Lefebvre, Romain A.; Schuurkes, Jan A. J.
European Journal of Pharmacology, 1995 , vol. 279, # 2-3 p. 123 - 134 Title/Abstract Full Text View citing articles Show Details
Messori; Rizzi; Candura; Lucchelli; Balestra; Tonini
British Journal of Pharmacology, 1995 , vol. 115, # 4 p. 677 - 683 Title/Abstract Full Text View citing articles Show Details
Molderings; Froelich; Likungu; Goethert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 272 - 280 Title/Abstract Full Text View citing articles Show Details
Kitazawa, Takio; Kubo, Osamu; Satoh, Masami; Taneike, Tetsuro
British Journal of Pharmacology, 1998 , vol. 123, # 2 p. 173 - 182 Title/Abstract Full Text View citing articles Show Details
Bach; Bach, Trond; Syversveen; Syversveen, Trygve; Kvingedal; Kvingedal, Ane Marit; Krobert; Krobert, Kurt Allen; Brattelid; Brattelid, Trond; Kaumann; Kaumann, Alberto Julio; Levy; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 2 p. 146 - 160 Title/Abstract Full Text View citing articles Show Details
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Yamada, Jun; Sugimoto, Yumi; Yoshikawa, Tomoko; Horisaka, Kazuyoshi
European Journal of Pharmacology, 1997 , vol. 323, # 2-3 p. 235 - 240 Title/Abstract Full Text View citing articles Show Details
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
1f
Fokas, Demosthenes; Patterson, Jean E.; Slobodkin, Gregory; Baldino, Carmen M.
Tetrahedron Letters, 2003 , vol. 44, # 27 p. 5137 - 5140 Title/Abstract Full Text View citing articles Show Details
1, R=CH3O, R1=R2=H
Novak; Hanania; Kovacs; Kolonits; Szantay
Synthesis, 2001 , # 1 p. 108 - 118 Title/Abstract Full Text View citing articles Show Details
8*HCl
Sapi, Janos; Patigny, Dominique; Laronze, Jean-Yves
Heterocycles, 1999 , vol. 51, # 2 p. 361 - 364 Title/Abstract Full Text View citing articles Show Details
3
Glennon, Richard A.; Bondarev, Mikhail; Roth, Bryan
Medicinal Chemistry Research, 1999 , vol. 9, # 2 p. 108 - 117 Title/Abstract Full Text View citing articles Show Details
11
Shen, Shuren; Bremont, Beatrice; Serraz, Isabelle; Andrieux, Jean; Poncet, Annie; Mathe-Allainmat, Monique; Chanut, Evelyne; Trouvin, Jean-Hugues; Langlois, Michel
European Journal of Pharmacology, 1996 , vol. 307, # 2 p. 133 - 140 Title/Abstract Full Text View citing articles Show Details
Table 1, 5-MeOT
Buhlen; Fink; Boing; Gothert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 281 - 289 Title/Abstract Full Text View citing articles Show Details
Patent-Specific Data (2) Related Markush Structure (RN)
Location in Patent
Reference
Claim
Wurtman, Richard J.; Lee, Robert K. K.
Patent: US2002/173511 A1, 2002 ; Title/Abstract Full Text Show Details
19816211
Les Laboratoires Servier
Patent: US6350757 B1, 2002 ;
Title/Abstract Full Text Show Details
Physical Data Melting Point (4) Melting Point
Solvent (Melting Point)
Comment (Melting Point)
Reference
120 °C
diethyl ether
Guengoer, Timur; Malabre, Patrice; Teulon, Jean-Marie; Camborde, Francoise; Meignen, Joelle; et al.
Journal of Medicinal Chemistry, 1994 , vol. 37, # 25 p. 4307 - 4316 Title/Abstract Full Text Show Details
121 °C
benzene
Alapishvili, M. G.; Popova, G. V.; Vorontsov, E. D.; Kireev, V. V.; Suvorov, N. N.
J. Gen. Chem. USSR (Engl. Transl.), 1983 , vol. 53, # 5 p. 1040 - 1044,919 - 923 Title/Abstract Full Text Show Details
234 - 235 °C
Quadbeck; Roehm
Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1954 , vol. 297, p. 229,233 Full Text Show Details
245 °C
ethanol
Decomp.
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Spectra NMR Spectroscopy (2) Description (NMR Spectroscopy)
Nucleus (NMR Spectroscopy)
Solvents (NMR Spectroscopy)
Chemical shifts
1H
dimethylsulfoxided6
Frequency (NMR Spectroscopy) 400 MHz
Original Text (NMR Spectroscopy)
Location
Reference
XH
Paragraph 0550
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ;
NMR (400 MHz, DMSO-i?) ? 10.60 (s, 1H), 8.01 (br, 2H), 7.27 - 7.1 1 (m, 1H), 7.05 (d, J= 2.0 Hz, 1H), 6.98 (d, J= 2.0 Hz, 1H), 6.75 - 6.62 (dd, J= 6.3 Hz, 2.0 Hz, 1H), 3.73 (s, 3H), 2.86 - 2.61 (m, 4H).
Title/Abstract Full Text Show Details
Chemical shifts
13C
dimethylsulfoxided6
101 MHz
13C
NMR (101 MHz, DMSO-i?) ? 153.29, 131.82, 128.06, 123.69, 1 12.81, 112.36, 11 1.37, 100.57, 55.76, 43.13, 30.08.
Paragraph 0550
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ; Title/Abstract Full Text Show Details
Mass Spectrometry (2) Description (Mass Spectrometry)
Location
Reference
electrospray ionisation (ESI) liquid chromatography mass spectrometry (LCMS) spectrum
Paragraph 0550
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ;
Title/Abstract Full Text Show Details
high resolution mass spectrometry (HRMS) spectrum
Paragraph 0550
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ; Title/Abstract Full Text Show Details
Bioactivity Pharmacological Data (45) 1 of 45
Comment (Pharmacological Data)
Bioactivities present
Reference
E. R. Squibb and Sons, Inc.
Patent: US4104467 A1, 1978 ; Title/Abstract Full Text Show Details
Novo Nordisk A/S
Patent: US5126363 A1, 1992 ; Title/Abstract Full Text Show Details
Eli Lilly and Company
Patent: US5688807 A1, 1997 ; Title/Abstract Full Text Show Details
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Patent: WO2002/48150 A2, 2002 ; Title/Abstract Full Text Show Details
FAUST PHARMACEUTICALS
Patent: WO2004/85392 A1, 2004 ; Title/Abstract Full Text Show Details
WARNER-LAMBERT COMPANY LLC
Patent: WO2005/100305 A1, 2005 ; Title/Abstract Full Text Show Details
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Logemann et al.
Chemische Berichte, 1955 , vol. 88, p. 1952,1954 Full Text Show Details
Quadbeck; Roehm
Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1954 , vol. 297, p. 229,233 Full Text Show Details
Misztal, Stanislaw; Bielecka, Zofia; Mokrosz, Jerzy L.
Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1991 , # 8 p. 1871 - 1874 Title/Abstract Full Text View citing articles Show Details
Elswood; Bunce
Journal of Pharmacy and Pharmacology, 1992 , vol. 44, # 3 p. 264 - 266 Title/Abstract Full Text View citing articles Show Details
Biswas, Kshetra M.; Jackson, Anthony H.; Kobaisy, Mozaina M.; Shannon, Patrick V. R.
Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992 , # 4 p. 461 - 468 Title/Abstract Full Text View citing articles Show Details
Burov, Yu. V.; Zagorevskii, V. A.; Zhukov, V. N.; Novikova, N. N.; Silenko, I. D.
Pharmaceutical Chemistry Journal, 1983 , vol. 17, # 8 p. 559 - 563 Khimiko-Farmatsevticheskii Zhurnal, 1983 , vol. 17, # 8 p. 936 - 940 Title/Abstract Full Text View citing articles Show Details
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Copinga, Swier; Tepper, Pieter G.; Grol, Cor J.; Horn, Alan S.; Dubocovich, Margarita L.
Journal of Medicinal Chemistry, 1993 , vol. 36, # 20 p. 2891 - 2898 Title/Abstract Full Text View citing articles Show Details
Alapishvili, M. G.; Popova, G. V.; Vorontsov, E. D.; Kireev, V. V.; Suvorov, N. N.
J. Gen. Chem. USSR (Engl. Transl.), 1983 , vol. 53, # 5 p. 1040 - 1044,919 - 923 Title/Abstract Full Text Show Details
Mokrosz, Maria J.; Kowalski, Piotr; Bojarski, Andrzej J.; Mokrosz, Jerzy L.
Heterocycles, 1994 , vol. 37, # 1 p. 265 - 274 Title/Abstract Full Text View citing articles Show Details
Depreux; Lesieur; Mansour; Morgan; Howell; Renard; Caignard; Pfeiffer; Delagrange; Guardiola; Yous; Demarque; Adam; Andrieux
Journal of Medicinal Chemistry, 1994 , vol. 37, # 20 p. 3231 - 3239 Title/Abstract Full Text View citing articles Show Details
Guengoer, Timur; Malabre, Patrice; Teulon, Jean-Marie; Camborde, Francoise; Meignen, Joelle; et al.
Journal of Medicinal Chemistry, 1994 , vol. 37, # 25 p. 4307 - 4316 Title/Abstract Full Text Show Details
Franks; Hardcastle; Sanger
Journal of Pharmacy and Pharmacology, 1995 , vol. 47, # 3 p. 213 - 218 Title/Abstract Full Text View citing articles Show Details
2 of 45
3 of 45
Comment (Pharmacological Data)
Bioactivities present
Reference
Kawashima; Horiguchi; Taguchi; Tuyuki; Karasawa; Araki; Hatayama
Chemical and Pharmaceutical Bulletin, 1995 , vol. 43, # 5 p. 783 - 787 Title/Abstract Full Text View citing articles Show Details
Audia, James E.; Evrard, Deborah A.; Murdoch, Gwyn R.; Droste, James J.; Nissen, Jeffrey S.; Schenck, Kathy W.; Fludzinski, Pawel; Lucaites, Virginia L.; Nelson, David L.; Cohen, Marlene L.
Journal of Medicinal Chemistry, 1996 , vol. 39, # 14 p. 2773 - 2780 Title/Abstract Full Text View citing articles Show Details
Cantrell, Amanda S.; Engelhardt, Per; Hoegberg, Marita; Jaskunas, S. Richard; Johansson, Nils Gunnar; Jordan, Christopher L.; Kangasmetsae, Jussi; Kinnick, Michael D.; Lind, Peter; Morin Jr., John M.; Muesing; Noreen, Rolf; Oeberg, Bo; Pranc, Paul; Sahlberg, Christer; Ternansky, Robert J.; Vasileff, Robert T.; Vrang, Lotta; West, Sarah J.; Zhang, Hong
Journal of Medicinal Chemistry, 1996 , vol. 39, # 21 p. 4261 - 4274 Title/Abstract Full Text View citing articles Show Details
Li, Jianxiong; Chen, Genhui; Webster, John M.
Bioorg. Med. Chem. Lett., 1997 , vol. 7, # 10 p. 1349 - 1352 Title/Abstract Full Text Show Details
Bezuglov; Manevich; Archakov; Bobrov; Kuklev; Petrukhina; Makarov; Buznikov
Russian Journal of Bioorganic Chemistry, 1997 , vol. 23, # 3 p. 190 - 198 Title/Abstract Full Text View citing articles Show Details
Yamano, Mayumi; Kamato, Takeshi; Miyata, Keiji
Arzneimittel-Forschung/Drug Research, 1997 , vol. 47, # 11 p. 1242 - 1246 Title/Abstract Full Text View citing articles Show Details
Leclerc, Veronique; Fourmaintraux, Eric; Depreux, Patrick; Lesieur, Daniel; Morgan, Peter; Howell, H. Edward; Renard, Pierre; Caignard, Daniel-Henri; Pfeiffer, Bruno; Delagrange, Philippe; Guardiola-Lemaitre, Beatrice; Andrieux, Jean
Bioorganic and Medicinal Chemistry, 1998 , vol. 6, # 10 p. 1875 - 1887 Title/Abstract Full Text View citing articles Show Details
Berner Hansen
Pharmacology and Toxicology, 1995 , vol. 76, # 2 p. 136 - 140 Title/Abstract Full Text View citing articles Show Details
Steward; Ge Jian; Stowe; Brown; Bruton; Stokes; Barnes
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 55 - 62 Title/Abstract Full Text View citing articles Show Details
Chesnoy-Marchais; Barthe
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 133 - 141 Title/Abstract Full Text View citing articles Show Details
Briejer, Michel R.; Akkermans, Louis M. A.; Lefebvre, Romain A.; Schuurkes, Jan A. J.
European Journal of Pharmacology, 1995 , vol. 279, # 2-3 p. 123 - 134 Title/Abstract Full Text View citing articles Show Details
Sapi, Janos; Patigny, Dominique; Laronze, Jean-Yves
Heterocycles, 1999 , vol. 51, # 2 p. 361 - 364 Title/Abstract Full Text View citing articles Show Details
Messori; Rizzi; Candura; Lucchelli; Balestra; Tonini
British Journal of Pharmacology, 1995 , vol. 115, # 4 p. 677 - 683 Title/Abstract Full Text View citing articles Show Details
Chesnoy-Marchais
British Journal of Pharmacology, 1996 , vol. 118, # 8 p. 2115 - 2125 Title/Abstract Full Text View citing articles Show Details
Odagaki; Fuxe
Journal of Pharmacology and Experimental Therapeutics, 1995 , vol. 274, # 1 p. 337 - 344 Title/Abstract Full Text View citing articles Show Details
Novak; Hanania; Kovacs; Kolonits; Szantay
Synthesis, 2001 , # 1 p. 108 - 118 Title/Abstract Full Text View citing articles Show Details
Shen, Shuren; Bremont, Beatrice; Serraz, Isabelle; Andrieux, Jean; Poncet, Annie; Mathe-Allainmat, Monique; Chanut, Evelyne; Trouvin, JeanHugues; Langlois, Michel
European Journal of Pharmacology, 1996 , vol. 307, # 2 p. 133 - 140 Title/Abstract Full Text View citing articles Show Details
Briejer; Schuurkes
European journal of pharmacology, 1996 , vol. 308, # 2 p. 173 - 180 Title/Abstract Full Text View citing articles Show Details
Dalpiaz, Alessandro; Borea, Pier Andrea; Gessi, Stefania; Gilli, Gastone
European Journal of Pharmacology, 1996 , vol. 312, # 1 p. 107 - 114 Title/Abstract Full Text View citing articles Show Details
Molderings; Froelich; Likungu; Goethert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 272 - 280 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
Bioactivities present
Reference
Buhlen; Fink; Boing; Gothert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 281 - 289 Title/Abstract Full Text View citing articles Show Details
Glennon, Richard A.; Bondarev, Mikhail; Roth, Bryan
Medicinal Chemistry Research, 1999 , vol. 9, # 2 p. 108 - 117 Title/Abstract Full Text View citing articles Show Details
Kitazawa, Takio; Kubo, Osamu; Satoh, Masami; Taneike, Tetsuro
British Journal of Pharmacology, 1998 , vol. 123, # 2 p. 173 - 182 Title/Abstract Full Text View citing articles Show Details
Bach; Bach, Trond; Syversveen; Syversveen, Trygve; Kvingedal; Kvingedal, Ane Marit; Krobert; Krobert, Kurt Allen; Brattelid; Brattelid, Trond; Kaumann; Kaumann, Alberto Julio; Levy; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 2 p. 146 - 160 Title/Abstract Full Text View citing articles Show Details
Fokas, Demosthenes; Patterson, Jean E.; Slobodkin, Gregory; Baldino, Carmen M.
Tetrahedron Letters, 2003 , vol. 44, # 27 p. 5137 - 5140 Title/Abstract Full Text View citing articles Show Details
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Goldhill, Ton; Porquet, Marie-France; Angel, Itzchak
European Journal of Pharmacology, 1997 , vol. 323, # 2-3 p. 229 - 233 Title/Abstract Full Text View citing articles Show Details
Yamada, Jun; Sugimoto, Yumi; Yoshikawa, Tomoko; Horisaka, Kazuyoshi
European Journal of Pharmacology, 1997 , vol. 323, # 2-3 p. 235 - 240 Title/Abstract Full Text View citing articles Show Details
Minami, Masaru; Endo, Toru; Tamakai, Hiroyuki; Ogawa, Takashi; Hamaue, Naoya; Hirafuji, Masahiko; Monma, Yoshio; Yoshioka, Mitsuhiro; Hagihara, Koichiro
European Journal of Pharmacology, 1997 , vol. 321, # 3 p. 333 - 342 Title/Abstract Full Text View citing articles Show Details
Bai, Fengju; Yin, Tinggui; Johnstone, Edward M.; Su, Chen; Varga, Gabor; Little, Sheila P.; Nelson, David L.
European Journal of Pharmacology, 2004 , vol. 484, # 2-3 p. 127 - 139 Title/Abstract Full Text View citing articles Show Details
Tuladhar; Costall; Naylor
British journal of pharmacology, 2002 , vol. 136, # 1 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
Fu, Xun; Albermann, Christoph; Zhang, Changsheng; Thorson, Jon S.
Organic Letters, 2005 , vol. 7, # 8 p. 1513 - 1515 Title/Abstract Full Text View citing articles Show Details
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Cheve, Gwenael; Duriez, Patrick; Fruchart, Jean-Charles; Teissier, Elisabeth; Poupaert, Jacques; Lesieur, Daniel
Medicinal Chemistry Research, 2002 , vol. 11, # 7 p. 361 - 379 Title/Abstract Full Text View citing articles Show Details
Rodriguez-Franco, Maria Isabel; Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Hernandez-Ledesma, Blanca; Bartolome, Begona
Journal of Medicinal Chemistry, 2006 , vol. 49, # 2 p. 459 - 462 Title/Abstract Full Text View citing articles Show Details
Schott, Yvonne; Decker, Michael; Rommelspacher, Hans; Lehmann, Jochen
Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 22 p. 5840 - 5843 Title/Abstract Full Text View citing articles Show Details
Liu, Fei; You, Qi-Dong
Synthetic Communications, 2007 , vol. 37, # 22 p. 3933 - 3938 Title/Abstract Full Text View citing articles Show Details
Wurtman, Richard J.; Lee, Robert K. K.
Patent: US2002/173511 A1, 2002 ; Title/Abstract Full Text Show Details
NEURIM PHARMACEUTICALS (1991) LTD.
Patent: US2008/132559 A1, 2008 ; Title/Abstract Full Text Show Details
BIOVITRUM AB
Patent: WO2005/48916 A2, 2005 ; Title/Abstract Full Text Show Details
4 of 45
Comment (Pharmacological Data)
Bioactivities present
Reference
Les Laboratoires Servier
Patent: US6350757 B1, 2002 ; Title/Abstract Full Text Show Details
Neurim Pharmaceuticals (1991) Ltd.
Patent: US6858642 B1, 2005 ; Title/Abstract Full Text Show Details
Yamazaki, Yoshimitsu; Kawano, Yasuhiro; Yamanaka, Akiko; Maruyama, Susumu
Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 15 p. 4178 - 4182 Title/Abstract Full Text View citing articles Show Details
NEURIM PHARMACEUTICALS (1991) LTD.
Patent: WO2007/93880 A2, 2007 ; Title/Abstract Full Text Show Details
Potapov; Polukhin; Firgang; Shestakov; Shikhaliev
Chemistry of Heterocyclic Compounds, 2012 , vol. 47, # 10 p. 1304 - 1305 Title/Abstract Full Text View citing articles Show Details
Yang, Yi; Jiang, Xueliang; Qing, Feng-Ling
Journal of Organic Chemistry, 2012 , vol. 77, # 17 p. 7538 - 7547 Title/Abstract Full Text View citing articles Show Details
Eschenbrenner-Lux, Vincent; Dückert, Heiko; Khedkar, Vivek; Bruss, Hanna; Waldmann, Herbert; Kumar, Kamal
Chemistry - A European Journal, 2013 , vol. 19, # 7 p. 2294 - 2304 Title/Abstract Full Text View citing articles Show Details
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; OZPOLAT, Bulent; LOPEZ-BERESTEIN, Gabriel; DALBY, Kevin N.; JOSE, Jiney
Patent: WO2013/63492 A1, 2013 ; Title/Abstract Full Text Show Details
Fozard; Mobarok Ali
Naunyn-Schmiedeberg's Archives of Pharmacology, 1978 , vol. 301, # 3 p. 223 - 235
Title/Abstract Full Text Show Details
UNIVERSITY OF CALCUTTA; COUNCIL OF SCIENTIFIC and INDUSTRIAL RESEARCH; Bandyopadhyay, Uday; Pal, Chinmay; Bindu, Samik; Adhikari, Susanta Sekhar
Patent: US2013/197052 A1, 2013 ; Title/Abstract Full Text Show Details
Nunez, Cristina; Silva Lopez, Carlos; Faza, Olalla Nieto; Fernandez-Lodeiro, Javier; Diniz, Mario; Bastida, Rufina; Capelo, Jose Luis; Lodeiro, Carlos
Journal of Biological Inorganic Chemistry, 2013 , vol. 18, # 6 p. 679 - 692 Title/Abstract Full Text View citing articles Show Details
Hirst; Minton; Bromidge; Moss; Latter; Riley; Routledge; Middlemiss; Price
British journal of pharmacology, 2000 , vol. 130, # 7 p. 1597 - 1605 Title/Abstract Full Text Show Details
Teitler, Milt; Scheick, Cynthia; Howard, Paul; Sullivan III, Joseph E.; Iwamura, Tatsunori; Glennon, Richard A.
Medicinal Chemistry Research, 1997 , vol. 7, # 4 p. 207 - 218 Title/Abstract Full Text View citing articles Show Details
Yeghiayan; Kelley; Kula; Campbell; Baldessarini
Pharmacology Biochemistry and Behavior, 1997 , vol. 56, # 2 p. 251 - 259 Title/Abstract Full Text View citing articles Show Details
Candura; Messori; Franceschetti; D'Agostino; Vicini; Tagliani; Tonini
British journal of pharmacology, 1996 , vol. 118, # 8 p. 1965 - 1970 Title/Abstract Full Text Show Details
Matsuyama; Sakiyama; Nei; Tanaka
Journal of Pharmacology and Experimental Therapeutics, 1996 , vol. 276, # 3 p. 989 - 995 Title/Abstract Full Text Show Details
Molderings; Frohlich; Likungu; Gothert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 272 - 280 Title/Abstract Full Text Show Details
Briejer, Michel R.; Schuurkes, Jan A.J.
European Journal of Pharmacology, 1996 , vol. 308, # 2 p. 173 - 180 Title/Abstract Full Text View citing articles Show Details
Briejer; Akkermans; Lefebvre; Schuurkes
European Journal of Pharmacology, 1995 , vol. 279, # 2-3 p. 123 - 133 Title/Abstract Full Text Show Details
Baxter; Murphy; Blackburn
British Journal of Pharmacology, 1994 , vol. 112, # 1 p. 323 - 331 Title/Abstract Full Text View citing articles Show Details
5 of 45
Comment (Pharmacological Data)
Bioactivities present
Reference
Gillon; Vitte; Lemonnier; Kato
Drug Development Research, 1994 , vol. 32, # 1 p. 42 - 49 Title/Abstract Full Text View citing articles Show Details
Medhurst; Kaumann
British journal of pharmacology, 1993 , vol. 110, # 3 p. 1023 - 1030 Title/Abstract Full Text Show Details
Beer; Middlemiss
European Journal of Pharmacology, 1993 , vol. 242, # 2 p. 195 - 198 Title/Abstract Full Text Show Details
Wilkinson; Hawkins; Beer; Hibert; Middlemiss
Neuropharmacology, 1993 , vol. 32, # 3 p. 205 - 208 Title/Abstract Full Text Show Details
Grossman; Kilpatrick; Bunce
British Journal of Pharmacology, 1993 , vol. 109, # 3 p. 618 - 624 Title/Abstract Full Text View citing articles Show Details
Johnson; Audia; Nissen; Nelson
European Journal of Pharmacology, 1993 , vol. 239, # 1-3 p. 111 - 118 Title/Abstract Full Text Show Details
Reeves; Bunce; Humphrey
British Journal of Pharmacology, 1991 , vol. 103, # 1 p. 1067 - 1072 Title/Abstract Full Text View citing articles Show Details
Elswood; Bunce; Humphrey
European Journal of Pharmacology, 1991 , vol. 196, # 2 p. 149 - 155 Title/Abstract Full Text Show Details
Lucot
European Journal of Pharmacology, 1990 , vol. 180, # 2-3 p. 193 - 199 Title/Abstract Full Text Show Details
Johnson; Mathis; Shulgin; Hoffman; Nichols
Pharmacology, biochemistry, and behavior, 1990 , vol. 35, # 1 p. 211 - 217 Title/Abstract Full Text Show Details
Schoeffter; Waeber; Palacios; Hoyer
Naunyn-Schmiedeberg's Archives of Pharmacology, 1988 , vol. 337, # 6 p. 602 - 608 Title/Abstract Full Text Show Details
Graham; Langer
Neuropharmacology, 1987 , vol. 26, # 8 p. 1093 - 1097 Title/Abstract Full Text Show Details
Markstein; Hoyer; Engel
Naunyn-Schmiedeberg's archives of pharmacology, 1986 , vol. 333, # 4 p. 335 - 341 Title/Abstract Full Text Show Details
De Vivo; Maayani
The Journal of pharmacology and experimental therapeutics, 1986 , vol. 238, # 1 p. 248 - 253 Title/Abstract Full Text Show Details
Engel; Gothert; Muller Schweinitzer; Mueller-Schweinitzer; Schlicker; Sistonen; Stadler
Naunyn-Schmiedeberg's Archives of Pharmacology, 1983 , vol. 324, # 2 p. 116 - 124 Title/Abstract Full Text Show Details
Baudry; Martres; Schwartz
Naunyn-Schmiedeberg's archives of pharmacology, 1979 , vol. 308, # 3 p. 231 - 237 Title/Abstract Full Text Show Details
Tuladhar; Costall; Naylor
British Journal of Pharmacology, 2002 , vol. 136, # 1 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
AUDIA, James, Edmund; COHEN, Marlene, Lois; GIDDA, Jaswant, Singh; NELSON, David, Lloyd, Garver; BAKER, Stephen, Richard; EZQUERRACARRERA, Jesus; LAMAS-PETEIRA, Carlos; PEDREGAL-TERCERO, Concepcion
Patent: WO2009/524200 A1, 1995 ; Title/Abstract Full Text Show Details
Full Text Show Details
Liew, Lydia P.P.; Fleming, Jessica M.; Longeon, Arlette; Mouray, Elisabeth; Florent, Isabelle; Bourguet-Kondracki, Marie-Lise; Copp, Brent R.
Tetrahedron, 2014 , vol. 70, # 33 p. 4910 - 4920 Title/Abstract Full Text View citing articles Show Details
6 of 45
Comment (Pharmacological Data)
Bioactivities present
Reference
Shimizu, Mai; Fukami, Tatsuki; Nakajima, Miki; Yokoi, Tsuyoshi
Drug Metabolism and Disposition, 2014 , vol. 42, # 7 p. 1103 - 1109 Title/Abstract Full Text View citing articles Show Details
Zhao, Xiaohu; Liu, Xiaohua; Mei, Hongjiang; Guo, Jing; Lin, Lili; Feng, Xiaoming
Angewandte Chemie - International Edition, 2015 , vol. 54, # 13 p. 4032 - 4035 Angew. Chem., 2015 , vol. 127, # 13 p. 4104 - 4107,4 Title/Abstract Full Text View citing articles Show Details
Davison, Emma K.; Sperry, Jonathan
Organic and Biomolecular Chemistry, 2015 , vol. 13, # 29 p. 7911 - 7914 Title/Abstract Full Text View citing articles Show Details
Vendrell-Navarro, Glòria; Rúa, Federico; Bujons, Jordi; Brockmeyer, Andreas; Janning, Petra; Ziegler, Slava; Messeguer, Angel; Waldmann, Herbert
ChemBioChem, 2015 , vol. 16, # 11 p. 1580 - 1587 Title/Abstract Full Text View citing articles Show Details
Jaswant S. Gidda; David L. Nelson; James E. Audia; Marlene Cohen
Patent: US5705519 A, 1998 ; Title/Abstract Full Text Show Details
James E. Audia; Marlene L. Cohen; Jaswant S. Gidda; David L. G. Nelson
Patent: US5736544 A, 1998 ; Title/Abstract Full Text Show Details
BAKER Stephen Richard; EZQUERRA-CARRERA Jesus; LAMAS-PETEIRA Carlos; AUDIA James Edmund; COHEN Marlene Lois; GIDDA Jaswant Singh; NELSON David Lloyd Garver; PEDREGAL-TERCERO Concepcion
Patent: WO1995/24200 A1, 1995 ; Title/Abstract Full Text Show Details
Megyesi, Rita; Forró, Enikő; Fülöp, Ferenc
ChemistryOpen, 2016 , vol. 5, # 3 p. 254 - 260 Title/Abstract Full Text View citing articles Show Details
Pires, Amanda do Rocio Andrade; Lecerf-Schmidt, Florine; Guragossian, Nathalie; Pazinato, Jaqueline; Gozzi, Gustavo Jabor; Winter, Evelyn; Valdameri, Glaucio; Veale, Alexander; Boumendjel, Ahcène; Di Pietro, Attilio; Pérès, Basile
European Journal of Medicinal Chemistry, 2016 , vol. 122, p. 291 - 301 Title/Abstract Full Text View citing articles Show Details
Chen, Jing; Tao, Ling-Xue; Xiao, Wei; Ji, Sha-Sha; Wang, Jian-Rong; Li, Xu-Wen; Zhang, Hai-Yan; Guo, Yue-Wei
Bioorganic and Medicinal Chemistry Letters, 2016 , vol. 26, # 15 p. 3765 - 3769 Title/Abstract Full Text View citing articles Show Details
Adhikari, Arijit A.; Chisholm, John D.
Organic Letters, 2016 , vol. 18, # 16 p. 4100 - 4103 Title/Abstract Full Text View citing articles Show Details
Saya, Jordy M.; Oppelaar, Barry; Cioc, RǍzvan C.; Van Der Heijden, Gydo; Vande Velde, Christophe M. L.; Orru, Romano V. A.; Ruijter, Eelco
Chemical Communications, 2016 , vol. 52, # 84 p. 12482 - 12485 Title/Abstract Full Text Show Details
Paoletti, Julie; Assairi, Liliane; Gelin, Muriel; Huteau, Valérie; Nahori, Marie-Anne; Dussurget, Olivier; Labesse, Gilles; Pochet, Sylvie
European Journal of Medicinal Chemistry, 2016 , vol. 124, p. 1041 - 1056 Title/Abstract Full Text Show Details
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE; PELLECCHIA, Maurizio; WU, Bainan; DE, Surya
Patent: WO2016/176562 A1, 2016 ; Title/Abstract Full Text Show Details
7 of 45
8 of 45
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Shimizu, Mai; Fukami, Tatsuki; Nakajima, Miki; Yokoi, Tsuyoshi
Drug Metabolism and Disposition, 2014 , vol. 42, # 7 p. 1103 - 1109 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2A receptor
Method (Pharmacological Data)
cloned 5-hydroxytryptamine receptor subtype; competition binding assay; <125I>(+/-)-DOI (0.2 nmol/l) used as radioligand; incubated for 15 min at 37 deg C; radioactivity determined by liquid scintillation counting
9 of 45
10 of 45
11 of 45
12 of 45
Further Details (Pharmacological Data)
DOI: 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
4.7 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2B receptor
Method (Pharmacological Data)
cloned 5-hydroxytryptamine receptor subtype; competition binding assay; <125I>(+/-)-DOI (0.2 nmol/l) used as radioligand; incubated for 15 min at 37 deg C; radioactivity determined by liquid scintillation counting
Further Details (Pharmacological Data)
DOI: 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
11 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT2C receptor
Method (Pharmacological Data)
cloned 5-hydroxytryptamine receptor subtype; competition binding assay; <125I>(+/-)-DOI (0.2 nmol/l) used as radioligand; incubated for 15 min at 37 deg C; radioactivity determined by liquid scintillation counting
Further Details (Pharmacological Data)
DOI: 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
7.5 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT1A receptor
Method (Pharmacological Data)
recombinant 5-hydroxytryptamine receptor subtype; competition binding assay; <3H>8-OH-DPAT (0.25 nmol/l) used as radioligand; Tris-HCl buffer, pH 7.4; incubated for 1 h at 27 deg C; radioactivity counted on β-counter
Further Details (Pharmacological Data)
positive control: (R)-8-hydroxy-2-(di-n-propylamino)tetralin ((R)-8-OH-DPAT; IC50 = 0.52 nmol/l)
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
1.47 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
CHO cells expressing human 5-HT1A receptor
Method (Pharmacological Data)
cloned 5-hydroxytryptamine receptor subtype; competition binding assay; <3H>8-OH-DPAT (0.25 nmol/l) used as radioligand; Tris-HCl buffer, pH 7.4; incubated for 1 h at 27 deg C; radioactivity counted on β-counter
13 of 45
14 of 45
15 of 45
16 of 45
Further Details (Pharmacological Data)
positive control: (R)-8-hydroxy-2-(di-n-propylamino)tetralin ((R)-8-OH-DPAT; EC50 = 2.59 nmol/l)
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
9.85 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
rat 5-HT2A receptor (cerebral cortex)
Method (Pharmacological Data)
5-hydroxytryptamine receptor subtype; competition binding assay; <125I>(+/-)-DOI (80 pmol/l) used as radioligand; incubated for 1 h, 23 deg C; nonspecific binding determined using 10 μmol/l methiothepin; radioactivity determined
Further Details (Pharmacological Data)
DOI: 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane; radioactivity determined by liquid scintillation counting
Type (Pharmacological Data)
IC50
Value of Type (Pharmacological Data)
5.74 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
intracellular calcium mobilization; effect on
Species or Test-System (Pharmacological Data)
rat vascular smooth muscle cells (A7r5)
Kind of Dosing (Pharmacological Data)
title comp. stored in 50 percent DMSO/50 percent ethanol and diluted 1:50 in 20 percent DMSO/20 percent ethanol
Method (Pharmacological Data)
cells cultured in 96-well plate; title comp. added; loaded in with calcium-sensitive dye; incubated for 1 h at 23 deg C; mobilization of intracellular calcium studied using fluorescence imaging plate reader
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
43.3 nmol/l
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
ocular pressure; reduction of
Species or Test-System (Pharmacological Data)
Macaca fascicularis, cynomolgus monkey
Sex
male and female
Route of Application
ocular
Concentration (Pharmacological Data)
500 μg
Kind of Dosing (Pharmacological Data)
title comp. in phosphate-buffered saline vehicle containing 0.01 percent benzalkonium chloride, 0.01 percent disodium EDTA, 0.1 percent polysorbate 80, 0.8 percent hydroxypropylmethylcellulose (pH 7.4) admin.
Method (Pharmacological Data)
conscious monkey with ocular hypertension; title comp. instilled to eye with higher intraocular pressure (other eye as control); intraocular pressure measured with pneumatonometer prior to treatment and at 1, 3, and 6 h
Further Details (Pharmacological Data)
IOP: intraocular pressure; control group: phosphate-buffered saline, pH 7.4; compound is considered efficacious in hypertensive eyes if there is a decrease from baseline IOP of at least 20 percent topical administration
Results
title comp. resulted in a marginal transient decrease of IOP (less than 20 percent); diagram
Reference
May, Jesse A.; McLaughlin, Marsha A.; Sharif, Najam A.; Hellberg, Mark R.; Dean, Thomas R.
Journal of Pharmacology and Experimental Therapeutics, 2003 , vol. 306, # 1 p. 301 - 309 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle relaxant
17 of 45
18 of 45
19 of 45
Species or Test-System (Pharmacological Data)
Hooded Lister rat terminal ileum
Sex
female
Concentration (Pharmacological Data)
Ca. 1E-07 - 0.001 mol/l
Kind of Dosing (Pharmacological Data)
dissolved in distilled water
Method (Pharmacological Data)
Bradford strain rats weighing 200-300 g; relaxation in absence and presence of fluoxetine (FL, 10 μM) from vehicle or p-chlorophenylalanine (p-CPA, 300 mg/kg for 6 d) treated rats in presence of methysergide and atropine; tissue tension isometerically
Further Details (Pharmacological Data)
ANOVA; Bonferroni Dunnett's t-test
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
4.93 - 5.12 dimensionless
Results
diagram; table; FL abolished relaxation to title comp. in tissues from vehicle-control animals but not in tissues from p-CPA-treated
Reference
Tuladhar; Costall; Naylor
British journal of pharmacology, 2002 , vol. 136, # 1 p. 150 - 156 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK293 cells (ATCC) expressing human 5-HT4(a) receptor
Method (Pharmacological Data)
in vitro; binding assays performed in 96-well, round-bottom microtitre plates with total reaction vol. of 50-200 μl, containing <3H>GR113808 with or without (control) competing title comp. and binding buffer Tris HCl (pH 7.5)
Further Details (Pharmacological Data)
incubation for 60 min at 37 deg C; harvesting, filtration, liquid scintillation counting; HEK: human embryonic kidney
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
6.5 mol/l
Results
title comp. competed with <3H>GR113808 receptor binding (diagram)
Reference
Bach; Bach, Trond; Syversveen; Syversveen, Trygve; Kvingedal; Kvingedal, Ane Marit; Krobert; Krobert, Kurt Allen; Brattelid; Brattelid, Trond; Kaumann; Kaumann, Alberto Julio; Levy; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 2 p. 146 - 160 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK293 cells (ATCC) expressing human 5-HT4(b) receptor
Method (Pharmacological Data)
in vitro; binding assays performed in 96-well, round-bottom microtitre plates with total reaction vol. of 50-200 μl, containing <3H>GR113808 with or without (control) competing title comp. and binding buffer Tris HCl (pH 7.5)
Further Details (Pharmacological Data)
incubation for 60 min at 37 deg C; harvesting, filtration, liquid scintillation counting; HEK: human embryonic kidney
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
6.6 mol/l
Results
title comp. competed with <3H>GR113808 receptor binding (diagram)
Reference
Bach; Bach, Trond; Syversveen; Syversveen, Trygve; Kvingedal; Kvingedal, Ane Marit; Krobert; Krobert, Kurt Allen; Brattelid; Brattelid, Trond; Kaumann; Kaumann, Alberto Julio; Levy; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 2 p. 146 - 160 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme; induction of
Species or Test-System (Pharmacological Data)
HEK293 cells (ATCC) expressing human 5-HT4 receptors
Concentration (Pharmacological Data)
Ca. 0.1 - 100000 nmol/l
20 of 45
Method (Pharmacological Data)
in vitro; cell homogenates from cells expressing 5-HT4(a) or 5-HT4(b) receptors were incubated with increasing conc. of title comp.; incub. for 20 min at 32 deg C; adenylyl cyclase activity measured by determ. conversion of <α-32P>ATP to <32P>cAMP
Further Details (Pharmacological Data)
effect of title comp. on adenylyl cyclase activity; cAMP formed was quantified by double-column chromatography system; HEK: human embryonic kidney
Results
title comp. activated adenylyl cyclase activ. in conc.-depend. manner in similar manner in both cells expressing 5-HT4(a) and 5-HT4(b) receptor splice variants (diagrams)
Reference
Bach; Bach, Trond; Syversveen; Syversveen, Trygve; Kvingedal; Kvingedal, Ane Marit; Krobert; Krobert, Kurt Allen; Brattelid; Brattelid, Trond; Kaumann; Kaumann, Alberto Julio; Levy; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 2 p. 146 - 160 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme; induction of
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration (Pharmacological Data)
Ca. 0.0001 - 100 μmol/l
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7d); expressed stably in HEK cells; adenylyl cyclase activity measured by determining conversion of <α-32P>ATP to <32P>cAMP; incubation at 32 deg C for 20 min
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
7.68 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Show next 20
21 of 45
22 of 45
23 of 45
Hide facts
Effect (Pharmacological Data)
enzyme; induction of
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration (Pharmacological Data)
Ca. 0.0001 - 100 μmol/l
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7b); expressed stably in HEK cells; adenylyl cyclase activity measured by determining conversion of <α-32P>ATP to <32P>cAMP; incubation at 32 deg C for 20 min
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
7.47 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
enzyme; induction of
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration (Pharmacological Data)
Ca. 0.0001 - 100 μmol/l
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7a); expressed stably in HEK cells; adenylyl cyclase activity measured by determining conversion of <α-32P>ATP to <32P>cAMP; incubation at 32 deg C for 20 min
Type (Pharmacological Data)
pEC50
Value of Type (Pharmacological Data)
7.47 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration
Ca. 1E-05 - 100 μmol/l
(Pharmacological Data)
24 of 45
25 of 45
26 of 45
27 of 45
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7a); expressed stably in HEK cells; incubation at 23 deg C for 60 min
Further Details (Pharmacological Data)
binding of <3H>5-hydroxytryptamine in the presence of title comp. (competing ligand); IC50 converted to Ki
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
9.15 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration (Pharmacological Data)
Ca. 1E-05 - 100 μmol/l
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7b); expressed stably in HEK cells; incubation at 23 deg C for 60 min
Further Details (Pharmacological Data)
binding of <3H>5-hydroxytryptamine in the presence of title comp. (competing ligand); IC50 converted to Ki
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
8.96 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK293 cell membranes
Concentration (Pharmacological Data)
Ca. 1E-05 - 100 μmol/l
Method (Pharmacological Data)
cloned human 5-HT7 receptor splice variant (5-HT7d); expressed stably in HEK cells; incubation at 23 deg C for 60 min
Further Details (Pharmacological Data)
binding of <3H>5-hydroxytryptamine in the presence of title comp. (competing ligand); IC50 converted to Ki
Type (Pharmacological Data)
pKi
Value of Type (Pharmacological Data)
9.09 dimensionless
Reference
Krobert, Kurt A.; Bach, Trond; Syversveen, Trygve; Kvingedal, Ane Marit; Levy, Finn Olav
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001 , vol. 363, # 6 p. 620 - 632 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
COS-7 cells
Method (Pharmacological Data)
h5-HT6 radioligand binding assay; 5-HT6-cDNA transfected by DEAE-dextran technique, harvested (centrifugated/washed) cells suspended in Tris-Cl/MgCl2/EDTA buffer (pH 7.40), room temp., 90 min, 1 nmol/l <3H>LSD, 10 μmol/l clozapine, title comp.
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
88 nmol/l
Reference
Glennon, Richard A.; Bondarev, Mikhail; Roth, Bryan
Medicinal Chemistry Research, 1999 , vol. 9, # 2 p. 108 - 117 Title/Abstract Full Text View citing articles Show Details
muscle relaxant
Effect (Pharmacological Data)
28 of 45
29 of 45
30 of 45
Endpoint of Effect (Pharmacological Data)
contraction amplitude
Species or Test-System (Pharmacological Data)
pig uterus circular muscle
Sex
female
Kind of Dosing (Pharmacological Data)
aq. solution; applied cumulatively to the organ bath at 3-min intervals
Method (Pharmacological Data)
circular muscle strip from the adtubal region equilibrated at 37 deg C and 2E-1 g tension; contractile activity registered; conc.-response curve constructed for title comp. in the absence or presence (30 min treatment) of 5-HT receptor antagonists
Further Details (Pharmacological Data)
sexually mature, 6-months old virgin pigs at proestrus phase; antagonists used: 30 - 300 nmol/l methiothepin, 1E-1 - 1 μmol/l metergoline, or 3E-1 - 3 μmol/l mianserin
Results
title comp. inhibited spontaneous contractions conc.-dependently; this effect was decreased by all antagonists tested in a conc.-dependent manner
Reference
Kitazawa, Takio; Kubo, Osamu; Satoh, Masami; Taneike, Tetsuro
British Journal of Pharmacology, 1998 , vol. 123, # 2 p. 173 - 182 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle relaxant
Endpoint of Effect (Pharmacological Data)
contraction amplitude
Species or Test-System (Pharmacological Data)
pig uterus circular muscle
Sex
female
Concentration (Pharmacological Data)
Ca. 0.001 - 100 μmol/l
Kind of Dosing (Pharmacological Data)
aq. solution; applied cumulatively to the organ bath at 3-min intervals
Method (Pharmacological Data)
circular muscle strip from the adtubal region suspended vertically, loaded at 2E-1 g and equilibrated at 37 deg C; contractile activity registered before and after title comp. administration
Further Details (Pharmacological Data)
sexually mature, 6-months old virgin pigs at proestrus phase; reference comp.: 5-carboxamidotryptamine (5-CT), 5-hydroxytryptamine (5-HT), (+/-)-8-hydroxy-2-(di-npropylamino)tetralin (8-OH-DPAT)
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
5.2 μmol/l
Results
title comp. decreased spontaneous contractions dose-dependently; the rank order of potency: 5-CT > 5-HT > title comp. > 8-OH-DPAT
Reference
Kitazawa, Takio; Kubo, Osamu; Satoh, Masami; Taneike, Tetsuro
British Journal of Pharmacology, 1998 , vol. 123, # 2 p. 173 - 182 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
effect on gastric emptying in rats
Reference
Yamano, Mayumi; Kamato, Takeshi; Miyata, Keiji
Arzneimittel-Forschung/Drug Research, 1997 , vol. 47, # 11 p. 1242 - 1246 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
releasing hormones
Species or Test-System (Pharmacological Data)
Sprague-Dawley rat
Sex
male
Route of Application
intraperitoneal
Concentration (Pharmacological Data)
0.5 - 5 mg/kg
Kind of Dosing (Pharmacological Data)
title comp. dissolved in saline
Method (Pharmacological Data)
serum insulin and plasma glucagon measured by radioimmunoassay 15 min after title comp. injection
Further Details (Pharmacological Data)
saline control
31 of 45
32 of 45
33 of 45
Comment (Pharmacological Data)
No effect
Reference
Yamada, Jun; Sugimoto, Yumi; Yoshikawa, Tomoko; Horisaka, Kazuyoshi
European Journal of Pharmacology, 1997 , vol. 323, # 2-3 p. 235 - 240 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
hyperglycaemic
Species or Test-System (Pharmacological Data)
Sprague-Dawley rat
Sex
male
Route of Application
intraperitoneal
Concentration (Pharmacological Data)
0.5 - 5 mg/kg
Kind of Dosing (Pharmacological Data)
title comp. dissolved in saline
Method (Pharmacological Data)
plasma glucose levels determined 15-60 min after title comp. injection
Further Details (Pharmacological Data)
saline control; sham-operated or adrenodemedullated rats; further investigations with selective 5-HT receptor antagonists: tropisetron, SDZ 205-557, methysergide, ketanserin, xylamidine and with dexamethasone
Results
title comp. induced hyperglycemia at doses above 1 mg/kg involving peripheral 5-HT2A receptors (diagram); this effect was elicited by adrenaline release from adrenal gland
Reference
Yamada, Jun; Sugimoto, Yumi; Yoshikawa, Tomoko; Horisaka, Kazuyoshi
European Journal of Pharmacology, 1997 , vol. 323, # 2-3 p. 235 - 240 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
dopamine release modulator
Species or Test-System (Pharmacological Data)
Wistar rat striatum
Sex
female
Route of Application
intracerebral
Concentration (Pharmacological Data)
10 μmol/l
Exposure Period (Pharmacological Data)
300 min
Method (Pharmacological Data)
in vivo; striatum continually perfused with artificial cerebrospinal fluid, pH 7.4, cont. 10 μM pindolol and 10 μM methysergide, using microdialysis probe implanted into striatum; dialysate dopamine analyzed by HPLC with electrochemical detection
Further Details (Pharmacological Data)
rats 150-250 g
Results
increased extracellular striatal dopamine level to maximum 220 percent; completely prevented by co-infusion of 1 μM GR113808
Reference
Steward; Ge Jian; Stowe; Brown; Bruton; Stokes; Barnes
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 55 - 62 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
dopamine release modulator
Species or Test-System (Pharmacological Data)
Wistar rat striatum
Sex
female
Concentration (Pharmacological Data)
10 μmol/l
Method (Pharmacological Data)
in vitro; striata continually perfused with Krebs buffer (cont. 50 μM tyrosine, 1.0 μM GBR12909, 1.0 μM (-)sulpiride); added title comp. in presence of 1 μM pindolol, 1 μM methysergide; dopamine in perfusate analyzed by HPLC, electrochem. detection
Further Details (Pharmacological Data)
rats 150-220 g
Results
stimulated dopamine release to maximum 214 percent of base level within first 2 min of title comp. application with subsequent decline
Reference
Steward; Ge Jian; Stowe; Brown; Bruton; Stokes; Barnes
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 55 - 62 Title/Abstract Full Text View citing articles Show Details
34 of 45
35 of 45
36 of 45
37 of 45
Effect (Pharmacological Data)
drug interaction
Species or Test-System (Pharmacological Data)
E16 rat embryos ventral spinal cord neurones
Concentration (Pharmacological Data)
1 - 100 μmol/l
Method (Pharmacological Data)
neurones were isolated enzymatically and mechanically, cultured in supplemented DMEM-F12 medium; whole-cell patch-clamp technique
Results
title compound blocked NMDA (100 μM) response at -100 mV dose dependently; external Mg ions (1 mM) reduced blocking effect; lowering NMDA conc. (to 20 μM) decreased blocking effect
Reference
Chesnoy-Marchais; Barthe
British Journal of Pharmacology, 1996 , vol. 117, # 1 p. 133 - 141 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
rat spinal neurones
Sex
female
Concentration (Pharmacological Data)
10 - 20 μmol/l
Method (Pharmacological Data)
in vitro; two-barrel perfusion system; whole-cell patch-clamp recording technique; 20 μmol/l glycine
Further Details (Pharmacological Data)
modulation of chloride responses to glycine by title comp. (5-HT receptor agonist)
Comment (Pharmacological Data)
No effect
Reference
Chesnoy-Marchais
British Journal of Pharmacology, 1996 , vol. 118, # 8 p. 2115 - 2125 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
muscle contractive
Species or Test-System (Pharmacological Data)
proximal colon from Dunkin-Hartley guinea-pig
Concentration (Pharmacological Data)
0.03 - 30 μmol/l
Method (Pharmacological Data)
400-600 g guinea-pigs of either sex sacrificed; 3 cm segments of the proximal colon mounted in organ bath (Dr Jalon sol.+1 μM methysergide; 37 deg C; O2:CO2=95:5); longitudinal contractions (LC) measured with 20 min title comp., 10 min washout cycle
Further Details (Pharmacological Data)
100 percent: LC to 3 μM methacoline; title comp. effect on LC studied
Results
monophasic conc.-LC curve; max. LC: 42.1 percent at 30 μM (graph)
Reference
Briejer; Schuurkes
European journal of pharmacology, 1996 , vol. 308, # 2 p. 173 - 180 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
human right atrial appendages
Sex
male and female
Concentration (Pharmacological Data)
1E-08 - 1E-05 mol/l
Method (Pharmacological Data)
strips of the atrial appendages incubated at 37 deg C for 60 min with (-)-(ring-2,5,6-,3H>-noradrenaline (NE), then mounted vertically in an organ bath between two platinium electrodes and superfused with NE-free soln. at 37 deg C
Further Details (Pharmacological Data)
superfusate collected in 4 min fractions; transmural electrical stimulation (2 Hz) applied to each strip after 94 (S1), 126 (S2), 158 (S3), 190 (S4) and 222 (S5) min of superfusion; strips solubilized radioactivity in the superfusate and samples detn.
Type (Pharmacological Data)
pIC50
Value of Type (Pharmacological Data)
6.40 dimensionless
Results
title comp. 5-HT receptor agonist (present 12 min before until 20 min after the onset of S3, S4 and S5 respectively) inhibited the evoked tritium overflow in a concn.dependent manner; maximum effect ca. 30 percent inhibition (pIC50 corresponds to pIC15 percent)
38 of 45
39 of 45
40 of 45
41 of 45
Reference
Molderings; Froelich; Likungu; Goethert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 272 - 280 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
guinea-pig cerebral cortex synaptosomes
Sex
male
Concentration (Pharmacological Data)
1E-11 - 1E-06 mol/l
Method (Pharmacological Data)
synaptosomes incubated with 6 - 8 nmol/l <3H>5-hydroxytryptamine (5-HT) for 30 min at 37 deg C in a buffer soln. contng. various concns. of title comp. and 100 nmol/l 8-OH-DPAT and 100 nmol/l mesulergine to mask 5-HT1A and 5-HT2c receptors resp.
Further Details (Pharmacological Data)
inhibition of specific <3H>5-HT binding by title comp. calculated; non specific binding of 5-HT (50 - 60 percent) was detn. in presence of 10 μmol/l unlabelled 5-HT
Type (Pharmacological Data)
pIC50
Value of Type (Pharmacological Data)
7.81 dimensionless
Results
title comp. 5-HT receptor agonist inhibited specific binding of <3H>5-HT in synaptosomes
Reference
Buhlen; Fink; Boing; Gothert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 281 - 289 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
guinea-pig occipitoparietal cortex slices
Sex
male
Concentration (Pharmacological Data)
1E-11 - 1E-06 mol/l
Method (Pharmacological Data)
membrane preprn. from cortex slices incubated with 6 - 8 nmol/l <3H>5-hydroxytryptamine (5-HT) for 30 min at 37 deg C in a buffer soln. contng. various concns. of title comp.
Further Details (Pharmacological Data)
incubation soln. contained 100 nmol/l 8-OH-DPAT and 100 nmol/l mesulergine to mask 5-HT1A and 5-HT2c receptors resp.; non specific binding of 5-HT (50 - 60 percent) was detn. in presence of 10 μmol/l unlabelled 5-HT
Type (Pharmacological Data)
pIC50
Value of Type (Pharmacological Data)
7.02 dimensionless
Results
title comp. 5-HT receptor agonist inhibited specific <3H>5-HT binding
Reference
Buhlen; Fink; Boing; Gothert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1996 , vol. 353, # 3 p. 281 - 289 Title/Abstract Full Text View citing articles Show Details
Comment (Pharmacological Data)
non-cumulative dose-response curves at 5-HT4 receptors in the jejunum, ileum and colon (male Wistar rats)
Reference
Franks; Hardcastle; Sanger
Journal of Pharmacy and Pharmacology, 1995 , vol. 47, # 3 p. 213 - 218 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
secretion stimulant
Species or Test-System (Pharmacological Data)
Danish Landrace/Yorkshire cross-bred pig
Sex
female
Exposure Period (Pharmacological Data)
45 min
Method (Pharmacological Data)
8-week-old fully weaned pigs, empty intestine; in vivo; tied-off loops in jejunum prepared; intraluminal addition with/without tropisetron (3-31 mmol/ml); i.p. incubation; loops removed; weighted with/without luminal fluid content
Further Details (Pharmacological Data)
final hypersecretion calculated
Results
3 mmol/ml tropisteron reduced title compound-induced hypersecretion by 30 percent; higher doses enhanced it dose-dependently
42 of 45
43 of 45
44 of 45
45 of 45
Reference
Berner Hansen
Pharmacology and Toxicology, 1995 , vol. 76, # 2 p. 136 - 140 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Dunkin-Hartley guineapig proximal colon
Sex
male and female
Concentration (Pharmacological Data)
1E-08 - 0.001 mol/l
Kind of Dosing (Pharmacological Data)
title comp., metergoline and pargyline HCl dissolved in distilled H2O; metergoline acidified with tartaric acid in stock soln. (pH >= 3)
Method (Pharmacological Data)
pig (400-600 g) killed; proximal colon removed; relaxation induced by title comp. in absence/presence of antagonists; ketanserin and tropisetron used (to block contractions mediated by 5-HT2A,3,4 receptors) and strips precontracted with methacholine
Further Details (Pharmacological Data)
antagonists: 3-30 nM metergoline and 1-10 μM pargyline; concentration-relaxation curve; relaxation expressed as percentage of relaxation induced by 10 μM 5hydroxytryptamine
Results
title comp. alone induced relaxation yielding biphasic concentration-response curve with pEC50 = 6.16; metergoline inhibited relaxation with pA2 = 9.3; pargyline depressed curve slightly, but no shift to left
Reference
Briejer, Michel R.; Akkermans, Louis M. A.; Lefebvre, Romain A.; Schuurkes, Jan A. J.
European Journal of Pharmacology, 1995 , vol. 279, # 2-3 p. 123 - 134 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
neuromuscular
Species or Test-System (Pharmacological Data)
guinea-pig
Sex
male
Concentration (Pharmacological Data)
0.1 - 30 μmol/l
Method (Pharmacological Data)
in vitro; isolated detrusor strips from guinea-pigs (weighing 400-600 g) urinary bladder; cumulative admin. of title comp.; contractile responses to electrical field stimulation
Further Details (Pharmacological Data)
conc.-response curve
Results
cocn.-dependent increase in the amplitude of twitch contractions; monophasic conc.-response profile; maximum effect 30 percent of that elicited by 30 μM 5-HT
Reference
Messori; Rizzi; Candura; Lucchelli; Balestra; Tonini
British Journal of Pharmacology, 1995 , vol. 115, # 4 p. 677 - 683 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
agonist
Species or Test-System (Pharmacological Data)
Sprague-Dawley rat hippocampal membrane
Sex
male
Concentration (Pharmacological Data)
1 - 10000 nmol/l
Kind of Dosing (Pharmacological Data)
dose in 25 μl assay buffer
Method (Pharmacological Data)
rat weight 200 - 250 g; decapitation; hippocampal membrane isolation; title comp. 15 min incubation at 30 deg C with 0.3 μmol/l <γ-32P>GTP and 2 mmol/l MgCl2; <32P>phosphate determined by liquid scintillation
Further Details (Pharmacological Data)
GTP hydrolysis by high-affinity GTPase in 5-HT1A receptor-coupled G protein
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
25 nmol/l
Results
title comp. dose-dependently and saturably increased the enzyme activity (concentration-response curve given); correlation with inhibition of forskolin-stimulated adenylyl cyclase activity in guinea pig hippocampal membranes (diagram)
Reference
Odagaki; Fuxe
Journal of Pharmacology and Experimental Therapeutics, 1995 , vol. 274, # 1 p. 337 - 344 Title/Abstract Full Text View citing articles Show Details
Comment
agonistic activity at the relaxant 5-hydroxytryptamine receptor in guinea-pig proximal colon in vitro
(Pharmacological Data) Elswood; Bunce
Journal of Pharmacy and Pharmacology, 1992 , vol. 44, # 3 p. 264 - 266 Title/Abstract Full Text View citing articles Show Details
Reference
Chemical Name: 5-methoxytryptamine-α,α,β,β-d4 hydrochloride
3 prep out of 6 reactions.
Identification Physical Data (1)
1
1 prep out of 1 reactions.
1
no reactions.
Bioactivity (1)
1
Reaxys Registry Number: 6455581
Type of Substance: heterocyclic Molecular Formula: C11H14N2O*ClH Linear Structure Formula: C11H10(2)H4N2O*ClH
5
Molecular Weight: 230.674
InChI Key: TXVAYRSEKRMEIF-HGFPCDIYSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine-α,α,β,β-d4 hydrochloride Identification Substance Label (1) Label
Reference
2-d&4%*HCl
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Physical Data Melting Point (1) Melting Point
Reference
230 - 236 °C
Gynther, Jukka; Peura, Pekka; Salmi, Seija
Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1985 , vol. 39, # 10 p. 849 - 860 Title/Abstract Full Text Show Details
Chemical Name: 5-methoxytryptamine fumarate
6
Reaxys Registry Number: 27624294
Molecular Formula: 0C4H4O4*C11H14N2O Linear Structure Formula: C11H14N2O*0.5C4H4O4
Molecular Weight: 248.282
InChI Key: XSFMPYDOHNPOAU-WLHGVMLRSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine fumarate Reaxys Registry Number: 25299318
Molecular Formula: C3H6O*C11H14N2O Linear Structure Formula: C3H6O*C11H14N2O Molecular Weight: 248.325
InChI Key: GDVJVELABUDPII-UHFFFAOYSA-N
7
Synthesize | Hide Details Find similar
Bioactivity Pharmacological Data (1) 1 of 1
Comment (Pharmacological Data)
Bioactivities present
Reference
Bedini, Annalida; Lucarini, Simone; Spadoni, Gilberto; Tarzia, Giorgio; Scaglione, Francesco; Dugnani, Silvana; Pannacci, Marilou; Lucini, Valeria; Carmi, Caterina; Pala, Daniele; Rivara, Silvia; Mor, Marco
Journal of Medicinal Chemistry, 2011 , vol. 54, # 24 p. 8362 - 8372 Title/Abstract Full Text View citing articles Show Details
Chemical Name: 5-Methoxytryptamine oxalate
8
Reaxys Registry Number: 9815206
Type of Substance: heterocyclic Molecular Formula: C2H2O4*C11H14N2O Linear Structure Formula: C11H14N2O*C2H2O4
Molecular Weight: 280.28
InChI Key: NMPVCLWZRQMCBX-UHFFFAOYSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-Methoxytryptamine oxalate Identification Substance Label (1) Label
Reference
3
Dukat, Malgorzata; Smith, Carol; Herrick-Davis, Katharine; Teitler, Milt; Glennon, Richard A.
Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 10 p. 2545 - 2552 Title/Abstract Full Text View citing articles Show Details
Bioactivity Pharmacological Data (2)
1 of 2
Comment (Pharmacological Data)
Bioactivities present
Reference
Dukat, Malgorzata; Smith, Carol; Herrick-Davis, Katharine; Teitler, Milt; Glennon, Richard A.
Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 10 p. 2545 - 2552 Title/Abstract Full Text View citing articles Show Details
Lyon; Titeler; Seggel; Glennon
European Journal of Pharmacology, 1988 , vol. 145, # 3 p. 291 - 297 Title/Abstract Full Text Show Details
no reactions.
Identification Bioactivity (2)
2
2 of 2
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
HEK cell membranes
Method (Pharmacological Data)
radioligand binding assay; in triplicate; assay tubes containing membranes, 2.5 nmol/l <3H>5-HT and varying concentrations of title comp. incubated for 20 min at 37 deg C; suspensions filtered and counted in liquid scintillation counter
Further Details (Pharmacological Data)
HEK cells stably expressing human 5-HT1E receptor; methiothepin (10 μmol/l) used to define nonspecific binding; 5-HT, serotonin
Type (Pharmacological Data)
Ki
Value of Type (Pharmacological Data)
945 nmol/l
Reference
Dukat, Malgorzata; Smith, Carol; Herrick-Davis, Katharine; Teitler, Milt; Glennon, Richard A.
Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 10 p. 2545 - 2552 Title/Abstract Full Text View citing articles Show Details
Chemical Name: 2-(5-methoxy-indol-3-yl)-ethylamine; benzoate
9
no reactions.
Physical Data (1)
1
no reactions.
Physical Data (1)
1
Reaxys Registry Number: 3802208
CAS Registry Number: 99001-06-6 Type of Substance: heterocyclic Molecular Formula: C7H6O2*C11H14N2O Linear Structure Formula: C11H14N2O*C7H6O2
Molecular Weight: 312.368
InChI Key: MFZCXYYOGDAULP-UHFFFAOYSA-N
Synthesize | Hide Details Find similar Chemical Names and Synonyms 2-(5-methoxy-indol-3-yl)-ethylamine; benzoate, 2-(5-Methoxy-indol-3-yl)-aethylamin; Benzoat Physical Data Melting Point (1) Melting Point
Solvent (Melting Point)
Reference
161 - 162 °C
ethanol
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Chemical Name: 2-(5-methoxy-indol-3-yl)-ethylamine; phenyl acetate Reaxys Registry Number: 3814177
CAS Registry Number: 110049-62-2 Type of Substance: heterocyclic Molecular Formula: C8H8O2*C11H14N2O Linear Structure Formula: C11H14N2O*C8H8O2
Molecular Weight: 326.395
InChI Key: CDGGZLFLSZIGRO-UHFFFAOYSA-N
10
Synthesize | Hide Details Find similar Chemical Names and Synonyms 2-(5-methoxy-indol-3-yl)-ethylamine; phenyl acetate, 2-(5-Methoxy-indol-3-yl)-aethylamin; Phenylacetat
Physical Data Melting Point (1) Melting Point
Reference
160 °C
Protiva et al.
Collection of Czechoslovak Chemical Communications, 1959 , vol. 24, p. 83,86 Full Text View citing articles Show Details
Reaxys Registry Number: 4081154
Type of Substance: heterocyclic Molecular Formula: C4H6O6*C11H14N2O Linear Structure Formula: C11H14N2O*C4H6O6
Molecular Weight: 340.333
InChI Key: KBTLGXRIOAEQSC-UHFFFAOYSA-N
1 prep out of 1 reactions.
Physical Data (1)
1
no reactions.
Identification Physical Data (2)
1
11
Synthesize | Hide Details Find similar
Physical Data Melting Point (1) Melting Point
Reference
166 - 167 °C
Grandberg; Bobrova
Chemistry of Heterocyclic Compounds (New York, NY, United States), 1973 , vol. 9, p. 196,199 Khimiya Geterotsiklicheskikh Soedinenii, 1973 , vol. 9, p. 213 Full Text Show Details
Reaxys Registry Number: 4086947
CAS Registry Number: 61580-19-6 Type of Substance: heterocyclic Molecular Formula: C10H9NO2*C11H14N2O Linear Structure Formula: C11H14N2O*C10H9NO2
Molecular Weight: 365.432
InChI Key: IKWQFQKTPLUXLD-UHFFFAOYSA-N
12
Synthesize | Hide Details Find similar
Identification Substance Label (1) Label
Reference
1:1-Komplex
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Physical Data Crystal Phase (2)
Description (Crystal Phase)
Reference
Crystal structure determination
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Solid state structure properties
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Reaxys Registry Number: 4094269
CAS Registry Number: 61580-18-5 Type of Substance: heterocyclic Molecular Formula: C11H11NO3*C11H14N2O Linear Structure Formula: C11H14N2O*C11H11NO3
Molecular Weight: 395.458
InChI Key: BDSFUASXKXVQMG-UHFFFAOYSA-N
no reactions.
Identification Physical Data (2)
1
1
13
Synthesize | Hide Details Find similar
Identification Substance Label (1) Label
Reference
1:1-Komplex
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Physical Data Crystal Phase (2) Description (Crystal Phase)
Reference
Crystal structure determination
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Solid state structure properties
Sakaki et al.
Acta Crystallographica, Section B: Structural Crystallography and Crystal Chemistry, 1976 , vol. 32, p. 3235,3238 Full Text Show Details
Chemical Name: 5-methoxytryptamine-α-lipoic acid Reaxys Registry Number: 30176300
Molecular Formula: C8H14O2S2*C11H14N2O Linear Structure Formula: C8H14O2S2*C11H14N2O Molecular Weight: 396.575
InChI Key: HKCOYJZESXPKIC-UHFFFAOYSA-N
14
Synthesize | Hide Details Find similar Chemical Names and Synonyms
no reactions.
5-methoxytryptamine-α-lipoic acid Chemical Name: 5-methoxytryptamine picrate
no reactions.
Reaxys Registry Number: 3867724
CAS Registry Number: 18658-01-0 Type of Substance: heterocyclic Molecular Formula: C6H3N3O7*C11H14N2O Linear Structure Formula: C11H14N2O*C6H3N3O7
Molecular Weight: 419.351
InChI Key: QIDMYKQXCMDJHZ-UHFFFAOYSA-N
15
Identification Physical Data (10)
5
Synthesize | Hide Details Find similar Chemical Names and Synonyms 5-methoxytryptamine picrate, 2-(5-methoxy-indol-3-yl)-ethylamine; picrate, 2-(5-Methoxy-indol-3-yl)-aethylamin; Picrat Identification Substance Label (1) Label
Reference
4
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058 Title/Abstract Full Text Show Details
Physical Data Melting Point (4)
Melting Point
Solvent (Melting Point)
Comment (Melting Point)
Reference
219 °C
ethanol
Decomp.
Abramovitch; Shapiro
Journal of the Chemical Society, 1956 , p. 4589,4591 Full Text Show Details
220 - 221 °C
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
220 °C
Decomp.
Wieland et al.
Justus Liebigs Annalen der Chemie, 1934 , vol. 513, p. 1,18 Full Text Show Details
214 - 215 °C
Decomp.
Spaeth; Lederer
Chemische Berichte, 1930 , vol. 63, p. 2102,2106 Full Text View citing articles Show Details
Density (1) Density
Type (Density)
Reference
1.469 g·cm-3
crystallographic
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058 Title/Abstract Full Text Show Details
Crystal Phase (1) Description (Crystal Phase) Crystal structure determination
Comment (Crystal Phase)
Reference
α=90 grad, β=91.9 grad, χ=90 grad, a=25.09 Angstroem, b=6.72 Angstroem, c=22.51 Angstroem, n=8. Temperature: 293 K. Method of determination: X-ray Diffraction
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058
Title/Abstract Full Text Show Details
Crystal Property Description (1) Colour & Other Properties
Reference
dunkelrot
Hoshino; Kobayashi
Justus Liebigs Annalen der Chemie, 1935 , vol. 516, p. 81,88 Justus Liebigs Annalen der Chemie, 1935 , vol. 520, p. 11,19 Full Text Show Details
Crystal System (1) Crystal System
Reference
monoclinic
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058 Title/Abstract Full Text Show Details
Interatomic Distances and Angles (1) Description
Reference
Interatomic distances and angles
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058 Title/Abstract Full Text Show Details
Space Group (1) Space Group
Reference
15
Nagata, Hiroomi; In, Yasuko; Doi, Mitsunobu; Ishida, Toshimasa; Wakahara, Akio
Acta Crystallographica, Section B: Structural Science, 1995 , vol. 51, # 6 p. 1051 - 1058 Title/Abstract Full Text Show Details
Chemical Name: 1:1 complex 5-methoxytryptamine*iodine
no reactions.
Reaxys Registry Number: 7781291
Type of Substance: heterocyclic Molecular Formula: C11H14N2O*I2
Linear Structure Formula: C11H14N2O*I2
Molecular Weight: 444.054
InChI Key: NGMFNSSBEOGTGD-UHFFFAOYSA-N
16
Synthesize | Hide Details Find similar Chemical Names and Synonyms 1:1 complex 5-methoxytryptamine*iodine Physical Data Electrochemical Behaviour (1) Description (Electrochemical Behaviour)
Reference
Stability constant
Abu-Eittah; Abdou
Journal de Chimie Physique et de Physico-Chimie Biologique, 1996 , vol. 93, # 11-12 p. 1958 - 1973 Title/Abstract Full Text View citing articles Show Details
Other Thermochemical Data (1) Description (Other Thermochemical Data)
Reference
Enthalpy
Abu-Eittah; Abdou
Physical Data (2)
1
17
Journal de Chimie Physique et de Physico-Chimie Biologique, 1996 , vol. 93, # 11-12 p. 1958 - 1973 Title/Abstract Full Text View citing articles Show Details
Chemical Name: 5-methoxytryptamine; tetrodotoxin; mixture of
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole Spheroidine
no reactions.
Bioactivity (2)
1
Reaxys Registry Number: 8192297 Type of Substance: mixture (composition partially given)
Hide Details Chemical Names and Synonyms 5-methoxytryptamine; tetrodotoxin; mixture of Composition
Spheroidine
3-(2-aminoethyl)-5-methoxyindole
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
18
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
tetrodoxin: 10 μM; 5-methoxytryptamine: 100 μM
Method (Pharmacological Data)
rats of 230-250 g; paired sheets of intact and stripped ileum; effect of tetrodoxin on potential difference (PD), short-circuit current (SCC) and tissue resistance generated in intact and stripped sheets in presence of 5-methoxytryptamine assessing
Further Details (Pharmacological Data)
incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; title comps. adding to serosal fluid; serosal fluid contained 10 mM glucose, mucosal fluid contained 10 mM mannitol
Results
tetrodoxin inhibited the response in SCC to 5-methoxytryptamine by 54 percent in intact sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole 5-hydroxytryptamine creatinine sulfate Hide Details
Chemical Name: 5-hydroxytriptamine; 5-methoxytryptamine; mixture of Reaxys Registry Number: 8192298 Type of Substance: mixture (composition partially given)
no reactions.
Bioactivity (2)
1
Chemical Names and Synonyms 5-hydroxytriptamine; 5-methoxytryptamine; mixture of Composition 5-hydroxytryptamine creatinine sulfate
3-(2-aminoethyl)-5-methoxyindole
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
19
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
two consecutive application to 100 μM of 5-methoxytryptamine; 100 μM 5-hydroxytryptamine
Method (Pharmacological Data)
paired sheets of intact and stripped ileum; effect of 5-methoxytryptamine on 5-hydroxytryptamine induced increase in short-circuit current (SCC) generated in intact and stripped sheets
Further Details (Pharmacological Data)
rats of 230-250 g; incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; pre-exposure to two consecutive application of 5methoxytriptamine with 10 min intervals; then response to 5-hydroxytryrtamine registering
Results
previous exposure to 5-methoxytryptamine led to significant reduction of 5-hydroxytryptamine-induced increase in SCC in intact sheets and to complete abolishing in stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole 1-phenylbiguanide Hide Details
Chemical Name: 5-methoxytryptamine; 1-phenylbiguanide; mixture of Reaxys Registry Number: 8192300 Type of Substance: mixture (composition partially given)
Chemical Names and Synonyms 5-methoxytryptamine; 1-phenylbiguanide; mixture of Composition 3-(2-aminoethyl)-5-methoxyindole
1-phenylbiguanide
no reactions.
Bioactivity (2)
1
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
20
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
two consecutive application of comps. both at concn. of 100 μM with 10 min interval
Method (Pharmacological Data)
rats of 230-250 g; paired sheets of intact and stripped ileum; effect of title comp. on short-circuit current (SCC) generated in intact and stripped sheets; repeated application to assess desensitization
Further Details (Pharmacological Data)
incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; title comp. adding to serosal fluid; serosal fluid contained 10 mM glucose, mucosal fluid contained 10 mM mannitol
Results
increase in SCC both in intact and stripped sheets after first application: 43 and 54.5 μA cm-2, resp.; loss of response after second application in both intact and stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole 1-phenylbiguanide 5-hydroxytryptamine creatinine sulfate Hide Details
Chemical Name: 5-hydroxytriptamine; 5-methoxytryptamine; 1-phenylbiguanide; mixture of
no reactions.
Bioactivity (2)
Reaxys Registry Number: 8192301 Type of Substance: mixture (composition partially given)
Chemical Names and Synonyms 5-hydroxytriptamine; 5-methoxytryptamine; 1-phenylbiguanide; mixture of Composition 3-(2-aminoethyl)-5-methoxyindole
1-phenylbiguanide
5-hydroxytryptamine creatinine sulfate
1
Synthesize
Synthesize
Synthesize
Find similar
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
21
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
two consecutive application to 100 μM of 1-phenylbiguanide and 5-methoxytryptamine; 100 μM 5-hydroxytryptamine
Method (Pharmacological Data)
paired sheets of intact and stripped ileum; effect of combined application of phenylbiguanide and 5-methoxytryptamine on 5-hydroxytryptamine induced increase in short-circuit current (SCC) generated in intact and stripped sheets
Further Details (Pharmacological Data)
rats of 230-250 g; incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; pre-exposure to 1-phenylbiguanide + 5-methoxytriptamine with 10 min intervals; then response to 5-hydroxytryrtamine registering
Results
previous exposure to a combination of 1-phenylbiguanide and 5-methoxytryptamine led to almost complete abolishing of 5-hydroxytryptamine-induced increase in SCC in both intact and stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione Hide Details
Chemical Name: 5-methoxytryptamine; ketanserin; mixture of
no reactions.
Reaxys Registry Number: 8192309 Type of Substance: mixture (composition partially given)
Chemical Names and Synonyms 5-methoxytryptamine; ketanserin; mixture of Composition 3-(2-aminoethyl)-5-methoxyindole
3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)quinazolinedione
Bioactivity (2)
1
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
22
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
ketanserin: 2.5 μM; 5-methoxytryptamine: cumulative addition at concns. of 1E-8-1E-4 M
Method (Pharmacological Data)
rats of 230-250 g; paired sheets of intact and stripped ileum; effect of ketanserin on potential difference (PD), short-circuit current (SCC) and tissue resistance generated in intact and stripped sheets in presence of 5-methoxytryptamine assessing
Further Details (Pharmacological Data)
incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; title comps. adding to serosal fluid; serosal fluid contained 10 mM glucose, mucosal fluid contained 10 mM mannitol
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
3.5 - 22.3 μmol/l
Results
ketanserin induced a small but significant increase in EC50 for 5-metoxytryptamine to 22.3 μM compared to 18.8 μM of 5-methoxytryptamine alone in intact sheets, but was without effect in stripped sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
3-(2-aminoethyl)-5-methoxyindole tropisetron Hide Details
Chemical Name: 5-methoxytryptamine; tropisetron; mixture of Reaxys Registry Number: 8192310 Type of Substance: mixture (composition partially given)
Chemical Names and Synonyms 5-methoxytryptamine; tropisetron; mixture of Composition 3-(2-aminoethyl)-5-methoxyindole
tropisetron
no reactions.
Bioactivity (2)
1
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (2) 1 of 2
2 of 2
23
Comment (Pharmacological Data)
Bioactivities present
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
Effect (Pharmacological Data)
receptor; binding activity
Species or Test-System (Pharmacological Data)
Wistar rat ileum
Sex
male
Kind of Dosing (Pharmacological Data)
tropisetron: 5 μM; 5-methoxytryptamine: cumulative addition at concns. of 1E-8-1E-4 M
Method (Pharmacological Data)
rats of 230-250 g; paired sheets of intact and stripped ileum; effect of tropisetron on potential difference (PD), short-circuit current (SCC) and tissue resistance generated in intact and stripped sheets in presence of 5-methoxytryptamine assessing
Further Details (Pharmacological Data)
incubation in Krebs bicarbonate saline at 37 deg C under 95 percent O2-5 percent CO2; title comps. adding to serosal fluid; serosal fluid contained 10 mM glucose, mucosal fluid contained 10 mM mannitol
Type (Pharmacological Data)
EC50
Value of Type (Pharmacological Data)
12.7 - 37.6 μmol/l
Results
tropisetron inhibited the response in both intact and stripped sheets, increasing the EC50 for 5-metoxytryptamine in both preparations and reducing the maximum response in intact sheets
Reference
Hardcastle
Journal of Pharmacy and Pharmacology, 1997 , vol. 49, # 11 p. 1114 - 1120 Title/Abstract Full Text View citing articles Show Details
mixture (composition partially given) :
5-hydroxy-1H-indole-3-acetic acid 3-(2-aminoethyl)-5-methoxyindole 5-OMe-DMT 3-(dimethylamino)methyl indole N-cyano-N'-(1H-indol-5-yl)guanidine
Reaxys Registry Number: 27883774 Type of Substance: mixture (composition partially given)
no reactions.
Hide Details
Composition 3-(dimethylamino)methyl indole
3-(2-aminoethyl)-5-methoxyindole
5-OMe-DMT
Bioactivity (1)
1
Synthesize
Synthesize
Synthesize
Find similar
Find similar
Find similar
5-hydroxy-1H-indole-3-acetic acid
N-cyano-N'-(1H-indol-5-yl)guanidine
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (1) 1 of 1
Comment (Pharmacological Data)
Bioactivities present
Reference
PRESIDENT AND FELLOWS OF HARVARD COLLEGE; Liberles, Stephen D.; Ferrero, David M.
Patent: US2014/221499 A1, 2014 ; Title/Abstract Full Text Show Details
24
mixture (composition partially given) :
5-methoxytryptamine B-190
Reaxys Registry Number: 29055069 Type of Substance: mixture (composition partially given)
Hide Details
Composition 5-methoxytryptamine
B-190
no reactions.
Bioactivity (1)
1
Synthesize
Synthesize
Find similar
Find similar
Bioactivity Pharmacological Data (1) 1 of 1
Comment (Pharmacological Data)
physiological behaviour discussed
Reference
Vasin; Ushakov; Antipov
Bulletin of Experimental Biology and Medicine, 2015 , vol. 159, # 5 p. 597 - 600 Title/Abstract Full Text View citing articles Show Details